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ABSTRACT OF THE DISSERTATION  
Development and Application of Fluxomics Tools for Analyzing Metabolisms in 
Non-Model Microorganisms  
by 
Xueyang Feng 
Doctor of Philosophy in Energy, Environmental and Chemical Engineering 
Washington University in St. Louis, 2012 
Professor Yinjie Tang, Chair 
 
Decoding microbial metabolism is of great importance in revealing the 
mechanisms governing the physiology of microbes and rewiring the cellular 
functions in metabolic engineering. Complementing the genomics, 
transcriptomics, proteinomics and metabolomics analysis of microbial 
metabolism, fluxomics tools can measure and simulate the in vivo enzymatic 
reactions as direct readouts of microbial metabolism. This dissertation develops 
and applies broad-scope tools in metabolic flux analysis to investigate metabolic 
insights of non-model environmental microorganisms.  
13
C-based pathway analysis has been applied to analyze specific carbon 
metabolic routes by tracing and analyzing isotopomer labeling patterns of 
different metabolites after growing cells with 
13
C-labeled substrates. Novel 
pathways, including Re-type citrate synthase in tricarboxylic acid cycle and 
. 
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citramalate pathways as an alternate route for isoleucine biosynthesis, have been 
identified in Thermoanaerobacter X514 and other environmental 
microorganisms. Via the same approach, the utilizations of diverse 
carbon/nitrogen substrates and productions of hydrogen during mixotrophic 
metabolism in Cyanothece 51142 have been characterized, and the medium for a 
slow-growing bacterium, Dehalococcoides ethenogenes 195, has been optimized. 
In addition, 
13
C-based metabolic flux analysis has been developed to 
quantitatively profile flux distributions in central metabolisms in a green sulfur 
bacterium, Chlorobaculum tepidum, and thermophilic ethanol-producing 
Thermoanaerobacter X514. The impact of isotope discrimination on 
13
C-based 
metabolic flux analysis has also been estimated.  
A constraint-based flux analysis approach was newly developed to 
integrate the bioprocess model into genome-scale flux balance analysis to 
decipher the dynamic metabolisms of Shewanella oneidensis MR-1. The sub-
optimal metabolism and the time-dependent metabolic fluxes were profiled in a 
genome-scale metabolic network. A web-based platform was constructed for 
high-throughput metabolic model drafting to bridge the gap between fast-paced 
genome-sequencing and slow-paced metabolic model reconstruction. The 
platform provides over 1,000 sequenced genomes for model drafting and diverse 
customized tools for model reconstruction. The in silico simulation of flux 
distributions in both metabolic steady state and dynamic state can be achieved via 
. 
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flux balance analysis and dynamic flux balance analysis embedded in this 
platform.  
Cutting-edge fluxomics tools for functional characterization and metabolic 
prediction continue to be developed in the future. Broad-scope systems biology 
tools with integration of transcriptomics, proteinomics and fluxomics can reveal 
cell-wide regulations and speed up the metabolic engineering of non-model 
microorganisms for diverse bioenergy and environmental applications. 
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Chapter 1 
Introduction 
1.1 Systems biology of microbial metabolism 
Microbial metabolism is a complex biological system that involves the 
interactions of thousands of genes, proteins and metabolites (1). Toward a system-
level investigation of microbial metabolism, high-throughput “omics” tools are 
being developed and applied to capture the behaviors of different metabolic 
components. Transcriptomics, proteomics and metabolomics tools have been used 
to characterize the responses of gene expressions, protein productions and 
metabolite concentrations, respectively, to metabolic perturbations. In 
complementary to the aforementioned omics tools, fluxomics analysis has become 
instrumental in the systems biology of microbial metabolism. In fluxomics study, 
the metabolite turnover rates (i.e. metabolic fluxes) are measured or predicted as a 
direct readout of the functional output of metabolism (2). By developing and 
applying diverse fluxomics tools, the novel metabolic features in environmental 
microorganisms can be revealed and the knowledge-based rewiring of cellular 
functions can be achieved in metabolic engineering.  
Fluxomics tools are often categorized into two groups based on the 
principles of design: constraint-based metabolic flux analysis and 
13
C-based 
pathway and flux analysis (Figure 1.1). Constraint-based metabolic flux analysis 
. 
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profiles the “optimal” microbial metabolisms for in silico simulations and 
predictions. Three components are utilized to find intracellular fluxes in this 
fluxomics approach: the stoichiometry of the metabolic reactions in a 
reconstructed metabolic model, an objective function based on prior knowledge of 
microbial metabolism, and a series of boundary conditions imposed on metabolic 
reactions (3). In comparison, 
13
C-based pathway and flux analysis measures in 
vivo operation of a metabolic network. It is carried out by culturing microbes with 
defined 
13
C-labeled carbon source, tracing the transitional paths of the labeled 
atoms between metabolites in the biochemical network, and analyzing the 
labeling profiles in various metabolites both qualitatively and quantitatively. 
13
C-
based pathway and flux analysis provides the most accurate readouts of microbial 
metabolisms (4).  
1.2 Constraint-based metabolic flux analysis 
Flux balance analysis (FBA) is commonly used for constraint-based 
metabolic flux analysis. To formulate a FBA problem, the metabolic model of a 
target microorganism, often in genome scale, needs to be reconstructed (3). A 
draft metabolic model is first constructed based on genome annotation, which is 
then iteratively refined by adjusting the metabolic functionality to fill the gaps 
between model simulations and experimental observations (5). From the 
reconstructed metabolic model, the stoichiometry matrix S is generated in FBA, 
with each row in S representing one metabolite and each column in S representing 
. 
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one metabolic flux. The vector of metabolic fluxes, v, follows S ∙ v = 0 under 
metabolic steady state and is constrained within feasible ranges identified from 
the physical, chemical and biological characteristics (e.g., thermodynamic 
directionality, and enzyme capacity). Since the FBA problem is normally 
underdetermined with a larger number of variables (i.e., reactions) than that of 
equations, an objective function (e.g., maximizing growth rate) is assumed for the 
microbial metabolism to pinpoint the unique flux distributions in the metabolic 
network. The FBA is constructed as a linear programming (3,6): 
 ubvlb      
0vS   s.t.
c max T v
 
where c is a vector that represents the objective function in FBA. 
As a mathematical approach for in silico simulation of microbial 
metabolism, FBA is equipped with a strong predictive capability to prove or 
disprove various assumptions in systems biology of microbial metabolism. 
However, since FBA relies on a biologically appropriate objective function to 
quantify the flow of metabolites through metabolic network, it cannot always give 
realistic metabolic readouts due to the lack of a priori knowledge of microbial 
metabolism (7).  
1.3 
13
C-based metabolic pathway and flux analysis  
. 
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The 
13
C-based metabolic pathway analysis aims at qualitative elucidation 
of metabolic pathway activity by applying isotopic labeling approaches (8). In 
general, the microbes are cultured using a carbon source with a known 
distribution of 
13
C isotopomers. As the 
13
C-labeled carbon source is being used 
for different metabolic pathways, the metabolites synthesized in microbial 
metabolism (e.g. amino acids) acquire unique labeling patterns, which are 
measured by gas chromatography–mass spectrometry (GC-MS). To elucidate the 
route for metabolites synthesis, the “fingerprinting” labeling patterns of 
metabolites are generated by tracing the 
13
C carbon transitions in the proposed 
pathway; and compared with the corresponding experimental measurements to 
reveal whether the metabolic pathway is active.  
The 
13
C-based metabolic flux analysis (
13
C-MFA) is a quantitative 
approach to identify the metabolic flux distributions under metabolic and isotopic 
steady state, in which the pool size and the 
13
C-labeling patterns of intracellular 
metabolites are invariable (4,9). By integrating isotopic labeling approach and in 
silico computation, 
13
C-MFA is formulated as an inverse problem to find a set of 
fluxes that leads to the best match of the experimentally measured isotopomer 
abundances. The nonlinear programming of 
13
C-MFA is formulated as follows 
(10,11): 
. 
5 
 
 ubvlb       
0vS   s.t.
)(
)(min 
2
0
n
i i
nii
n
vNM
v
 
where vn are the unknown fluxes to be optimized in the program, Mi are the 
measured isotopomer labeling patterns of metabolites from GC-MS, Ni are the 
corresponding model-simulated labeling patterns of metabolites, and δi are the 
corresponding standard deviation in GC-MS measurement. The unknown 
metabolic fluxes are searched to minimize ε. 
The method of 
13
C-based pathway and flux analysis allows for precise 
determinations of metabolic states in a particular growth condition. Compared to 
FBA, 
13
C-based pathway and flux analysis cannot directly predict the metabolic 
behaviors. However, it provides a physiologically reliable description of 
microbial metabolism.  
1.4 Recent advances in fluxomics 
Fluxomics study is an emerging area in systems biology. In the past 
decade, various approaches have been developed and improved to investigate the 
cellular metabolic behaviors in response to environmental and genetic 
perturbations; which yield significant achievements in both mechanistic studies of 
cell physiology and rational designs in metabolic engineering. 
. 
6 
 
1.4.1 Advances in constraint-based metabolic flux analysis   
By integrating genome annotations, gene-protein-flux (GPR) correlations, 
and experimental validations, genome-scale metabolic models are powerful 
platforms in constraint-based flux analysis and have been constructed and applied 
for various microorganisms (5). Simulations from genome-scale FBA have been 
widely used in a number of studies (12), including interpreting various “omics” 
data (13), directing hypothesis-driven discoveries (14), investigating metabolic 
network properties (15), and predicting dynamic metabolisms of microorganisms 
(16,17). Advanced computational approaches, such as MOMA (18), OptKnock 
(19), and OptStrain (20), have been developed to guide the in silico design of 
genetic manipulations in metabolic engineering. Additionally, the multi-species 
relationships in mixed cultures are starting to be analyzed by constraint-based 
metabolic flux analysis (21).  
1.4.2 Advances in 
13
C-based pathway and flux analysis   
State-of-the-art mass spectrometry technologies, such as liquid 
chromatography–mass spectrometry (LC-MS), have been developed to directly 
measure the 
13
C-labeling patterns of low-abundant and fast-turnover metabolites. 
Mass spectrometry technologies could take the snapshot of transient metabolism 
and can be used for novel pathways identification (22) and kinetic flux profiling 
(23). As an improvement to conventional 
13
C-MFA under metabolic and isotopic 
steady state, an advanced experimental and computational framework has been 
. 
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proposed and employed to quantitatively investigate intracellular metabolism 
under metabolic steady state but isotopic non-steady state (24,25). To unravel the 
time profiles of metabolic fluxes under metabolic non-steady state, several 
approaches have been developed by tracing and analyzing the 
13
C-labeling 
patterns of either fast-turnover intracellular metabolites (26), or slow-turnover 
proteinogenic amino acids (27). Additionally, pioneering fluxomics studies have 
recently been achieved to provide subpopulation-specific metabolic pathway 
usage in mixed cultures via 
13
C-MFA of reporter proteins (28).  
1.4.3 Advances in fluxomics software development   
Multiple software toolboxes have been developed to facilitate fluxomics 
studies. The hallmark of software development in constraint-based metabolic flux 
analysis is the COBRA toolbox (29), which provides a computational platform for 
model constructions and FBA studies. Other toolboxes, such as OptFlux (30), 
have facilitated advanced FBA approaches for microbial strain design. A few 
software tools for 
13
C-MFA are also available, including OpenFLUX (31) and 
FiatFlux (32). Moreover, web-based platforms have been constructed for 
metabolic model generations and FBA. For example, BioMet Toolbox is a web-
based resource for FBA and transcriptome analysis (33). Webcoli supplies diverse 
approaches for users to reconstruct a genome-scale E.coli metabolic model (34). 
Model SEED (35) has been developed to automatically generate genome-scale 
metabolic models for different microbes.  
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1.5 Scope of dissertation 
Decoding microbial metabolisms is of great importance in revealing the 
mechanisms governing the physiology of microbes and rewiring the microbial 
metabolism for bioenergy and biomaterial production. As one of the fundamental 
approaches to characterize microbial metabolism, the fluxomics tools have not yet 
been developed or applied as extensively as the other omics approaches in 
systems biology. Noteworthy hurdles are also present in fluxomics study of 
industrial biotechnology (Chapter 2). During my Ph.D. training, the 
13
C-based 
pathway analysis has been applied to a wide range of environmental 
microorganisms, including Cyanothece 51142 (36,37), Thermoanaerobacter 
X514 (38), Mycobacteria smegmatis (39), Shewanella oneidensis MR-1 (40), 
Roseobacter denitrificans (41), Heliobacterium modesticaldum (42), and 
Dehalococcoides ethenogenes 195 (43), with a cluster of novel metabolic features 
uncovered to enrich the knowledge of microbial metabolisms (Chapter 3). The 
metabolic flux distributions in a green sulfur bacterium, Chlorobaculum 
tepidumgreen (10), have been investigated by 
13
C-MFA to reveal the functionality 
of reversed TCA cycle; and the impact of isotope discrimination on 
13
C-MFA has 
been rigorously evaluated using flux analysis of heterotrophic metabolism in 
E.coli (Chapter 4). A novel computational approach has been developed to 
decipher the dynamic metabolism of Shewanella oneidensis MR-1 by integrating 
the bioprocess model with dynamic flux balance analysis (Chapter 5). In addition, 
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MicrobesFlux, a web-based platform for metabolic model drafting has been 
constructed to bridge the gap between fast-paced genome-sequencing and slow-
paced metabolic model reconstruction (Chapter 6). Several broad-scope studies 
have also been accomplished to supplement the systems biology of microbial 
metabolism; and advanced fluxomics tools are expected to be developed in future 
investigations (Chapter 7). 
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Figure 1. Fluxomic analysis of microbial metabolisms.  
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2.1 Abstract 
Metabolic flux analysis is a vital tool used to determine the ultimate output 
of cellular metabolism and thus detect biotechnologically relevant bottlenecks in 
productivity. 
13
C-based metabolic flux analysis (
13
C-MFA) and flux balance 
analysis (FBA) have many potential applications in biotechnology (1). However, 
noteworthy hurdles in fluxomics study are still present. First, several technical 
difficulties in both 
13
C-MFA and FBA severely limit the scope of fluxomics 
findings and the applicability of obtained metabolic information. Second, the 
complexity of metabolic regulation poses a great challenge for precise prediction 
and analysis of metabolic networks, as there are gaps between fluxomics results 
and other omics studies. Third, despite identified metabolic bottlenecks or sources 
of host stress from product synthesis, it remains difficult to overcome inherent 
metabolic robustness or to efficiently import and express non-native pathways. 
Fourth, product yields often decrease as the number of enzymatic steps increases. 
Such decrease in yield may not be caused by rate-limiting enzymes, but rather is 
accumulated through each enzymatic reaction. Fifth, high throughput fluxomics 
tool hasn’t been developed for characterizing non-model microorganisms and 
maximizing their application in industrial biotechnology. Refining fluxomics 
tools and understanding these obstacles will improve our ability to engineer 
highly-efficient metabolic pathways in microbial hosts.   
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2.2 Introduction 
Numerous chemical compounds, ranging from the anti-malaria drug 
artemisinin (2) to the “biofuel” butanol (3,4), have been produced with the aid of 
synthetic biology tools. The ability to efficiently synthesize natural or unnatural 
products requires a systems-level understanding of metabolism. Functional 
genomics tools such as genome sequencing, profiling of mRNA transcripts, and 
proteomics, are widely used to attain a comprehensive knowledge of how 
metabolic components (genes, proteins and metabolites) are regulated. In contrast 
to traditional omics tools, flux analysis (measurement of metabolite turnover 
rates) has become instrumental for physiological prediction and enzymatic rate 
quantification in metabolic networks (5). This technology also allows for the 
identification of metabolic interactions and the knowledge-based design of 
cellular functions. As such, one can utilize this tool to rationally modify biological 
hosts and analyze global physiological changes resulting from genetic 
modifications.  
Fluxomics, the cell-wide quantification of intracellular metabolite turnover 
rates, was first performed via Flux Balance Analysis (FBA). This method uses the 
stoichiometry of the metabolic reactions in addition to a series of physical, 
chemical and biological characteristics (thermodynamics, energy balance, gene 
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regulation, etc.) to constrain the feasible fluxes under a given objective function 
(e.g., maximal biomass production). FBA is an underdetermined model (the 
number of constraints is smaller than the number of reactions in the metabolic 
network), which may give unrealistic metabolic readout.  In spite of this 
limitation, FBA provides a useful framework for predicting a wide variety of 
cellular metabolisms. A complementary approach, 
13
C-based metabolic flux 
analysis (
13
C-MFA) allows for precise determinations of metabolic status under a 
particular growth condition. The key to 13C-MFA is isotopic labeling, whereby 
microbes are cultured using a carbon source with a known distribution of 
13
C.  By 
tracing the transition path of the labeled atoms between metabolites in the 
biochemical network, one can quantitatively determine intracellular fluxes.  
Flux analysis can not only provide genetic engineers with strategies for 
“rationally optimizing” a biological system, but also reveal novel enzymes useful 
for biotechnology applications (5). However, flux analysis platforms are still not 
routinely established in biotechnology companies. This review paper addresses 
current developments and challenges in the field of fluxomics, which may guide 
future study to bridge the gap between systems analysis of cellular metabolism 
and application in biotechnology. 
2.3 Advances and limitations in metabolic flux analysis 
2.3.1 Steady-state flux model 
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FBA and 
13
C-MFA concentrate on the stoichiometric (rather than kinetic) 
properties of metabolic networks. FBA has been widely applied to predict cell 
growth rate, product yield using different feedstocks, lethality of gene knockouts, 
and advantageous pathway modifications (6). Such a model provides general 
guidelines for metabolic engineering and thus is a viable first step towards 
improving biosynthetic yield (7). The hallmark of large scale FBA is the 
COnstraint-Based Reconstruction and Analysis Toolbox (COBRA) (8), which 
provides a general platform for fluxomics studies. 
A number of optimization algorithms and computational strategies for 
resolving in silico and in vivo inconsistencies have been proposed to improve the 
applicability of FBA (7,9). For example, incorporation of thermodynamic 
principles into FBA can constrain solution space (i.e., energy balance analysis) 
and obtain both stoichiometrically and thermodynamically feasible fluxes (1). To 
describe the “non-optimal” metabolic behaviors, FBA can use a bi-level 
optimization approach to estimate the potential trade-off between biomass 
accumulation and the yield of a desired product (10). FBA can also relax the 
objective function for maximization of the biomass and apply a Minimization of 
Metabolic Adjustment Algorithm to solve fluxes in mutant strains (1). Such an 
algorithm calculates fluxes by minimizing the difference between the wild-type 
flux distributions and the knockout-strain fluxes. Furthermore, FBA can be 
integrated with metabolic pathway analysis (MPA). MPA is a qualitative 
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technique that examines functional routes existing in a metabolic network without 
requiring knowledge of reaction rates (11). Combining MPA with FBA can 
quantitatively trace the plausible paths for optimal product synthesis, calculate 
cellular metabolism, and predict phenotypes under genetic manipulations or 
culture conditions (12). One main advantage of FBA is its capability for genome-
scale modeling (including thousands of reactions), which bridge genomic 
annotation and functional metabolic output. Accordingly, the number of FBA 
models has increased exponentially since 1999 (13).  
13
C-MFA aims to rigorously quantify pathway activities in intracellular 
metabolism by using both the isotopic labeling approach and in silico 
computation. 
13
C-MFA is accomplished by feeding microbes a 
13
C-labeled carbon 
source, measuring the enrichment pattern of the isotopomer in metabolites (e.g. 
amino acids), and deciphering the fluxes via computational routines (14). Since 
carbon fluxes through a metabolic network generate unique labeling patterns in 
metabolites, the overall flux distributions can be determined using isotopomer 
information. Advances in 
13
C-MFA, including mass spectrometry-based 
metabolomics and isotopomer modeling approaches (such as novel algorithm 
using elementary metabolite units), have been discussed in recent papers 
(5,15,16).  
Furthermore, open-source software has recently been published that 
facilitates in silico modelling. For example, WEbcoli is web-based software for 
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flux balance analysis of E.coli (17). In addition, OpenFLUX is computationally 
efficient software for 
13
C-MFA (15), which incorporates the Elementary 
Metabolite Unit (EMU) framework for calculation of isotopomer balances (18). 
User-friendly software such as this allows biologists to perform fluxomics studies 
with little programming knowledge. 
Methodologies for FBA and 
13
C-MFA share two key characteristics: the 
use of a metabolic network and the assumption of a steady metabolic state (for 
internal metabolites). However, the two techniques have different purposes. FBA 
profiles the “optimal” metabolism for the desired performance; 13C-MFA 
measures in vivo operation of a metabolic network. The two approaches to flux 
analysis are complementary when developing a rational metabolic engineering 
strategy. By comparing existent metabolic fluxes which were empirically 
determined via 
13
C-MFA to the optimal metabolisms predicted by both FBA and 
other “omics” tools (such as transcription analysis), one can deduce gene targets 
for solving biotechnologically relevant productivity bottlenecks (19). Figure 2.1 
shows that iterative flux analysis and genetic engineering of microbial hosts can 
remove competitive pathways or toxic byproducts, amplify genes encoding key 
metabolites, and balance energy metabolism (7). 
2.3.2 Metabolic control and dynamic flux analysis 
FBA and 
13
C-MFA disregard dynamic intracellular behavior. This avoids 
the difficulties in developing kinetic models and performing intracellular 
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experimental measurements. However, many biological systems may not maintain 
a meaningful metabolic (or isotopic) steady state during the fermentation process 
(20,21,22). The description of metabolic perturbation and regulatory mechanisms 
requires kinetic modeling and control theories. For example, metabolic control 
analysis (MCA) couples local enzyme kinetics with systematic behavior to predict 
the control exerted on the targeted pathways by different components (e.g. 
transcription, enzymes) (23). Although MCA is not a quantitative measurement of 
flux, MCA can pinpoint bottle-neck enzymes (enzymes having the largest effect 
on the desired flux) in a pathway and allow the analysis of steady-state 
metabolism in response to changes in the cellular environment (24). In addition to 
MCA, the cybernetic approach (a model based on process dynamics and control) 
has been introduced for study of multi-enzyme systems and metabolic regulation 
(25). By incorporating both the enzyme kinetics in pathways and the enzyme 
synthesis kinetics, the cybernetic approach emphasizes microbial process 
dynamics and control during complicated fermentations (26).  
Both MCA and the cybernetics approach focus on a simplified pathway 
network. To perform cell-wide quantitative analysis of a dynamic system, it is 
necessary to integrate the kinetic modeling with FBA and 
13
C-MFA. Dynamic 
FBA (dFBA) has been developed to illuminate changing global enzyme activities 
(27,28). To avoid ordinary differential equations and dynamic optimization for 
describing intracellular metabolism, dFBA can use the Static Optimization 
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Approach (SOA) (29) which divides the time-course into numerous small 
intervals. At each time interval, a steady-state flux is calculated under the 
assumption of fast intracellular dynamics. By combining stoichiometric FBA for 
intracellular metabolism with dynamic mass balances on extracellular substrates 
and products, it is possible to reconstruct dFBA model for genome-scale analysis 
of microbial metabolisms in industrial fermentations, where product synthesis is 
often under dynamic control (30,31).  
Recently, 
13
C-dMFA (dynamic metabolic flux analysis) has been 
developed for isotopically nonstationary cultures. To profile the flux distributions 
for fed-batch cultures (slow dynamic metabolism), isotopic pseudo-steady state 
was assumed and two dilution parameters were introduced to account for isotopic 
transients. Another approach (Kinetic Flux Profiling) for solving intracellular 
fluxes is to create
 
a sudden increase of the portion of 
13
C in the substrate feed, 
then measure time-course samples as 
13
C moves from the substrate into the 
metabolites (32). The fluxes can be calculated based on the rates of isotopic 
enrichment multiplied by the intracellular metabolite concentrations. A similar 
principle has been proposed for the flux analysis of photoautotrophic 
microorganisms (33) and E. coli in an isotopic transient phase (34). If the culture 
is under both metabolic and isotopic non-stationary state, exploratory and 
sophisticated 
13
C-dMFA (dynamic 
13
C-MFA) models have to be used to calculate 
both metabolic and isotopic kinetics (20,35,36). To solve the 
13
C-dMFA problem 
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efficiently, a set of computational algorithms have been developed for tracing 
non-stationary isotopomer labeling in response to in vivo flux distributions 
(20,35,36). The EMU (elementary metabolite unit) framework has also been 
applied in 
13
C-dMFA (18,37), because such algorithm can significantly improve 
computational times for tracing the labeling information (38). To avoid extensive 
simulation of dynamic isotopomer patterns, the SOA has to be applied by dividing 
the growth period into small time intervals (30~60 min), then the “mini” quasi-
steady state 
13
C-MFA can be applied at each time interval based on constraints 
from simultaneous isotopomer analysis of the fast turnover metabolites (39). By 
examining flux profiles over all time intervals, one can resolve the metabolic 
transients during the entire cultivation period. 
2.3.3 Technical limitations of fluxomics  
Cell-wide fluxomics tools (i.e., FBA and 
13
C-MFA) have technical 
limitations. In genome-scale FBA models, the number of constraints (i.e., the 
availability of quantitative metabolite data) is much smaller than the number of 
reactions in the metabolic network. The calculation of such underdetermined 
systems depends on objective functions where one assumes that the metabolism 
optimizes its native ‘‘goals’’ (such as biomass or co-factor production) (40). This 
optimization principle has been questioned for several reasons. First, biological 
systems (e.g., Bacillus subtilis) seem to display sub-optimal growth performance 
(41). Second, a previous study examined 11 objective functions in E. coli and 
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found no single objective function that can perfectly describe flux states under 
various growth conditions (42). For example, unlimited aerobic growth on 
glucose is best described by a nonlinear maximization of the ATP yield per flux 
unit, but nutrient-limited continuous cultures favor biomass yield as the objective 
function. Third, some native cellular processes cannot be simply described by 
FBA. For example, cyanobacterial species (i.e., Cyanothece 51142) maintain their 
circadian rhythms (e.g., nitrogen fixation and light dependent reaction activities) 
under nutrient-sufficient and continuous light conditions (43,44).  
The application of 
13
C-MFA in industrial biotechnology also has several 
bottlenecks. The most prevalent constriction occurs because current techniques 
are insufficient for measuring large-scale metabolic networks. Obtaining labeling 
information of free metabolites rather than amino acids and solving large-scale 
nonlinear flux models pose two key challenges. As a result, most obtained flux 
information is limited to central metabolism. To date, only two large-scale 
13
C-
MFA (>300 reactions) have been reported, but many fluxes in their reports cannot 
be precisely determined due to insufficient constraints (45,46). The genome-scale 
13
C-MFA is still in its infancy and requires further development of the relevant 
experimental techniques and computational tools (47). A second issue is that 
13
C-
dMFA is still poorly developed for determining dynamic metabolic behavior. It is 
difficult for rapid sampling and precise measurements of metabolites at short time 
intervals throughout the entire culture period. For example, to measure absolute 
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intracellular metabolite concentrations, one has to grow cell in fully 
13
C-labeled 
medium, then the labeled cells are extracted with quenching solvent containing 
known concentrations of unlabeled internal standards (the concentrations of 
metabolites are calculated using the isotope ratio-based approach) (48). Such 
measurement requires extremely high cost of analytical efforts including quick 
sampling, rapid metabolite extraction, and a high resolution LC-MS instrument. 
Furthermore, the time-dependent model includes ordinary differential equations 
and significantly increases the computational complexity (20,34). Third, flux 
determination assumes that enzymatic reactions are homogenous inside the cell 
and that there are no transport limitations between metabolite pools. However, 
eukaryotes have organelles (compartments) that may have diffusion limitations or 
metabolite channeling (14,49). Compartmentalization of amino acid biosynthesis 
further clouds the obtained amino acid-based labeling information (50). 
Therefore, confident 
13
C-MFA for eukaryotes not only requires the combination 
of different analytical tools (GC-MS, LC-MS and NMR) to obtain extensive 
labeling information (51), but also adequate sample processing and extraction 
methods (e.g. separation of compartments by ultracentrifugation). A fourth 
problem is that some industrial hosts and the great majority of environmental 
microbes resist cultivation in minimal media, and introducing other nutrient 
sources often significantly complicates metabolite labeling measurements and 
flux analyses (52). Finally, a microbial community demonstrates complex 
metabolic interactions between species. To date, only a few FBA models have 
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been developed for community studies (53,54). The exchange of metabolites 
among species is nearly impossible to unravel by 
13
C-MFA because complete 
separation and measurement of metabolites from a single species in a microbial 
community is impossible (5). These technical limitations in both FBA and MFA 
models are responsible for the gap between fluxomics and its applicability in 
biotechnology. 
2.4 Integration of fluxomics with other “omics” 
It is desirable to integrate the concepts of systems biology (which 
combines the readouts from transcription as well as protein/metabolite profiling) 
with fluxomics (Figure 2.2) (47). For example, 
13
C-MFA, enzyme activity assays, 
and RT-PCR analysis can be used together to study E.coli mutants’ metabolism 
(55). Additionally, the responses
 
of E. coli to genetic modification have been 
systematically examined by utilizing multiple high-throughput “omics” methods 
(56). The results illuminate relatively small changes in mRNA and proteins in 
response to genetic disruptions, which allow the cell to maintain a stable 
metabolic
 
state under changing growth conditions. A similar approach to the study 
of Synechocystis 6803 has shown that the regulation of some enzymes is sensitive 
to light conditions (57). Many other regulatory mechanisms, however, still remain 
unknown. Furthermore, global regulators in industrial microorganisms have been 
successfully identified by correlating transcript/transduction levels and metabolic 
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fluxes (58,59,60,61). The discovery of functioning regulators provides insight to 
the entire regulation in metabolic network. 
On the other hand, challenges in integrated “omics” studies are also 
present. The lack of understanding of metabolic regulation at different metabolic 
levels complicates the rational design of biological systems, which is a major 
barrier in industrial biotechnology. For example, post-transcriptional regulation 
poses a significant challenge in integrating fluxomics with other “omics” studies. 
It is well known that transcript and protein data correlate relatively well for 
specific pathways, yet this correlation can be poor in cell-wide analyses (62). 
Furthermore, most mRNA expression studies insufficiently predict enzyme 
activities or flux changes in many E. coli pathways (63). In studies on the 
adaptation of E. coli to environmental perturbations, the tricarboxylic acid cycle is 
found to correlate well with molecular changes at the transcriptional level, but 
flux alterations in other central metabolic pathways seem to be uncorrelated to 
changes in the transcriptional network (64). Because of the complexity of 
regulatory mechanisms spanning multiple cellular processes, fluxomics and other 
“omics” studies may have inconsistent observations which complicate systems-
level analyses. 
2.5 Fluxomics of microbes for industrial biotechnology  
FBA allows in silico simulations of metabolism in “industrial 
workhorses,” from which desired strains or targeted mutations can be identified. 
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13
C-MFA can assess in vivo metabolism of engineered strains under specific 
growth conditions and validate FBA results. Here, we summarize recent 
applications of FBA and 
13
C-MFA for commonly-used industrial chassis (i.e., E. 
coli, B. subtilis and S. cerevisiae) and for non-model microorganisms (i.e., less-
characterized or newly-discovered microorganisms). 
2.5.1. Escherichia coli model   
E. coli is the most commonly utilized species in fermentation industry. E. 
coli flux models were reported as early as the 1990s (65,66). For biotechnology 
applications, the Liao group first applied metabolic pathway analysis (MPA) to 
guide the genetic manipulation of E.coli strains and channel the metabolic fluxes 
from carbohydrate to the aromatic amino acid pathway (67). The Maranas group 
has integrated cell growth and product synthesis in the OptKnock toolbox (10) 
and applied it to construct high performance mutants. The computer-aided designs 
have shown improved lactic acid, succinate, and 1,3-propanediol production (68). 
FBA can predict lethality in a metabolic network where deletions of more than 
one non-essential gene mutants may trigger the death of the organism. For 
example, the Maranas group (69) analyzed the gene/reaction essentiality in a 
genome-scale model of E. coli and systemically identified possible pairs of 
synthetic lethals: non-essential genes whose simultaneous knockouts would have 
a potentially lethal effect. Incorporating information about synthetic lethality into 
the new model will curb the construction of ill-designed biological systems for 
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biotechnology. Furthermore, FBA can be used to find rate-limiting steps for 
product synthesis. For example, FBA revealed gene targets, and modification of 
those genes (i.e., knocking out the genes for pyruvate forming enzymes, over-
expression of the glyoxylate shunt and glucose transport system) resulted in more 
than a ten-fold increase in succinate production (70,71,72). FBA has also been 
used to improve genetic strategies for the overproduction of secondary 
metabolites, such as amino acids (73) and lycopene (74).  
Besides genetic strategies, FBA can provide useful information for the 
design of optimal fermentation conditions. For example, an FBA model was used 
to identify nutrient limitations during recombinant interleukin-2 (IL-2) production 
in E. coli. By supplementing specific amino acids, IL-2 production increased two-
fold in fed-batch fermentation (75). Recently, a reactor-scale dFBA model was 
developed via a Static Optimization Approach to analyze E. coli metabolism for 
the production of a biopharmaceutical drug (27). dFBA contains a steady state 
FBA model embedded within a dynamic kinetic model that describes the time 
evolution of fermentation process variables (e.g., biomass growth, glucose 
consumption and products synthesis). Such a model provided guidelines for the 
optimization of fermentations at the scale of a 1000L process. 
The 
13
C-MFA model was first used to investigate metabolic regulation in 
E.coli under different genetic and environmental conditions (76). 
13
C-MFA has 
also been used to examine various biotechnological processes involved in the 
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production of pharmaceuticals, amino acids and polymers. A large scale 
13
C-MFA 
with over 300 reactions was successfully developed for amorphadiene (a 
precursor of the anti-malaria drug) producing E. coli strains (45). Another study 
revealed a growth phase-dependent metabolic shift in a lysine-producing E. coli 
strain (77).  This work was performed in a fed-batch culture with rich medium 
(containing yeast extract), and metabolic fluxes in both exponential growth and 
stationary phases were estimated by measuring free metabolites. Metabolic 
analysis of the stationary phase is important since many products are synthesized 
during a non-growth phase. In a third example, 
13
C-MFA of a 1,3-propanediol 
producing E. coli strain was conducted in fed-batch fermentation  (78). The 
13
C-
MFA results showed a decrease in the split ratio between glycolysis and the 
pentose phosphate pathway over the time-course of the culture in response to 
increasing 1,3-propanediol fluxes.  
2.5.2 Bacillus subtilis model 
B. subtilis is the industrial organism of choice for the production of 
vitamins, antibiotics, enzymes, and nucleosides. The FBA model for B. subtilis 
was constructed based on a combination of genomic, biochemical, and 
physiological information (79). The FBA model was iteratively corrected and 
improved using information from high-throughput phenotypic screens of mutants, 
substrate utilization, gene essentiality, and sequence analyses. The B. subtilis flux 
model is mostly studied for riboflavin production, focusing on four aspects: 
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investigating phenotypes of wild type and knock-out strains, assessing production 
capacity, identifying the impact of different carbon sources on biosynthesis, and 
characterizing the cellular response to different culture conditions. The Sauer 
group has extensively investigated riboflavin-producing strains. They first used an 
FBA model to quantify growth maintenance coefficients, the maximum growth 
yield, and the specific riboflavin production rate in continuous cultivation (80). 
Later on, they applied 
13
C-MFA to the same strain and found that genetic 
manipulations should target the NADPH balance and riboflavin biosynthetic 
pathways (81). In other studies on B. subtilis, they revealed several guidelines for 
high yield riboflavin production: 1. they compared the metabolic flux 
distributions and maintenance energy of eight Bacillus strains and discovered that 
B. licheniformis was the most suitable for industrial biotechnology (82); 2. they 
found that using malate as a substrate resulted in a suppressed respiratory TCA 
cycle and an enhanced overflow metabolism (83); 3. they found the pentose 
precursors of riboflavin were mainly synthesized via the non-oxidative pentose-
phosphate pathway, so any suggested genetic modification should decrease the 
activity of the oxidative pentose phosphate pathway (84). Recently, they 
developed a 
13
C-dMFA model for B. subtilis to identify the metabolic response of 
riboflavin overproduction under a glucose-limited fed-batch culture (39). This 
dynamic flux analysis was obtained by recording changes in labeling patterns of 
intracellular amino acids under a metabolic pseudo-steady state assumption. 
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2.5.3 Saccharomyces cerevisiae model 
S. cerevisiae is a robust eukaryotic chassis used for the expression of a 
wide range of products. For example, flux analysis revealed target genes in two 
native pathways for the over-expression of succinate: the TCA and glyoxylate 
cycles (85). Another study showed the enhancement of sesquiterpene production 
via in silico driven metabolic engineering (86). Additionally, flux analysis has 
been extensively applied for improving ethanol production. First, a number of 
strategies were developed for the metabolic engineering of redox processes in S. 
cerevisiae, resulting in a decrease in the yield of glycerol by 40% and an increase 
in ethanol production under both glucose and xylose/glucose growth conditions 
(87). Second, Dikicioglu et al. (88) applied a genome-scale FBA model to analyze 
respiration-deficient mutants of S. cerevisiae for ethanol production. They found 
that many genetic manipulation strategies (e.g., the overexpression of the 
glutamate synthase gene) were unnecessary in a respiration-deficient metabolic 
background. This indicates that the rate limiting steps for ethanol production can 
change after the initial genetic manipulations of targeted genes. Third, a
 13
C-MFA 
model was used to screen ethanol production in 14 hemiascomycetous yeast 
strains (50). This study suggests that S. cerevisiae is the ideal ethanol production 
candidate due to a strong NADPH-driven pentose phosphate pathway. Other 
13
C-
MFA studies characterized the metabolic shift between oxidative growth and 
fermentative growth with ethanol production (89), investigated alternative carbon 
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substrate (xylose) metabolisms (90), revealed key factors influencing biomass 
growth on xylose (91), and examined the consumption of ethanol and other 
storage carbohydrates in a glucose-limited chemostat culture (92). 
Furthermore, a genome-scale FBA indicates an apparent enzyme 
dispensability, i.e., 80% of yeast genes seem to be non-essential for viability 
under laboratory conditions (93). The FBA illustrated the influence of non-
essential genes on metabolic robustness and environmental fitness due to genetic 
buffering through alternative genes, while a 
13
C-MFA (consisting of over 700 
reactions) revealed a similar effect of metabolic network robustness on null 
mutations (46). Understanding the role of these redundant genes is important for a 
valid and efficient genetic modification.   
2.5.4 Non-model microorganisms 
Fluxomics is an important tool for the rigorous study of metabolism in 
less-characterized microbes that provides novel insights for application of these 
species to biotechnology. However, fluxomics have not been sufficiently applied 
to non-model microorganisms as compared to model microbial hosts. Table 2.1 
summarizes some milestone papers in fluxomics studies on non-model species 
that are potentially useful for synthetic biology. Compared to the work done in the 
field of fluxomics for industrial workhorses, far fewer studies have been 
performed on non-model microorganisms.  This is due to the complicated growth 
conditions, poorly-understood metabolic networks, and significant lack of genetic 
. 
35 
 
and molecular biology tools. However, non-model environmental microorganisms 
are also important for industrial biotechnology because they often possess native 
biochemical pathways for chemical synthesis or the ability to utilize cheap 
substrates (94). Furthermore, flux analysis can be used to discover novel enzymes 
that can be cloned into industrial microbes to improve their capacity for product 
synthesis. For example, 
13
C-MFA revealed a citramalate pathway for isoleucine 
biosynthesis (independent of the common threonine ammonia-lyase pathway) 
(95,96). Citramalate synthase, which has also been detected in some 
environmental bacteria (97,98,99), can be engineered into E. coli for 1-propanol 
and 1-butanol production. The new pathway bypasses threonine biosynthesis and 
represents the shortest keto-acid-mediated pathway; as such, it improved biofuel 
yield 9 to 22-fold (100). Currently, high-throughput genome sequencing methods 
are mapping genomes in novel microbes at a pace that far exceeds the pace of 
functional characterization of these species. Therefore, a high throughput 
13
C-
MFA technique is required for screening non-model microorganisms for new 
enzymes and maximizing their application in industrial biotechnology (5). 
2.6 Finding bottlenecks for Industrial Biotechnology 
One of the main goals of fluxomics is to indentify bottlenecks for 
industrial biotechnology and thereby assist in the creation of rational engineering 
strategies. Simple measurements of metabolism, however, are not enough to 
overcome unpredictable challenges in industrial biotechnology. Metabolic 
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regulation is very complex, and systems biology tools are incapable of revealing a 
general strategy for synthetic biology (101).  
Bottlenecks in industrial biotechnology can be explained from the view of 
fluxomics. First, metabolic robustness (the ability to maintain metabolic 
performance under genetic or environmental perturbations) is a long-recognized 
key property of microbial systems (102). This basic mechanism is often 
responsible for the gap between computationally aided design and final 
experimental outcomes. For example, a 
13
C-MFA study indicates that E. coli 
shows remarkable robustness in the central carbon metabolism in the presence of 
genetic variation, and is even more flexible in response to altered environmental 
conditions (e.g., different nutrients or oxygen levels) (76). Analyses of E.
 
coli 
components at multiple “omics” levels also reveal unexpectedly small changes in 
messenger RNA, proteins and metabolite levels for most genetic disruptions.
 
This 
is because E.
 
coli actively regulates enzyme levels to maintain a stable metabolic
 
state in the presence of perturbations (56,64). Similarly, B. subtilis shows rigidity 
and suboptimal performance for its flux regulation in over 137 genetic 
backgrounds (41). Furthermore, gene essentiality and pairwise genetic 
interactions have been investigated in S. cerevisiae (93,103). It has been found 
that a gene’s function is buffered by duplication in S. cerevisiae genomic DNA or 
by an alternative biochemical pathway. Although only 13% of genes were 
suggested to be essential by single knockout experiments, simultaneous deletion 
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of pairs of non-essential genes (>70% of the total metabolic genes) were found to 
inhibit growth. Invariability of metabolic flux under mutagenic genotypes seems 
to be an important feature in many biological systems, and thus successful 
metabolic strategies highly depend on an understanding of robust cellular nature 
(104,105,106).  
Metabolic engineering of industrial chassis is based on the premise that 
the yield of a desired product can be increased by identifying and over-expressing 
the enzymes that catalyze the rate-limiting steps in a given metabolic pathway. 
However, a method based on over-expressing rate-limiting enzymes will only 
work if these rate-limiting enzymes exist and remain rate-limiting when their 
activities are increased. Previous studies have shown that the commonly-believed 
“rate-limiting” enzymes may not exist in some industrial microbes and an 
increase in productivity has to be achieved by coordinated expression of entire 
pathways (107). Furthermore, rate-limiting steps in a metabolic network often 
shift after initial targets have been engineered. For example, phenotypic data in S. 
cerevisiae mutants revealed that some FBA-predicted gene targets for ethanol 
production are invalid if the cell’s respiratory genes have been knocked-out (88). 
Another example of this phenomenon is highlighted by the metabolic 
consequences of the deletion of the methionine and cysteine biosynthesis 
repressor protein (McbR) in Corynebacterium glutamicum, which yielded no 
overproduction of methionine but drastic accumulation of homolanthionine (108). 
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The above evidence indicates that rate-limiting steps often shift after initial targets 
have been engineered. Additionally, simultaneous importation and expression of a 
few heterologous genes to improve the rate-limiting pathway may fail if the non-
native pathway is incompatible with the host. These efforts often lead to 
metabolic imbalance and accumulation of toxic metabolites (3,4).  
Based on the recent publications, we have constructed a linear regression 
model which shows that the yield of biosynthetic products decreases 
exponentially as a function of the steps away from central metabolism in S. 
cerevisiae (Figure 2.3). It is easier to achieve high carbon fluxes to the central 
metabolites, possibly because enzyme efficiency in central metabolism is usually 
high (109). However, the yields of secondary metabolites are smaller because 
each additional enzymatic step may not be perfectly efficient (model regression 
shows an average of ~67% efficiency in each enzymatic step in secondary 
metabolisms). This loss of yield is unavoidable due to the metabolism channeling 
the intermediates away from the desired product. Potential solutions to this 
problem include: 1. designing host-compatible enzymes with high product 
specificity (110); 2. feeding intermediates to the cell to reduce the number of 
enzymatic steps to final product (111); 3. creating synthetic protein scaffolds, 
which significantly improve intermediate conversion efficiency and overall 
biosynthetic yield (112). 
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In conclusion, fluxomics studies enable the quantification of intracellular 
metabolism.  However, this tool is not fully developed, and it remains difficult to 
deduce cell-wide pathway bottlenecks and to provide effective strategies for 
biotechnology applications. Numerous technical difficulties in developing flux 
analysis methods and complicated metabolic regulatory mechanisms have 
severely limited the scope of fluxomics in industrial biotechnology. It is necessary 
for the future development of flux analysis to combine other advanced “omics” 
analysis and molecular biology techniques to resolve challenges in the fluxomics 
fields.   
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Figure 2.1. An iterative approach of fluxomic analysis and rational metabolic 
engineering 
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Figure 2.2. 
13
C-assisted cellular metabolism analysis 
 
 
 
 
 
  
 
 
 
. 
54 
 
Figure 2.3. Product yields as a function of enzymatic steps from central 
metabolism. The solid line is the regression of published product yields by S. 
cerevisiae as a function of reaction steps from intermediate metabolites in central 
metabolism (including glycolysis, TCA cycle and pentose phosphate pathways).  
The yield declines exponentially as the number of reaction steps increases. The 
dotted lines are boundary curves with yield efficiencies of 30% and 70% 
respectively.  All yield data from initial carbon sources are estimated from recent 
papers using our best judgment. The synthesized products and reaction steps are: 
Poly(R-3-hydroxybutyrate) (113) (steps=3); Glycerol (114) (steps=2); 
Artemisinic acid (2) (steps=10); Amorphadiene (115) (steps=9); Pyruvate (116) 
(steps=0); Geranylgeraniol (117) (steps=10); Hydrocortisone (118) (steps=19); 
Squalene (119) (steps=9); β-carotene (120) (steps=12); Lycopene (120) 
(steps=11); Phytoene (120) (steps=10); p-hydroxycinnamic acid (121) (steps=12); 
Naringenin (122) (steps=14); Pinocembrin (122) (steps=14); Xylitol and Ribitol 
(123) (steps=3); Ethanol (124) (steps=2); L-ascorbic acid (125) (steps=8). 
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Table 2.1. Recent application of fluxomics of non-model microbes to bio-product 
synthesis 
Species Product Substrate 
Model 
description 
Results from study Reference 
Corynebacterium 
glutamicum 
Lysine 
Glucose 
(sucrose, 
fructose) 
13C-MFA 
 
MFA models 
(combining 
transcriptome, 
metabolome 
analysis) have been 
developed to study 
fluxes under 
different cultivation 
modes (mini-
bioreactor, batch, 
fed-batch) using 
various carbon 
sources. 
 
(126) 
Corynebacterium 
glutamicum 
Methionine Glucose 
13C-MFA 
only focuses 
on flux 
distribution 
in the 
methionine 
pathway. 
The C. glutamicum 
mutant (mcbR) 
showed no 
overproduction of 
methionine, but 
accumulation of 
homolanthionine. 
 
(108) 
Corynebacterium 
glutamicum 
Glutamate Glucose 
13C-MFA 
(focus on 
anaplerotic 
pathways) 
The flux from 
phosphoenolpyruvat
e to oxaloacetate 
catalyzed by 
phosphoenolpyruvat
e carboxylase 
(PEPc) was active in 
the growth phase, 
whereas pyruvate 
carboxylase was 
inactive.  
 
(127) 
Actinobacillus 
succinogenes 
 
Succinate 
formate and 
acetate 
Glucose 
NaHCO3 
13C-MFA 
(via NMR 
and GC-MS) 
and enzyme 
assay 
The model indicated: 
1. NADPH was 
produced primarily 
by transhydrogenase 
and/or by NADP-
dependent malic 
enzyme; 2. 
oxaloacetate and 
malate were 
converted to 
pyruvate; 3. the 
effects of NaHCO3 
and H2 on metabolic 
fluxes were 
quantified. 
(128,129) 
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Geobacillus 
thermoglucosidasiu
s 
Ethanol Glucose 
FBA and 13C-
MFA 
The model 
characterized the 
ethanol production 
under three oxygen 
conditions. The FBA 
analysis pointed out 
several gene targets 
for improving 
ethanol production.  
 
(19) 
Clostridium 
acetobutylicum 
Butanol Glucose 
Genome 
scale-FBA 
The engineered 
strain was able to 
produce 154 mM 
butanol with 9.9 mM 
acetone at pH 5.5, 
resulting in a butanol 
selectivity (a molar 
ratio of butanol to 
total solvents) of 
0.84. 
 
(130) 
Penicillium 
chrysogenum 
 
Penicillin 
Gluconate 
/glucose 
13C -MFA 
(focus on 
pentose 
phose phase 
pathway and 
glycolysis) 
 
The model 
determined the 
pentose phosphate 
pathway split ratio 
and estimated 
NADPH 
metabolism.  
 
(131) 
Synechocystis sp. 
PCC6803 
Hydrogen CO2 FBA 
The results included 
H2 photoproduction, 
strategies to avoid 
oxygen inhibition, 
and analysis of 
hetero-, auto-, and 
mixotrophic 
metabolisms. 
 
(132,133) 
 
Synechocystis sp. 
PCC6803 
Light energy 
& Biomass 
Glucose/CO2 
13C-MFA and 
dynamic 13C -
MFA 
The model analyzed 
heterotrophic, 
autotrophic and 
mixotrophic 
metabolisms. 
 
(33,57) 
 
Chlamydomonas 
reinhardtii 
Light energy 
& Biomass 
CO2 
FBA model 
including 
three 
metabolically 
active 
compartment
s 
The model indicated 
that heterotrophic 
growth had a low 
biomass yield on 
carbon, while 
mixotrophical and 
autotrophical growth 
had higher carbon 
utilization 
efficiency. 
 
(134) 
Zymomonas mobilis Ethanol Glucose/ FBA with Model analyzed the (135) 
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xylose various 
biological 
objectives 
metabolic 
boundaries of Z. 
mobilis. The study 
indicated that 
ethanol and biomass 
production depend 
on anaerobic 
respiration 
stoichiometry and 
activity. 
 
Zymomonas mobilis Ethanol 
Glucose 
/frucose/ 
xylose 
13C–MFA via  
1H-NMR 
31P-NMR 
spectroscopy 
The model 
characterized the 
intracellular 
metabolic state 
during growth on 
glucose, fructose and 
xylose in defined 
continuous cultures. 
 
(136) 
Coculture 
(Desulfovibrio 
vulgaris and 
Methanococcus 
maripaludis) 
CH4 Lactate 
FBA analysis 
of microbial 
consortia 
The model predicted 
the ratio of D. 
vulgaris to M. 
maripaludis cells 
during growth. It 
was possible to 
eliminate formate as 
an interspecies 
electron shuttle, but 
H2 transfer was 
essential for 
syntrophic growth. 
(54) 
Community 
(oxygenic 
phototrophs, 
filamentous 
anoxygenic 
phototrophs, and 
sulfate-reducing 
bacteria). 
Biomass and 
nitrogen 
fixation 
CO2 
FBA and 
elementary 
mode 
analysis 
The model predicted 
and described 
relative abundances 
of species, by-
products, and the 
metabolic 
interactions. 
(53) 
 
Phaffia rhodozyma 
and Haematococcus 
pluvialis 
 
Astaxanthin 
Glucose with 
(peptone & 
yeast extract) 
FBA analysis 
of mix 
culture 
The two major 
astaxanthin-
producing 
microorganisms 
exhibited elevated 
yields (2.8-fold) 
under mixed culture 
conditions compared 
to pure culture. 
 
(137) 
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Chapter 3 
 
13
C-Pathway Analysis of Environmental Microorganisms  
3.1 
13
C-pathway analysis protocol 
Novel metabolic features of environmental microorganisms can be 
revealed by 
13
C-pathway analysis. As a complementary method to transcriptomics 
and proteomics studies, 
13
C-pathway analysis can be used to uncover novel 
enzymes, investigate mixotrophic metabolism, and optimize the medium for slow-
growing microbes. A protocol for 
13
C-pathway analysis of environmental 
microorganisms is attached in Appendix 1. In general, 
13
C-pathway analysis has 
three major steps.  
 The first step is to grow microbes on 
13
C-labeled carbon substrates. Three 
key factors affect the 
13
C-pathway analysis: medium composition, 
13
C-labled 
carbon substrate, and culture modes. To avoid measurement noises from non-
labeled carbon in nutrient supplements, a minimal medium with only one 
13
C-
labeled carbon source is required in tracer experiments. To collect the 
“fingerprinting” labeling patterns of metabolites synthesized from different 
pathways, singly labeled carbon substrates (>98% pure) are normally 
recommended in 
13
C-pathway analysis. To guarantee both metabolite and 
isotopomer steady state are achieved in 
13
C-pathway analysis, microbes can either 
. 
60 
 
be cultured under chemostat mode, using typical bioreactors with continuous 
feeding, or batch mode, using shake flasks or small-scale mini-batch reactors. 
The second step is to analyze amino acid labeling patterns using GC-MS. 
Amino acids are abundant in protein and thus can be obtained from biomass 
hydrolysis. To make the amino acids volatile enough for GC separation, amino 
acids are derivatized by N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide 
(TBDMS) prior to analysis. The TBDMS-derivatized amino acids can be 
fragmented by MS and result in different arrays of fragments, including four 
characteristic arrays of fragments that can reflect the 
13
C-labeling patterns of 
amino acids: fragment (M-15)
+
, which contains the entire amino acid but has lost 
a 15 MW methyl group; fragment (M-57)
+
, which contains the entire amino acid 
but has lost a 57 MW tert-butyl group; fragment (M-159)
+
, which has lost a 159 
MW group that contains the 1
st
 carbon (α carboxyl group) of the amino acid; and 
fragment (f302)
+
, which consists of a 302 MW group containing the amino acid 
without its R group. The final isotopic labeling patterns of proteinogenic amino 
acids are reported as mass fractions, such as M0, M1, M2, M3 and M4, to 
represent the percentage of fragments containing zero to four 
13
C labeled carbons.  
The third step is to trace 
13
C carbon transition in the proposed pathways 
and to verify whether the labeling patterns in key metabolites are consistent with 
the annotated enzymatic reactions. Since errors or gaps within annotated 
pathways are common for poorly characterized microorganisms, the pathway 
. 
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activity uncovered from 
13
C-pathway analysis can be useful in functional 
characterization of metabolic pathway activities. Derived from the isotopic 
analysis of amino acids, labeling information about eight metabolites in the 
central carbon metabolism is provided and is used to reflect the functions of 
associated metabolic pathways.  
  13
C-pathway analysis is a powerful tool to probe active carbon metabolic 
pathways in vivo. Table 3.1 illustrates several carbon metabolic pathways that can 
be revealed by 
13
C-labeled proteinogenic amino acids. In cooperation with in vivo 
physiological studies, transcription assays, and in vitro biochemical 
characterizations, new insights to carbon metabolisms of organisms can be 
illustrated. 
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Table 3.1 Fingerprinting 
13
C-labeling patterns of amino acids for identifying 
novel metabolic pathways and enzymes.  
Pathways and 
enzymes  
13
C-carbon 
substrate 
Key amino 
acids 
“Fingerprinting” 
labeling patterns 
The Entner-
Duodroff (ED) 
pathway 
[1-
13
C] glucose, or                   
[6-
13
C] glucose 
Ser & Ala  
Notably lower (with [1-
13
C] glucose) or higher 
(with [6-
13
C] glucose) 
13
C abundance in Ser  
The reductive 
TCA cycle 
Non-labeled CO2 
with [3-
13
C] 
pyruvate 
Ala, Asp, & 
Glu 
Notably lower 
13
C 
abundance in Asp and 
Glu than in Ala 
The branched 
TCA cycle 
[3-
13
C] pyruvate, 
or 
[2-
13
C] glycerol 
Asp & Glu 
Different labeling 
patterns in Asp versus in 
Glu 
 (Re)-citrate 
synthase in TCA 
cycle 
[1-
13
C] pyruvate Glu 
Non-labeled α-carboxyl 
group of Glu 
The citramalate-
pathway in 
isoleucine 
biosynthesis 
[2-
13
C] pyruvate 
 or [1-
13
C] acetate 
Leu & Ile 
Identical labeling 
patterns in Leu and Ile 
The Calvin-
Benson cycle 
Non-labeled CO2 
with labeled 
organic carbon 
His & Ser  
Significantly low 
13
C 
abundance in Ser and 
His  
The oxidative 
pentose phosphate 
pathway 
[1-
13
C] glucose Ala  non-labeled Ala >50% 
The CO2-
anaplerotic 
pathways 
13
C-bicarbonate 
with non-labeled 
organic carbon 
Ala & Asp 
Enriched 
13
C abundance 
in Asp 
 
 
. 
63 
 
3.2 Mixotrophic and photoheterotrophic metabolism in Cyanothece sp. 
ATCC 51142 under continuous light 
 
Xueyang Feng
1
, Anindita Bandyopadhyay
2
, Bert Berla
1
, Lawrence Page
2
, Bing 
Wu
1
, Himadri B. Pakrasi
1,2
, and Yinjie J. Tang
1,* 
1
Department of Energy, Environmental and Chemical Engineering, Washington 
University, St. Louis, MO 63130, USA 
2
Department of Biology, Washington University, St. Louis, MO 63130, USA 
Corresponding author: 
*: yinjie.tang@seas.wustl.edu; phone: 314-935-3441 
 
 
 
This section was previously published in  
Feng X, Banerjee A, Berla B, Page L, Wu B, Pakrasi H.B, and Tang YJ. 
Mixotrophic and photoheterotrophic metabolisms in Cyanothece sp. ATCC 51142 
under continuous light.” Microbiology. 2010, 156(Pt 8):2566-74 
. 
64 
 
3.2.1 Abstract 
The unicellular diazotrophic cyanobacterium, Cyanothece sp. ATCC 
51142 (Cyanothece 51142), is able to grow aerobically in nitrogen-fixing 
conditions under alternating light-dark cycles or continuous illumination. This 
study investigated the impacts of carbon and nitrogen sources on Cyanothece 
51142 metabolism via 
13
C-assisted metabolite analysis and biochemical 
measurements. Under continuous light (50 µmol photons/m
2
/s) and nitrogen-
fixing conditions, we find glycerol addition promoted aerobic biomass growth (by 
twofold) and nitrogenase-dependent hydrogen production (up to 25 µmol H2/mg 
chlorophyll/hr), but strongly reduced phototrophic CO2 utilization. Under 
nitrogen-sufficient conditions, Cyanothece 51142 was able to metabolize glycerol 
photoheterotrophically, and the activity of light dependent reactions (e.g., oxygen 
evolution) was not significantly reduced. In contrast, Synechocystis sp. PCC 6803 
showed apparent mixotrophic metabolism under similar growth conditions. 
Isotopomer analysis also detected that Cyanothece 51142 was able to fix CO2 via 
anaplerotic pathways, and to uptake glucose and pyruvate for mixotrophic 
biomass synthesis. 
Key words: 
13
C-assisted, anaplerotic pathway, CO2 utilization, glycerol, 
hydrogen, nitrogenase 
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3.2.2 Introduction 
Rising concerns about global warming due to the greenhouse effect have 
renewed research focused on biological capture of CO2. Cyanobacteria have 
versatile metabolic capabilities, which allow them to grow under autotrophic, 
heterotrophic, and mixotrophic conditions (1,2,3). More importantly, some 
cyanobacteria can capture solar energy to fix nitrogen and generate H2, thereby 
serving as a source of biofertilizer and biofuel, while simultaneously consuming 
atmospheric CO2 (4,5,6,7,8,9). Cyanothece 51142, a unicellular diazotrophic 
cyanobacterium, is able to grow aerobically under nitrogen-fixing conditions and 
has been recognized for contributing to the marine nitrogen cycle. The recent 
sequencing of the Cyanothece 51142 genome and its transcriptional analysis 
uncovered the bacterium’s diurnally oscillatory metabolism in alternating light-
dark cycles (photosynthesis during the day and nitrogen fixation at night) 
(10,11,12). In general, cyanobacteria use spatial or temporal separation of the 
oxygen-sensitive nitrogen-fixation and the oxygen-evolving photosynthesis as a 
strategy for diazotrophic growth (9,13). Interestingly, Cyanothece 51142 
demonstrates simultaneous N2 fixation and O2 evolution under continuous light 
conditions, though it appears to be unicellular (14,15). For example, a recent 
study on transcriptional and translational regulation of continuously-illuminated 
Cyanothece has revealed strong synthesis capability for nitrogenase and circadian 
expression of 10% of its genes (10,11).  Furthermore, Cyanothece strains usually 
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utilize exogenous carbon substrates for mixotrophic growth under light and for 
heterotrophic growth under dark conditions (16). Carbon substrates are key 
factors controlling the efficiency of cyanobacterial aerobic growth and hydrogen 
production (7,16,17,18,19). Genome analysis studies have revealed that 
Cyanothece 51142 has a unique gene cluster on its linear chromosome containing 
key genes involved in glucose and pyruvate metabolism (12). However, the 
ability of this strain to metabolize glucose or pyruvate remains unknown.  
To quantitatively examine the effect of carbon and nitrogen sources on 
Cyanothece central metabolism, this study investigated the impact of three carbon 
sources (glucose, glycerol, and pyruvate as representatives of sugar, lipid 
derivatives, and organic acids from central metabolic pathways, respectively) on 
Cyanothece 51142 growth and metabolism. Two nitrogen sources other than N2, 
ammonia and nitrate, were also examined. Precise readouts on metabolic state and 
activity were based on
 13
C-assisted metabolite analysis integrated with 
biochemical assays and the gene expression patterns obtained by reverse 
transcription PCR (RT-PCR) (20,21,22,23,24,25). Superior to the traditional 
14
C 
method (1), the non-radioactive 
13
C method can provide rich information about 
which carbons within a metabolite are labeled, and thus enable an in-depth 
understanding of carbon utilization and metabolic regulation in Cyanothece 
51142.   
3.2.3 Materials and methods 
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Bacterial strains and growth conditions. Cyanothece 51142 were first 
grown in 150 mL Erlenmeyer flasks fed with ASP2 medium (16) without nitrate. 
Ambient carbon dioxide provided the sole carbon source. For experiments 
examining the effect of nitrogen sources, 18 mM NaNO3 or 17 mM NH4Cl was 
added into the medium. Cultures were grown aerobically under continuous light 
(50 µmol photons∙m-2∙s-1) on a shaker at 150 rpm and 30°C. Cells at late mid-log 
phase were sub-cultured into different cultural media with various nitrogen and 
carbon sources. Isotopically-labeled carbon substrates (Cambridge Isotope 
Laboratories, Andover, MA) were used for mixotrophic growth, including 54 mM 
glycerol (2-
13
C, >98%), 26 mM glucose (U-
13
C, >98%) and 11 mM sodium 
pyruvate (3-
13
C, >98%). For tracer experiments, a 3% inoculum from unlabeled 
stock culture was used to inoculate a 50 mL medium containing labeled carbon 
sources. At the mid-log phase of growth, a 3% inoculum from the first isotopic 
labeled culture was used to inoculate 50 mL sub-cultures with the same medium 
to remove the effect of unlabeled carbon introduced from the initial inoculum. 
Cell growth was monitored by a UV-Vis spectrometer (Genesys, Thermo 
Scientific, USA) at 730 nm. To perform a comparative study, a glucose tolerant 
Synechocystis strain PCC 6803 (a model cyanobacterium for studying 
fundamental processes of photosynthetic metabolism) was also cultured in BG11 
medium (pH=7.6) under the same growth conditions (continuous light and 30 
o
C, 
(26). The BG11 medium was supplemented with 6 mM glucose (U-
13
C, >98%) to 
support mixotrophic growth. Synechocystis PCC 6803 were also sub-cultured in 
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the same labeled medium twice before sampling for 
13
C-labeled metabolite 
analysis. 
Metabolite and photosynthetic activity analysis. To analyze metabolites 
in Cyanothece 51142, biomass was harvested at the middle-log phase of growth 
(~90 hours) by centrifugation at 7,000 rpm for 15 min at 10˚C. The concentrations 
of pyruvate, glucose and glycerol were analyzed with enzymatic assay kits (R-
Biopharm, Germany). To measure hydrogen produced by Cyanothece 51142, 20 
ml of culture solution was taken from the culturing flask after three days and 
transferred into 35.2 ml glass vials sealed with rubber septa and kept under 
continuous light (50 µmol photons∙m-2s-1). A modified protocol was used to 
quantify hydrogen (27).  Briefly, hydrogen that accumulated in the headspace of 
the sealed culture vials (for 5 hours) was withdrawn with a Hamilton gas-tight 
syringe and quantified on an Agilent 6890N Gas Chromatograph with a molseive 
5A 60/80 column (inner dimensions 6’×1/8”) and Thermal Conductivity Detector.  
Injection, oven, and detector temperatures were 100°C, 50°C, and 100°C, 
respectively. Argon was the carrier gas (flow rate of 65 ml∙min-1). All 
measurements included three biological replicates. 
Photosynthesis activities were determined based on measurements of 
chlorophyll fluorescence and oxygen evolution. Chlorophyll fluorescence profiles 
of photosystem II (PSII) of Cyanothece 51142 under different nutrient conditions 
were detected by a FL100 fluorometer (Photon Systems Instruments, Brno, Czech 
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Republic) as detailed before (28). All samples taken for measurement were 
diluted to OD730 ~0.2 using cell-free ASP2 medium. The samples were first 
adapted for 3 min in total darkness. During the measurement (performed at room 
temperature), the fluorometer emitted saturating light pulses to determine 
samples’ fluorescence yield. The photosynthesis activity was derived by the 
maximum quantum yield (Fv/Fm) according to the formula Fv/Fm = (Fm - F0)/Fm, 
where F0 is initial fluorescence and Fm is maximum fluorescence at the beginning 
of measurement (29).  
Oxygen evolution rates of Cyanothece 51142 grown under different 
nutrient conditions were measured with a Hansatech oxygen electrode. Assays 
were performed at 30 °C on whole cells in ASP2 media with a saturating light 
intensity of 8,250 μmol photons∙m-2s-1 for 2 mins in a 2.5-mL reaction volume. 
For each reaction, the chlorophyll concentration of each sample was diluted to ~6 
μg∙ml-1. The oxygen evolution rates (μmol O2•mg chlorophyll
-1•hr-1) were then 
measured and normalized based on chlorophyll concentration.  
RNA extraction and reverse transcription PCR (RT-PCR). The 
bacteria grown under different cultural conditions were harvested at mid-log 
phase according to the corresponding growth curves. The total RNA was 
extracted by using a PureLink™ RNA Mini Kit (Invitrogen, California), 
following the manufacturer’s instruction. cDNA was synthesized from ~2 μg 
RNA by using a High-Capacity cDNA Reverse Transcription Kit (Invitrogen, 
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California). The primers for RT-PCR reactions were designed using Primer 
Premier 5 software (PREMIER Biosoft) and analyzed by OligoAnalyzer 3.0 
software (Integrated DNA Technologies, Coralville, USA). The forward primer 
(AGCGGTGGAGTATGTGGT) and reverse primer 
(GGCTGGGTTTGATGAGATT) were employed to amplify a 16S rRNA gene as 
a control. The forward primer (CCGACTACACTCCGAAAG) and reverse primer 
(ACGTAACGCCCGTAATGC) were used to amplify the Rubisco (rbcL) gene 
and the forward primer (TAATCACGAAACGGGAG) and reverse primer 
(CACCACATCAGCGTATTG) to amplify the prk gene. The PCRs were 
conducted with the following cycle conditions: 2 min of activation of the 
polymerase at 94 °C followed by 30 cycles consisting of 1 min at 94 °C, 30 s at 
53 °C and 2 min at 72 °C; finally, a 10 min extension process was performed at 
72 °C. The final PCR product was observed directly on 2% agarose gels after 
electrophoresis. 
 Isotopic analysis. The preparation and isotopic analysis of proteogenic 
amino acids were performed as previously described (30,31). In brief, 
exponentially growing biomass from ~20 ml culture was collected by 
centrifugation (8,000×g, 10 min, 4˚C) and hydrolyzed in 6 M HCl at 100°C for 24 
h. The amino acid mix was dried and derivatized in tetrahydrofuran (THF) and N-
(tert-butyl dimethylsilyl)-N-methyl-trifluoroacetamide (Sigma-Aldrich, St. Louis, 
MO) at 70°C for 1 h. A gas chromatograph (GC) (Hewlett-Packard, model 
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7890A, Agilent Technologies Inc., Ballwin, MO) equipped with a DB5-MS 
column (J&W Scientific, Folsom, CA) and a mass spectrometer (MS) (5975C, 
Agilent Technologies Inc., Ballwin, MO) were used for analyzing amino acid 
labeling profiles. The ion [M-57]
+
 from unfragmented amino acid was detected 
and mass fractions of key amino acids were calculated (32). The substrate 
utilization ratios R (reflecting the degree of mixotrophic metabolism) were 
calculated from the labeling patterns of proteogenic amino acids:  
Amino acid X: 
C
Mi
VVm
VVn
C
i
i
COsub
COsub 1
2
2
)(
01.098.0
             
2CO
sub
V
V
R  (1) 
where the ratio R indicated the utilization of labeled carbon substrate over 
unlabeled CO2 for producing an amino acid X (and its precursors). Mi was the 
GC-MS isotopomer fraction for the given amino acid X (i.e., M0 was the 
unlabeled fraction, M1 was the singly labeled fraction, M2 was the doubly labeled 
fraction, M3 was the triply labeled fraction, etc). C was the total number of carbon 
atoms in the amino acid molecule. Vsub was the carbon flux from 
13
C labeled 
substrate, VCO2 was the carbon flux from CO2; 0.98 was the purity of the labeled 
carbon substrate; 0.01 was the natural abundance of 
13
C, m was the total number 
of carbons in the substrate molecule, and n was the total number of labeled 
carbons in the substrate molecule. The ratio R indicated the amount of labeled 
carbon that percolated through the central metabolic networks (Figure 3.2.1).  
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3.2.4 Results 
Cell growth with different carbon and nitrogen sources. Figure 3.2.2 
and Supplementary Figure 3.2.S1 shows the effect of carbon and nitrogen 
substrates on the growth of Cyanothece 51142 under continuous light. Biomass 
growth was significantly enhanced by addition of glycerol to ASP2 medium. For 
example, glycerol addition doubled the specific growth rate from 0.28 day
-1
 to 
0.63 day
-1
 under N2 fixing conditions. These results are consistent with an earlier 
report on two Cyanothece strains (16). On the other hand, Cyanothece growth was 
not apparently enhanced by either glucose or pyruvate (Supplementary Figure 
3.2.S1), and high concentration pyruvate (64 mM) inhibited Cyanothece growth. 
Compared to nitrogen fixing cultures, the presence of nitrate salts in the growth 
media increased Cyanothece autotrophic growth rates from 0.28 day
-1
 (N2 fixation 
condition) to 0.37 day
-1
 (nitrate-sufficient condition). Similarly, the presence of 
glycerol enhanced growth rate by two-fold (from 0.60 day
-1
 to 1.02 day
-1
). As 
expected, high concentrations of ammonium salts (17 mM) fully inhibited growth 
(data not shown) because of its well-known deleterious effect on photosystems of 
cyanobacteria (33,34). 
Isotopic analysis of amino acids. 
13
C enrichment patterns in key 
metabolites were used to estimate the relative utilization of labeled carbon 
substrates (i.e., glucose, pyruvate, or glycerol) and CO2 for metabolite synthesis 
under mixotrophic growth. Figure 3.2.1 shows the central metabolic pathways in 
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Cyanothece 51142 (http://www.genome.jp/kegg/). Five amino acids were 
analyzed for their labeling: histidine (precursor: ribose-5-phosphate and 5,10 
methyl-THF), synthesized from the Calvin Cycle and pentose phosphate pathway; 
serine (precursor: 3-phosphoglycerate, a product from the Calvin Cycle); alanine 
(precursor: pyruvate, originated from carbon substrate or CO2 fixation); and 
aspartate and glutamate (precursors: oxaloacetate and 2-oxoglutarate, 
respectively, synthesized from the citric acid cycle). Under nitrate-sufficient 
conditions, glycerol could be used as the sole carbon source for synthesis of 
alanine, serine, and histidine (as indicated by approximately infinite R values). 
This indicates that the cell was undergoing completely heterotrophic metabolism. 
R values of some key amino acids in glucose and pyruvate cultures were positive 
and thus the two carbon sources were actually utilized for biomass synthesis 
(Table 3.2.1). However, their measured R values were between 0 and 0.3, which 
indicated that CO2 was the main carbon source for metabolite synthesis. This 
result was consistent with the fact that glucose and pyruvate did not apparently 
improve the biomass growth. Compared to nitrogen-sufficient conditions, 
nitrogen fixing conditions further limited glucose and glycerol utilization, as 
shown by the decreased labeling fractions of three key amino acids (i.e., alanine, 
serine, and histidine) (Table 3.2.1).  
Nitrogenase-dependent hydrogen production, photosynthesis and 
Calvin Cycle activity. Hydrogen production under continuous light with different 
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carbon substrates (N2 as the sole nitrogen source) was measured in the 
exponential (day 4) and stationary (day 9) growth phases, respectively 
(Supplementary Figure 3.2.S2). In the exponential growth phase under nitrogen 
fixing conditions, hydrogen production rates were as follows: for glycerol (25±6 
µmol H2/mg chlorophyll/hr); for glucose (13±9 µmol H2/mg chlorophyll/hr); for 
pyruvate (4±2 µmol H2/mg chlorophyll/hr); and in the photoautotrophic condition 
(5±1 µmol H2/mg chlorophyll/hr). Under all nitrate or ammonium chloride 
conditions, hydrogen production was not detected regardless of the carbon 
substrate.  
The measurement of photosynthetic parameters (Figure 3.2.3) suggested 
that, compared to photoautotrophic conditions, addition of an exogenous carbon 
source (glycerol, glucose, or pyruvate) did not strongly suppress the maximal 
quantum yield of PSII (Fv/Fm) or the oxygen evolution rate. Nitrate-sufficient 
conditions enhanced the oxygen evolution rates by 2~3 fold compared to 
nitrogen-fixing conditions, while the change of quantum yields of PSII were much 
less significant (10~30%). Gene expression in the carbon fixation pathway was 
also determined (Figure 3.2.4). Reverse transcription PCR (RT-PCR) results 
indicated that two key enzymes in Calvin Cycle (ribulose-1,5-bisphosphate 
carboxylase oxygenase (Rubisco, rbcL) and phosphoribulokinase (prk)) were 
functional under growth conditions with glycerol or glucose. The above 
measurements confirm that the light dependent reactions were active under all 
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culture conditions, even though carbon substrates reduced the relative amount of 
CO2 fixation for biomass synthesis.  
3.2.5 Discussion  
Carbon substrate utilization and regulation.  In continuous light, 
Cyanothece 51142 can efficiently utilize glycerol for aerobic growth. Based on 
the measurement of carbon substrates in the culture medium during the 
exponential growth phase, the uptake rates of glycerol were 0.22±0.05 g∙(g dry 
biomass•day)-1 under nitrogen fixing and 0.35±0.06 g∙(g dry biomass•day)-1 under 
nitrate-sufficient conditions. Glycerol promoted Cyanothece 51142 growth 
because it provided carbon and energy sources. Under nitrate-sufficient 
conditions, the unlimited large value of R from serine, alanine and histidine 
labeling data indicated that 3-phosphoglycerate node, pyruvate node and ribose-5-
phosphate node in the central metabolic pathways (Figure 3.2.1) were completely 
originating from glycerol, while the contribution of CO2 photofixation to those 
metabolite nodes was negligible. As a comparison, a glucose-tolerant strain of 
Synechocystis sp. strain 6803 was cultured with fully labeled glucose under 
continuous light and nitrogen-sufficient conditions (Supplementary Figure 3.2.3). 
The measured R values (Table 3.2.1) for serine (0.87), alanine (0.92) and histidine 
(1.73) indicated that Synechocystis 6803 had a typical mixotrophic growth. In 
general, cyanobacterial heterotrophic growth has been reported only under three 
conditions: complete darkness, dim light, and pulses of light (35,36). When the 
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light is sufficient for photoautotrophy, Cyanothece photoheterotrophic growth 
was only achieved by addition of photosystem II inhibitors (16). This study shows 
that rapidly-growing Cyanothece 51142 cells can shift their metabolic strategies 
from mixotrophic or autotrophic growth to photoheterotrophic growth, possibly 
because maximal utilization of energy-rich carbon substrate (glycerol) can reduce 
energy costs related to CO2 fixation (fixation of one CO2 consumes two ATP and 
one NADPH) and building block synthesis so that maximal biomass growth can 
be achieved.  
On the other hand, glucose was not apparently consumed by Cyanothece 
51142 (the consumed concentrations were below 1mM in all experiments). In the 
[U-
13
C] glucose experiments (Table 3.2.1), all five amino acids contained labeled 
carbons, which indicated that the labeled glucose had percolated through the 
entire central metabolic pathways, thereby confirming the ability of Cyanothece 
51142 to metabolize glucose. The R values of all key amino acids were below 
0.05 for both nitrogen fixation and nitrate-sufficient conditions, suggesting that a 
large fraction of the carbon in the biomass had originated from CO2 fixation. In 
contrast, glucose was the most favorable carbon source for Synechocystis species 
(3), and the R values (Table 3.2.1) from key amino acids were around (0.4~1.7). 
While both Synechocystis 6803 and Cyanothece 51142 have completely annotated 
central pathways for glucose metabolism, Synechocystis 6803 contains a glucose 
transporter (gene code Sll0771) that shares a sequence relationship with 
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mammalian glucose transporters (1,37,38). So far, the presence of a glucose 
transporter in Cyanothece 51142 has not been rigorously verified. From the 
genome database (DOE Joint Genome Institute, www.jgi.doe.gov/), a gene 
(cce_3842) was identified as a glucose transport protein that shared weak (25%) 
amino acid identity with the Sll0771 protein of Synechocystis PCC6803. Based on 
the glucose-dependent growth data, we conclude that the enzymes involved in 
glucose transport or utilization in Cyanothece 51142 may not be as efficient as 
those of Synechocystis PCC6803. 
Analysis of labeled pyruvate-grown Cyanothece cells showed that serine 
(whose precursor is 3-phosphoglycerate) and histidine (whose precursor is ribose-
5-phosphate) were completely unlabeled (R=0). Such labeling profiles suggest 
that CO2 was used as the sole carbon source for synthesis of metabolites in 
glycolysis and the pentose phosphate pathway (i.e., there was no gluconeogenesis 
activity). Pyruvate was used only to synthesize alanine (R=0.3~0.6) and 
metabolites in the TCA Cycle: (pyruvateoxaloacetateAsp) (pyruvateacetyl-
CoAcitrate2-oxoglutarateGlu), as reflected by the labeled carbon present 
in glutamate and aspartic acid. Interestingly, the R values of alanine (=0.60) and 
glutamate (=1.25) were higher under nitrogen-fixing conditions compared to the 
nitrate-sufficient conditions, indicating that relatively more labeled pyruvate was 
used for glutamate synthesis under these conditions. The nitrogen fixation was via 
nitrogenase: N2 + 6 H
+
 + 6 e
−
 → 2 NH3, and the nitrogenase-generated 
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ammonium was assimilated into amino acids through the glutamine 
synthetase/glutamate synthase pathway (39). Utilization of supplemented 
pyruvate for glutamate synthesis could facilitate the nitrogen fixation process.  
The enzyme ribulose-1,5-bisphosphate carboxylase oxygenase (RuBisCO) 
is known to be the rate-limiting factor in the Calvin Cycle for capturing CO2 to 
synthesize three-carbon sugar (glycerate 3-phosphate) (40,41,42). We examined 
Rubisco (rbcL) and phosphoribulokinase (prk) gene expression to reveal the 
metabolic regulation in the Calvin Cycle at the transcriptional level. Under 
photoautotrophic, mixotrophic, and heterotrophic growth conditions, the 
expression of the two genes encoding ribulose-1,5-bisphosphate carboxylase 
oxygenase (rbcL) and phosphoribulokinase (prk) were clearly observed. Although 
Calvin Cycle genes were expressed, Cyanothece 51142 still grew 
heterotrophically in the presence of glycerol and nitrate based on the isotopomer 
data (no apparent incorporation of CO2 from Calvin Cycle). These inconsistencies 
indicate that 
13
C-assisted metabolite analysis provides direct readout on actual 
metabolic status, while gene expression results cannot be solely relied upon as 
there are many possible post-transcriptional regulations involved.   
Furthermore, Cyanothece 51142 can fix CO2 via anaplerotic pathways 
(i.e., C4 carbon fixation) (43). In the presence of glycerol and nitrate-sufficient 
conditions (Table 3.2.1), R ratios for aspartate synthesis were 1.53, much smaller 
than the R ratios (R=∞) of Ala, Ser, and His. This indicates the utilization of CO2 
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for the synthesis of C4 metabolites in the TCA Cycle via anaploric pathways, 
even though phototrophic CO2 fixation was significantly inhibited: (1) 
PEP+CO2oxaloacetate (catalyzed by phosphoenolpyruvate carboxylase or 
phosphoenolpyruvate carboxykinase) or (2) pyruvate+CO2malate (catalyzed by 
malic oxidoreductase). Such anaplerotic pathways synthesized key TCA Cycle 
metabolites like oxaloacetate and succinate (precursors for chlorophyll).  
Meanwhile, CO2 was generated by two reactions (i.e., 
pyruvateacetylCoA+CO2; isocitrate2-oxoglutarate+CO2), which are essential 
steps for glutamate synthesis. These catabolic processes cause the loss of 
unlabeled carbon when 2
nd
 position labeled glycerol is used as the main carbon 
source. Therefore, the coefficients VCO2 (CO2 utilization flux) and R (carbon 
utilization ratio) were both negative for glutamate synthesis (Equation 1) in 
glycerol supplemented cultures (both nitrogen fixation and nitrate-sufficient 
conditions) (Table 3.2.1). 
Photosynthesis activity. Photosynthesis activity was estimated by the 
Fv/Fm parameter (maximum quantum efficiency of photosystem II) (44). When 
glycerol or glucose were utilized, the maximum quantum yield Fv/Fm (i.e, 
efficiency of photosystem II) in Cyanothece 51142 was not significantly affected 
(changes are within ~30%, Figure 3.2.3a). Although chlorophyll fluorescence 
estimation is not an accurate method for determination of absolute PSII activity 
(45,46), we have used it in our study as a tool only to confirm active photon 
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capture in the light-harvesting antenna complexes of photosystem II under both 
heterotrophic and mixotrophic conditions.  
Oxygen evolution was measured as one molecule of the pigment 
chlorophyll absorbs one photon and uses its energy to generate NADPH, ATP, 
and O2 in the light-dependent reactions (47). The oxygen evolution rates in 
Cyanothece 51142 rose by 2~3 fold under all nitrate-sufficient conditions 
compared to corresponding nitrogen fixation conditions (Figure 3.2.3b). The 
significantly higher rates of oxygen evolution indicated that the photosynthetic 
process of water splitting was more active and provided more energy (ATP and 
NADPH) to support biomass growth under nitrate-sufficient conditions.  
Finally, precise determination of the photosynthetic activity is difficult for 
Cyanothece 51442, since the metabolic behavior of Cyanothece 51442 fluctuates 
under continuous light due to its circadian rhythm (10,15). The photoreaction 
activities in Figure 3.2.3 are only qualitative (not quantitative) evidences to 
support the presence of active light-dependent reactions under all culture 
conditions.  
Nitrogen utilization and nitrogenase-dependent hydrogen production. 
Under anaerobic condition (using argon gas to flush the culture), hydrogen 
production rates of Cyanothece 51142 were as high as 100 µmol/mg 
chlorophyll/hr (data not shown). Under aerobic conditions, hydrogen production 
enzyme (hydrogenase) was completely inactivated by oxygen (7). Cyanothece 
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51142 used nitrogenase for both nitrogen fixation and hydrogen production. 
Nitrate, ammonium or some amino acids inhibit nitrogenase activity and thus 
fully prohibit aerobic hydrogen production by cyanobacteria (48). Furthermore, 
NH4
+
 is a direct nitrogen source (nitrate is reduced to NH4
+
) that can be 
incorporated into biomass via glutamine / glutamate synthase (49).  Cyanothece 
51142, however, only grows with low concentration NH4
+
 (below 1 mM) because 
of an observed inhibition effect (48,50). Nitrogen fixation is an energy demanding 
process (N2+8H
+
+8e
-
+16ATP→2NH3+H2+16ADP +16Pi). Addition of glycerol 
reduces CO2 fixation via the Calvin Cycle, so more energy (ATP and NADH) can 
be directed to nitrogen fixation and thus improve hydrogen production by 4~5 
fold (4,5). Glucose and pyruvate cannot significantly promote hydrogen 
production because their utilization is very low and their effect on energy 
economy is limited. Hydrogen production rates dropped for all mixotrophic 
cultures of Cyanothece 51142 after 9 days, suggesting that inhibitory metabolites 
accumulated during the cultivation which reduced nitrogenase activities 
(40,41,42). Finally, the coexistence of oxygen-evolving photosynthesis and 
oxygen-sensitive nitrogen fixation (indicated by hydrogen evolution) is an 
attractive characteristic in some cyanobacteria (13,14). Unlike filamentous 
cyanobacterial species where nitrogen fixation and oxygenic photosynthesis are 
spatially segregated (51), Cyanothece 51142 is able to maintain activities for N2 
fixation, respiration, and photosynthesis within the same cell under continuous 
light. The strain not only has a strong ability to scavenge intracellular oxygen and 
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synthesize nitrogenase (9,15), but also develops a highly circadian mechanism for 
nitrogen fixation (52). 
  This study improves our understanding of Cyanothece 51142 physiology 
under different carbon and nitrogen sources as well as its potential application for 
hydrogen production applications. In general, exogenous carbon substrates may 
improve cellular growth, but have strong negative effects on CO2 fixation. 
Continuously illuminated Cyanothece 51142 shows simultaneous oxygen 
evolution and nitrogenase-dependent hydrogen production, while hydrogen 
production can be significantly enhanced by the addition of glycerol. A 
comparison of metabolic status under autotrophic, mixotrophic and heterotrophic 
growth conditions indicated that Cyanothece 51142 has an inherent metabolic 
strategy for maximal biomass production at low energy cost. Finally, this study 
has further confirmed that 
13
C-assisted metabolite analysis is a high throughput 
method which can provide new and precise information to understand a biological 
system. 
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Figure 3.2.1. Central metabolic pathways of Cyanothece 51142 with glucose, 
glycerol, and pyruvate as carbon substrates. The dashed line shows the metabolic 
pathway with glycerol as carbon substrate; the bold line indicates glucose; the 
solid line shows the common pathway for all carbon conditions.  Abbreviations: 
ACCOA, acetyl-coenzyme A; Ala, alanine; E4P, erythrose-4-phosphate; F6P, 
fructose-6-phosphate; G6P, glucose-6-phosphate; GAP, glyceraldehyde 3-
phosphate; 3PG, 3-phosphoglycerate; GLY, glycerol; GLU, glucose; His, 
histidine; ICIT, citrate/isocitrate; MAL, malate; OAA, oxaloacetate; OXO, 2-
oxoglutarate; PEP, phosphoenolpyruvate; PYR, pyruvate; R5P, ribose-5-
phosphate (or ribulose-5-phosphate); R15P, ribulose-1,5-bisphosphate; S7P, 
sedoheptulose-7-phosphate; Ser, serine; Xu5P: xylulose-5-phosphate. 
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Figure 3.2.2. Cyanothece 51142 growth curves under different nitrogen and 
carbon sources (biological replicates, n=3). ◊: Glycerol+Nitrate; □: Glycerol+N2; 
Δ: CO2+ Nitrate; ○: CO2+N2. The error bars are smaller than the symbols.   
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Figure 3.2.3. Maximum quantum yields (Figure 3.2.3a) of PSII and oxygen 
evolution rates (Figure 3.2.3b) in Cyanothece 51142 under different growth 
conditions (biological replicates, n=3). All samples were taken at the exponential 
growth phase based on the growth curve. Black column, N2 as nitrogen source; 
white column, NaNO3 as nitrogen source; Error bars, SD. 
 
(a) 
 
(b) 
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Figure 3.2.4. Reverse transcription PCR (RT-PCR) study for ribulose-1,5-
bisphosphate carboxylase oxygenase (rbcL) and phosphoribulokinase (prk) under 
different mixotrophic growth conditions. (a) CO2+N2; (b) CO2+NaNO3; (c) 
glycerol+NaNO3; (d) glucose+NaNO3. The 16S rRNA gene was used as the 
internal reference; the no template control (NTC) was added under each 
mixotrophic growth conditions. 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) (c) (d) 
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Supplementary Figure 3.2.S1. The growth of Cyanothece 51142 in the presence 
of different carbon and nitrogen substrates under continuous light (n=3). (a) N2 as 
nitrogen source; (b) NaNO3 as nitrogen sour □, glucose 
(26 ▲, pyruvate (9 mM). The error bars are smaller 
than the symbols. 
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Supplementary Figure 3.2.S2. Hydrogen production under mixotrophic 
conditions. Open bars, hydrogen production at day 4; filled bars, hydrogen 
production at day 9. The asterisk indicates that hydrogen production was below 
the minimum detectable level. 
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Supplementary Figure 3.2.S3. Growth of Synechocystis 6803 in the presence of 
glucose (6 mM) under continuous light (n=3). 
13
C-labelled samples were taken in 
the midexponential phase (~80 h), when there was still sufficient glucose in the 
medium. The error bars are smaller than the symbols. 
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Table 3.2.1. Isotopic analysis of the labeling profiles of amino acids in 
Cyanothece 51142 and Synechocystis 6803 under different growth conditions (the 
standard error for GC-MS measurement was below 0.02, technical replicates, 
n=2)  
 
Amino  
[M-57]+ 
N2 NaNO3 
Synechocystis 
6803 (nitrate-
medium) 
Acids Glucose R1 Pyruvate R Glycerol R Glucose R Pyruvate R Glycerol R Glucose R 
Ala 
M0 0.67  
0.032 
0.41  
0.597 
0.19  
4.2 
0.61  
0.042 
0.51  
0.327 
0.07  
+∞ 
0.04  
M1 0.19 0.55 0.71 0.19 0.48 0.85 0.05 0.92 
M2 0.11 0.03 0.10 0.17 0.01 0.07 0.28  
Ser 
M0 0.65  
0.033 
0.98  
0 
0.20  
3.7 
0.58  
0.046 
0.97  
0 
0.08  
+∞ 
0.04  
    
0.87 
M1 0.22 0.02 0.72 0.22 0.03 0.81 0.06 
M2 0.10 0 0.09 0.16 0 0.10 0.28 
Asp 
M0 0.58  
0.030 
0.54  
0.195 
0.10  
2.2 
0.59  
0.032 
0.94  
0.005 
0.07  
1.53 
0.04  
0.44 M1 0.24 0.43 0.64 0.20 0.06 0.78 0.05 
M2 0.11 0.04 0.25 0.17 0 0.15 0.19 
 M3 0.06  0  0.01  0.03  0  0  0.47 
Glu2 
M0 0.43  
0.041 
0.15  
1.25 
0.02  
- 
1.78 
0.38  
0.051 
0.47  
0.170 
0.01  
- 
2.11 
0.02  
0.76 M1 0.26 0.44 0.14 0.22 0.49 0.15 0.02 
M2 0.21 0.37 0.62 0.27 0.04 0.74 0.04 
M3 0.07 0.04 0.21 0.09 0 0.10 0.07 
 M4 0.02  0  0.01  0.03  0  0  0.53 
His 
M0 0.44  
 
0.032 
0.91  
 
0 
0.05  
 
2.83 
0.33  
 
0.049 
0.92  
 
0 
0.01  
 
+∞ 
0.01  
 
1.73 
M1 0.28 0.08 0.28 0.24 0.08 0.21 0.01 
M2 0.17 0 0.50 0.22 0 0.55 0.02 
M3 0.07 0 0.16 0.12 0 0.20 0.03 
 M4 0.03  0  0  0.07  0  0.03  0.06 
 M5 0  0  0  0.01  0  0  0.22 
 
Note: 1. Bold values were the carbon substrate (glycerol, pyruvate, or glucose) utilization 
ratios (substrate/CO2 fixation) for amino acid synthesis calculated according to Equation 
(1). 2. The glutamate synthesis pathway involved the loss of two carbons from pyruvate 
to α-ketoglutarate. Such a microbial process changed the labeling enrichment, and the 
negative value indicated the net loss of unlabeled CO2. 
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3.3 Characterization of the central metabolic pathways in 
Thermoanaerobacter sp. X514 via isotopomer-assisted metabolite analysis 
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Feng X, Mouttaki H, Lin L, Huang R, Wu B, Hemme CL, He Z, Zhang B, Hicks 
LM, Xu J, Zhou J, Tang YJ. Characterization of the central metabolic pathways in 
Thermoanaerobacter sp. strain X514 via isotopomer-assisted metabolite analysis. 
Appl Environ Microbiol. 2009, 75(15):5001-8. 
3.3.1 Abstract 
Thermoanaerobacter sp. X514 has great potential in biotechnology due to 
its capacity to ferment a range of C5 and C6 sugars to ethanol and other 
metabolites under thermophilic conditions.  This study investigated the central 
metabolism of strain X514 via 
13
C-labeled tracer experiments using either glucose 
or pyruvate as both the carbon and energy source. X514 grew on a minimal 
medium and thus contains complete biosynthesis pathways for all macromolecule 
building blocks. Based on genome annotation and isotopic analysis of amino 
acids, three observations can be obtained about the central metabolic pathways in 
X514.  First, the oxidative pentose phosphate pathway in X514 is not functional, 
and the TCA cycle is incomplete under fermentative growth conditions. Second, 
X514 contains (Re)-type citrate synthase activity, although no gene homologous 
to the recently characterized (Re)-type citrate synthase of Clostridium kluyveri 
was found. Third, the isoleucine in X514 is derived from acetyl-CoA and 
pyruvate via the citramalate pathway rather than being synthesized from threonine 
via threonine ammonia-lyase. The functionality of the citramalate synthase gene 
(CimA, Teth514_1204) has been confirmed by enzymatic activity assay, while the 
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presence of intracellular citramalate has been detected by mass spectrometry. This 
study demonstrates the merits of combining 
13
C-assisted metabolite analysis, 
enzyme assays, and metabolite detection not only to examine genome sequence 
annotations but also to discover novel enzyme activities.  
 Key words: ethanol, 
13
C, (Re)-type citrate synthase, isoleucine, citramalate 
3.3.2 Introduction 
Rising global energy demand and the depletion of fossil energy resources 
have resulted in significant environmental, economic, and social impacts. 
Production of renewable, biomass-derived energy sources has been suggested as a 
partial solution to this problem. Among renewable energy sources, ethanol is an 
attractive short-term solution owing to its strong research foundation and its ready 
integration with the current petroleum-based infrastructure (53,54). Plant-based 
cellulose is the most attractive raw material for bioethanol production (55). 
However, the use of anaerobic cellulosic bacteria in consolidated bioreactors has 
been proposed as an efficient means of rapid conversion of cellulosic biomass to 
ethanol (56). Thermophilic bacteria of the genus Thermoanaerobacter have the 
ability to naturally ferment a wide variety of monomeric and polymeric 
carbohydrates, including D-xylose, into ethanol (57,58,59). While not cellulose-
utilizing themselves, Thermoanaerobacter species in co-culture with thermophilic 
cellulose-utilizing Clostridium species have significantly higher yields of ethanol 
from both cellulose and hemicellulose than from monoculture alone (60,61). 
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Therefore, the investigation of carbon metabolism in Thermoanaerobacter sp. 
X514 has implications for understanding X514’s potential in bioenergy 
production.  
Despite the potential importance of X514 in biofuel production, a rigorous 
investigation of the central metabolic pathways in X514 has yet to be conducted. 
Although an array of functional genomics tools has been applied in predicting this 
species’ metabolism (62,63,64), a precise description of cellular metabolism is 
complicated by misannotation and by post-transcriptional regulation of protein 
synthesis (20,65). The complete genome sequence of X514 from the KEGG 
database (http://www.genome.jp/kegg/) suggests a few gaps in several essential 
pathways involved in the biosynthesis of amino acids (e.g. isoleucine) and in the 
TCA cycle (e.g., citrate synthase). Therefore, X514 would not survive without 
supplements of isoleucine or other essential nutrients. However, X514 can 
actually grow in a completely minimal medium. Hence, the metabolism of X514 
cannot be precisely revealed by genome sequence annotation alone. At this time, 
one of the most physiologically reliable methods for determining cell metabolism 
remains 
13
C-based isotopic analysis (20,21,22,66). Based on 
13
C-labeling patterns 
in key amino acids, the active pathways can be traced back, and new enzymes can 
be revealed. In this study, 
13
C-based isotopic analysis was applied to accurately 
examine the annotated pathways in X514 and to investigate gaps in key 
biosynthetic pathways (22,31,67). Specifically, glucose (1
st
 or 6
th
 carbon labeled) 
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and pyruvate (1
st
 carbon labeled) were used respectively as the sole source of 
carbon to grow X514. By analyzing the mass spectra of different fragmentations 
in proteogenic amino acids derived from various pathways, we have determined 
the active fluxes of intracellular pathways (e.g., the pentose phosphate pathway 
and citric acid cycle). Meanwhile, misannotations in the genome sequence were 
checked and unknown enzymes involved in the pathway were identified. The 
isotopomer analysis linked the genome annotation to the final enzyme-functional 
output and thus significantly improved our understanding of the regulation of the 
central metabolism of X514. 
3.3.3 Materials and methods 
Medium and cultivation conditions. Thermoananerobacter sp. X514 
was grown anaerobically at 60°C without shaking (68). The minimal medium 
contained (per liter) 1 g of NaCl, 0.5 g of MgCl2, 0.2 g of KH2PO4, 0.3 g of 
NH4Cl, 0.3 g of KCl, 0.015 g of CaCl2, 0.25 mg of resazurin, 0.031 g of L-
cysteine-HCl, 0.048 g of Na2S,  2.52 g of NaHCO3 and 1 ml trace element 
solution. One liter of trace element solution included: 10 ml 25% w/w HCl 
solution, 1.5 g of FeCl2, 0.19 g of CoCl2, 0.1 g of MnCl2, 70 mg of ZnCl2, 6 mg of 
H3BO3, 36 mg of Na2MoO4, 24 mg of NiCl2, 2 mg of CuCl2, 6 mg of Na2SeO3, 8 
mg of Na2WO4, and 0.5 g of NaOH. The pH of the medium was adjusted with 
NaOH to 7.2-7.3. The vitamin solution was prepared according to the method 
developed by Wolin et al. (69). The rich medium was prepared by adding 0.1% 
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yeast extract to the minimal medium. Three types of 
13
C-labeled carbon substrates 
were obtained from Cambridge Isotope Laboratories, Inc. (Andover, MA) and 
used for cell culture:  pyruvate ([1-
13
C], 98%), glucose ([1-
13
C], 98%), or glucose 
([6-
13
C] , 98%). The medium was flushed with N2 and was filter-sterilized. All 
gases, including nitrogen and a nitrogen-CO2 mixture, were obtained from Airgas, 
Inc. (Radnor, PA). The strain was initially grown in a 50-ml culture medium with 
an unlabeled carbon source (glucose or pyruvate). At the mid-log phase of 
growth, a 3% inoculum was added to a 50-ml culture containing one of the 
following carbon sources: 2.1 g/L of [1-
13
C] glucose, 2.1 g/L of [6-
13
C] glucose, 
or 2.2 g/L 1
st
-position labeled pyruvate. At the mid-log phase of growth in this 
culture, 3% inoculum from the first 
13
C-labeled culture medium was used to 
inoculate a 50-ml sub-culture (with the same labeled carbon source), which 
reduced the effect of unlabeled carbon from the initial stock. 
Analytical methods. Biomass was harvested at the late-log phase of 
growth by centrifugation at 8,000 g for 15 min at 10°C.  The concentrations of 
glucose, acetate, ethanol, and lactate were analyzed with a high performance 
liquid chromatography apparatus (Agilent Technologies, CA) equipped with a 
variable wavelength (190-600 nm) detector (VWD) (the UV absorption at 245 
nm), and an ion exclusion column (Aminex HPX-87H, 300 mm × 7.8 mm, Bio-
Rad Laboratories, CA) operating at 55°C. The mobile phase consisted of 0.025 % 
sulfuric acid at a flow rate of 0.6 ml/min. 
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Isotopic analysis. The preparation and isotopic analysis of proteogenic 
amino acids were performed as previously described (30,67).  In brief, biomass 
was hydrolyzed in 6 M HCl at 100°C for 24 h.  The amino acid solution was dried 
under air flush overnight, and amino acid samples were derivatized in 
tetrahydrofuran (THF) and N-(tert-butyl dimethylsilyl)-N-methyl-
trifluoroacetamide (Sigma-Aldrich, St. Louis, MO) at 70°C for 1 h.  A gas 
chromatograph (GC) (Hewlett-Packard, model 7890A, Agilent Technologies, CA) 
equipped with a DB5-MS column (J&W Scientific, Folsom, CA) and a mass 
spectrometer (MS) (model 5975C, Agilent Technologies, CA) was used for 
analyzing amino acid labeling profiles.  Three types of charged fragments were 
detected by GC-MS for most amino acids: the [M-57]
+
 group, which contained 
unfragmented amino acids; the [M-159]
+
 group, which contained amino acids 
losing α carboxyl group; and the [f302]+ group, which contained only 1st (α 
carboxyl group) and 2
nd
 carbons in an amino acid backbone. (However, [f302]
+
 
cannot be detected in some amino acids.) Published algorithms were used to 
correct the effects of natural isotopes on the mass distributions of amino acids 
(32), and the final isotopomer distribution was shown in Tables 3.3.S1 and 3.3.S2. 
Ion mass fractions in Tables 3.3.S1 and 3.3.S2 were given for the amino acid 
fragments. M0, M1, M2… were fractions of unlabeled, singly labeled, and doubly 
labeled amino acids, respectively.  
Confirmation of citramalate synthase. The citramalate synthase activity 
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was assayed by monitoring the pyruvate-dependent production of CoA over time 
(70,71). In brief, X514 cells from a 10-ml culture in the mid-log phase were 
centrifuged (19,000 g for 10 min, 4°C). The total protein content in the biomass 
was estimated using Bradford protein assay (Bio-Rad Laboratories, Inc, CA). 
X514 cell extracts were then prepared by sonication of X514 pellets for 3 minutes 
(30 sec on / 20 sec off) in 2 ml of a 0.1 M TES [N-tris (hydroxymethyl) methyl-2-
aminoethanesulfonic acid, pH 7.5] buffer. Samples to be measured were brought 
to a final volume of 1000 μl by mixing with cell extracts (100 μl), the TES buffer 
(0.2 M, pH 7.5, 500 μl), pyruvate (10 mM, 100 μl), acetyl-CoA (50 mM, 20 μl), 
and distilled water. The resulting solutions were then incubated in the oven at 
60°C for 2 h. At intervals of 20 min, 100 μl of either test samples or blank 
samples were taken from the oven and mixed with a 900-μl stop solution. The 
stop solution was prepared in distilled water with 50 μl of 10 mM DTNB [5, 5’-
dithio-bis (2-nitrobenzoic acid)] in 0.1 M Tris-HCl and with 70 μl of 1 M Tris-
HCl. The absorbance at 412 nm was recorded immediately and blanked against an 
identical incubation sample without pyruvate. The micromoles of HS-CoA 
produced were calculated from a standard curve generated with known 
concentrations (0 to 1 mM) of 2-mercaptoethanol and based on the linear function 
between the product formation and the amount of enzyme added over the 2-hour 
time period of the assay. All the chemicals employed in this measurement were 
from Sigma-Aldrich (MO, USA). 
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LC-MS/MS was further applied to confirm the presence of citramalate in 
X514. In this study, the free intracellular metabolites were extracted with a cold 
methanol-water solution (60%, v/v) and chloroform mixture (1:1), held at -20°C 
overnight. Subsequently, cold water was added to separate free metabolites from 
those components that might interfere with the results. The extracts were then 
lyophilized. After being dissolved with 1% formic acid in water, 50 µL samples 
were injected into the LC-MS/MS for separation and detection. The LC-MS/MS 
system was composed of a Shimadzu LC system (Shimadzu Corporation, Japan, 
http://www.shimadzu.com), a LEAP CTC PAL autosampler (LEAP 
Technologies, USA, http://www.leaptec.com), and an Applied Biosystems 4000 
QTRAP mass spectrometer (Applied Biosystems, USA, 
http://www.appliedbiosystems.com) equipped with a TurbolonSpray electrospray 
ion source. 5 µM of citrate, malate, and citramalate standards (Sigma, MO, USA) 
in water were separately infused into the mass spectrometer to optimize 
compound-dependent parameters for multiple reaction monitoring (MRM) 
detection and to obtain corresponding MS/MS spectra. LC separation was 
achieved by coupling three 4.6×300 mm Onyx Monolith C18 columns 
(Phenomenex, CA) in tandem. The LC gradient was delivered at 1 ml/min with 
Solvent A: 0.1% formic acid in water, and Solvent B: 0.1% formic acid in 
methanol. The gradient started from 5% B and was kept isocratic for 4 min, then 
ramped to 20% within 7 min, and increased to 95% B within 1 min. Finally, after 
being held at 95% B for 8 min, the gradient was ramped down to 5% B, where it 
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remained for 4 min to re-equilibrate the column. 
3.3.4 Results  
Growth and metabolite curves. When X514 was cultivated in the 
minimal medium, the lag phase for X514 in the 
13
C labeled glucose was 12 hours 
and was followed by an exponential growth phase with a doubling time of ~15-19 
hours (Fig. 3.3.1a). This rate was much slower than X514’s growth rate in the rich 
medium (with 0.1% yeast extract), which was measured a doubling time of 6 
hours.  Fig. 3.3.1b shows both the glucose consumption and the production of 
ethanol, acetate, and lactate when X514 was grown in the minimal glucose 
medium. No formate was detected during the culturing.  The ability to grow in the 
minimal medium using glucose (or pyruvate, data not shown) indicates that X514 
contains the necessary biosynthetic pathways for all macromolecule building 
blocks (i.e., for synthesizing amino acids).  
Confirmation of amino acid biosynthetic pathways. According to the 
genome annotation from the KEGG resource (http://www.genome.jp/kegg/), two 
amino acid biosynthetic pathways (isoleucine and proline) were incomplete. To 
examine biosynthetic pathways in X514, the labeling profiles of 14 proteogenic 
amino acids were analyzed (Tables 3.3.S1 and 3.3.S2). Since pyruvate is the key 
metabolite in the central pathway (i.e., glycolysis, pentose phosphate pathway, 
and TCA cycle), the labeling profiles of amino acids from tracer experiments that 
use 1
st
-position labeled pyruvate as the carbon source can easily identify the 
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precursors of several key amino acids (Table 3.3.S2). For example, alanine, 
valine, and serine demonstrated the same carbon molecule-labeling pattern as that 
of pyruvate (Table 3.3.S2), which confirms that pyruvate is the common precursor 
of these three amino acids (Fig. 3.3.2). The aromatic amino acids phenylalanine 
and tyrosine were derived from phosphoenolpyruvate (also synthesized from 
pyruvate). The labeling patterns of the [f302]
+
 group (containing the 1
st
 and 2
nd
 
carbons of fragmented amino acids) for alanine, phenylalanine, and tyrosine were 
all identical. This fact indicates that the 1
st
 and 2
nd
 carbons of all three amino 
acids are originally derived from the 1
st
 and 2
nd
 carbons of pyruvate. 
In tracer experiments using the 1
st
-position labeled pyruvate, the similar 
labeling patterns of aspartate, methionine, and threonine in Table 3.3.S2 suggest 
the same precursor (oxaloacetate) for the three amino acids. Based on the KEGG-
generated pathway map, oxaloacetate is expected to be synthesized from pyruvate 
(labeled at its first position), and CO2 (labeled because it is cleaved from the 1
st
 
carbon of pyruvate), leading to the labeling of two carbons in oxaloacetate and 
aspartate (both α- and β- carboxyl group) (Fig. 3.3.2).  In tracer experiments using 
[1-
13
C] or [6-
13
C] glucose as the carbon source, the labeling percentage of 
methionine was higher than that of aspartate from the same experiment, as a result 
of the addition of 
13
C-enriched C1 pool (5, 10 methyl-THF) into the carbon 
backbone of methionine (synthesis route: aspartate + C1 poolmethionine). The 
labeled carbon entered the C1 pool via the glucoseserineglycine+C1 pool 
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(Fig. 3.3.2), which caused more methionine to be labeled. 
Alternate isoleucine pathway. Anaerobic bacteria such as 
Methanococcus jannaschii and Leptospira can biosynthesize isoleucine from 
citramalate by direct condensation of acetyl-CoA and pyruvate (70,72). Recently, 
Risso et al. (71) first used 
13
C-assisted metabolic flux analysis and biochemistry 
assays to discover an alternate isoleucine pathway in Geobacter sulfurreducens. 
Interestingly, X514 may also contain a similar alternate isoleucine pathway. The 
labeling patterns of leucine and isoleucine in both glucose and pyruvate tracer 
experiments were similar. For example, the pyruvate experiment demonstrated 
that the M0 ([M-159]
+
, without the carboxyl group) of both leucine and isoleucine 
was >91%, indicating that the C2~C6 carbons in both leucine and isoleucine were 
mostly unlabeled. Such labeling patterns in isoleucine are unexpected unless 
isoleucine shares the same precursors (pyruvate and acetyl-CoA) as leucine. 
According to the genome annotation, X514 lacks threonine ammonia-lyase (EC 
4.3.1.19), which is necessary for the biosynthesis of isoleucine from threonine; 
this result is supported by our labeling data: when [1-
13
C] pyruvate was used as 
the carbon source, threonine was labeled with two carbons (M2 [M-57]
+
 >93%), 
while isoleucine (C2~C6) was not labeled (note: the GC-MS could not detect the 
labeling information for the first carbon of isoleucine due to the peak overlap 
(73)). We propose an alternate isoleucine synthesis pathway via the citramalate 
pathway that uses pyruvate and acetyl-CoA as precursors (Fig. 3.3.3). The key 
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enzyme regulating the citramalate pathway (citramalate synthase, CimA) is 
annotated in X514 (gene: Teth514_1204) (22,71).  
In order to determine whether the citramalate pathway was active in X514, 
crude soluble extracts from mid-log phase cells were tested for the presence of 
citramalate synthase activity (about 27±9 nmol/mg protein/min). Furthermore, we 
applied high sensitivity mass spectrometry to detect whether there was any 
intracellular citramalate in X514. Fig. 3.3.S1 indicates that malate, citrate, and 
citramalate were clearly detected in the X514 soluble extracts by LC/MS/MS in 
the MRM mode. The retention time and the ratio of multiple MRM transitions 
selected for each of the three targeted compounds are in agreement with those of 
the respective authentic standards. Although CID spectra signals for the three 
targeted compounds in X514 soluble extracts were lower than the spectra signals 
of authentic standards, the major fragments and their relative abundance agreed 
with their corresponding standards (Fig. 3.3.S2).  This result provides additional 
evidence to prove the presence of citramalate synthase in X514. 
(Re)-type citrate synthase. In spite of the production of citrate by X514 
(Fig. 3.3.S1), the genome annotation indicates that the enzyme in the first step of 
TCA cycle, i.e. the (Si)-type citrate synthase, is missing. Interestingly, the 
isotopomer data from the 1
st
-position labeled pyruvate experiment suggests that 
the α-carboxyl group of glutamate is not labeled (Table 3.3.S2). Such an 
observation of the labeling pattern of glutamate is consistent with the main 
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characteristics of (Re)-type citrate synthase, which has been discussed in detail in 
our previous study on (Re)-type citrate synthase in Desulfovibrio vulgaris 
Hildenborough (22). Due to the lack of a regular (Si)-type citrate synthase, X514 
may employ the (Re)-type citrate synthase. Fig. 3.3.2 shows the proposed carbon 
transition routes from labeled pyruvate (α-carboxyl group) to doubly labeled 
oxaloacetate (both α- and β- carboxyl group). The β-carboxyl group of 2-
oxoglutarate and the β-carboxyl group of glutamate were ultimately derived from 
the β-carboxyl group of oxaloacetate.  
Pentose phosphate pathway. About 50% of alanine was not labeled ([M-
57]
+
, M0 =0.51) when the [1-
13
C] glucose was used as the carbon source (Table 
3.3.S1). The glucose carbon backbone loses the first
 
carbon as CO2 when it is 
metabolized via the oxidative pentose phosphate pathway (PP pathway) to 
synthesize 5-carbon sugars (C5P) (Fig. 3.3.2). If the oxidative pentose phosphate 
pathway is not active, one glucose molecule (with either 1
st
 or 6
th
 carbon labeled) 
converts to two pyruvate molecules, and thus ~50% of pyruvate (inferred from 
alanine) is expected to be unlabeled.  The fact that the fraction of unlabeled 
alanine was 51±2% indicates the very low activity of the oxidative pentose 
phosphate pathway, i.e., the carbon flux split ratio between G6PC5P (oxidative 
pentose phosphate pathway) and G6PG3P (glycolysis) was <3% (the algorithm 
for calculating the split ratio was provided in the supplementary material). Since 
the oxidative pentose phosphate pathway was not active, the isotopomer labeling 
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patterns of most amino acids in the [1-
13
C] glucose experiment were identical to 
those in the [6-
13
C] experiments (Table 3.3.S1). 
3.3.5 Discussion 
This study has examined the pentose phosphate pathway, amino acid 
biosynthesis and TCA cycle in Thermoanaerobacter sp. X514 by 
13
C labeling 
experiments. X514 shows very low activity in the oxidative phase of the pentose 
phosphate pathway under glucose fermentation conditions. Such an observation is 
consistent with the missing of 6-phosphogluconolactonase (EC 3.1.1.31) gene, 
which catalyzes 6-phospho-D-glucono-1,5-lactone to 6-phospho-D-gluconate. 
Considering the important role of the oxidative pentose phosphate pathway in 
providing NADPH for biosynthesis, alternate NADPH pathways should be 
present in X514. Some bacteria utilize transhydrogenase
 
PntAB or UdhA for 
NADPH generation (74), but a BLASTP search (75) indicates that neither of the 
two transhydrogenases is encoded in the X514 genome (Fig. 3.3.S3). Although 
NADPH-dependent isocitrate dehydrogenase is annotated in X514 
(Teth514_0327), it may provide only limited NADPH since the TCA cycle is 
branched and is mainly used for biosynthesis. On the other hand, ferredoxin-
NADP
+
 reductase (e.g., Teth514_0652) and pyruvate:ferredoxin oxidoreductase 
(e.g., Teth514_0781, the enzyme that catalyzes the production of ferredoxin from 
pyruvate) are annotated in the X514 genome and may be key sources of NADPH 
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in X514. Ferredoxin-NADP
+
 reductase activity has been well documented in 
certain thermophilic anaerobes for NADPH production (76).  
The discovery of an alternative pathway for isoleucine synthesis and (Re)-
type citrate synthase activity demonstrates the unique metabolism of X514. 
Isoleucine is synthesized from the citramalate pathway so that both leucine and 
isoleucine share the same precursors (pyruvate and acetyl-CoA). Multiple lines of 
evidence support an alternate isoleucine biosynthesis pathway via citramalate in 
X514: 1) labeling patterns in key amino acids, 2) genomic evidence (i.e. presence 
of citramalate synthase gene but absence of threonine deaminase gene), 3) 
detection of citramalate synthase activity, 4) detection of citramalate via LC-
MS/MS. In some organisms, citramalate is used for reactions other than 
isoleucine biosynthesis. For example, during Rhodospirillum rubrum phototrophic 
growth on acetate and CO2, citramalate (formed via the condensation of acetate 
and pyruvate) can be degraded to glyoxylate and propionate (77). This pathway 
allows R. rubrum to assimilate acetate and synthesize intermediates in TCA cycle 
(i.e., succinate).  On the other hand, Atsumi and Liao (78) introduced citramalate 
synthase (CimA) to E.coli and successfully evolved a new 2-oxobutanoate 
synthetic pathway for both 1-propanol and 1-butanol production (9- and 22-fold 
higher production, respectively). Therefore, the citramalate pathway in X514 
could be potentially utilized in bio-butanol production.   
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A (Re)-type citrate synthase was recently reported in both Clostridium 
kluyveri (CKL 0973) and Desulfovibrio spp. (79). (Re)-type citrate synthase and 
(Si)-type citrate synthase are phylogenetically unrelated. (Re)-type citrate 
synthase is O2 sensitive and thus restricted to anaerobic microorganisms. Using a 
JGI genome database search by May 2009 (http://img.jgi.doe.gov, with the 
BLAST search score >400 and with identity of amino acid sequences >40%), we 
found that ~200 microbial species may be annotated with citramalate synthase (a 
key step for an alternate isoleucine synthesis pathway), while ~40 stains may have 
(Re)-type citrate synthase (with the BLAST search score >290 and with identity 
>40%). A few species may contain both citramalate synthase and the (Re)-type 
citrate synthase (Table 3.3.1), including Desulfovibrio desulfuricans and 
Desulfovibrio vulgaris Hildenborough. Thermoanaerobacter sp. X514, 
Dehalococcoides ethenogenes and Pelotomaculum thermopropionicum species 
contain neither (Si)-type citrate synthase nor the documented (Re)-type citrate 
synthase, but all encode citramalate synthase. Table 3.3.1 indicates that the 
citramalate pathway and (Re)-type citrate synthase may be more widespread in 
microorganisms than originally thought. 
 (Re)-type citrate synthase-like activity was observed in X514. A 
candidate (Re)-type citrate synthase gene in X514 should be identifiable through a 
BLAST search of the polypeptide amino acid sequences (Fig. 3.3.S4). However, 
no gene candidate is identical to the reported (Re)-type citrate synthase in 
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Clostridium kluyveri (CKL 0973), and thus, X514 may contain an undocumented 
(Re)-type citrate synthase. However, X514 contains homocitrate synthase 
(Teth514_0415: 2-oxoglutarate+acetylCoAhomocitrate) and isopropylmalate 
synthase (Teth514_0014: 3-methyl-2-oxobutanoate+acetylCoA2-
isopropylmalate), which are phylogenetically related to the reported (Re)-type 
citrate synthase (oxalacetate+acetylCoAcitrate). More importantly, 
Teth514_0416 is annotated as aconitate hydratase (citrateisocitrate), and this 
gene is in the same operon with homocitrate synthase (Teth514_0415). Therefore, 
homocitrate synthase (Teth514_0415) can be a potential (Re)-type citrate synthase 
candidate, and further experimentation is required to test this hypothesis. 
Interestingly, citramalate synthase (Teth514_1204: pyruvate+acetyl-
CoAcitramalate) condenses acetyl-CoA and organic acids to form metabolites 
structurally similar to citrate. This enzyme also belongs to the isopropylmalate 
synthase/homocitrate synthase family.  
In summary, 
13
C isotopic analysis is a powerful tool to examine the 
metabolic networks of sequenced species and to predict novel enzymes. Our 
results suggest an inactive pentose phosphate pathway and an alternate isoleucine 
biosynthesis pathway via citramalate in X514. Furthermore, X514 also 
demonstrates the (Re)-type citrate synthase activity. A comprehensive 
understanding of metabolism in Thermoanaerobacter sp. X514 could have dual 
significance for both rational genetic engineering of microorganisms in biofuel 
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production (78) and the investigating of the evolution for phylogenetically related 
pathways.  
3.3.6 Supporting information 
Flux calculations in oxidative pentose phosphate pathway. The flux 
directed into the oxidative pentose phosphate (PP) pathway can be measured 
using the labeling profile of alanine. We assume that the flux through glycolysis is 
v1 and that the flux through oxidative pentose phosphate pathway is v2. The 
replenished route from the oxidative pentose phosphate pathway to glycolysis is 
v3. Hence, the percentage of fluxes directed into the pentose phosphate pathway 
would satisfy: 
%100
21
2
vv
v
.
 
In pure [1-
13
C]-glucose experiments, the flux to unlabeled alanine through 
glycolysis is 0.5 v1, while the flux to unlabeled alanine through pentose phosphate 
pathway is v3. Hence, the percentage of unlabeled alanine satisfies: 
1 3
1 3
0.5
100%ala
v v
v v
 
When G6P enters the pentose phosphate pathway, the first carbon is lost 
as CO2. Hence, only five carbons from the six-carbon glucose flow into C5P. C5P 
is then re-formed to synthesize G3P. Based on the mass balance, the equilibrium 
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should satisfy: 
23
6
5
vv
.
 
From the [M-57]
+
 data in GC-MS, the percentage of unlabeled alanine is 
51%. Hence, 
%51%100
5.0
31
31
vv
vv
ala
.
 
With all the equations above, the percentage of flux directed into the 
pentose phosphate pathway is 2.4%. 
Note: when the 6
th
 carbon of glucose was labeled, the labeled carbon 
incorporated into E4P (the precursor of phenylalanine) via the reductive PP 
pathway.  However, when the 1
st
 carbon of glucose was labeled, the resulting E4P 
was not labeled via PP pathway, so the labeling percentage of phenylalanine was 
lower when the 1
st
 carbon of glucose was used as carbon source (Table 3.3.S1). 
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Figure 3.3.1. Thermoanaerobacter sp. X514 growth and metabolite secretion. (a) 
Growth curves of Thermoanaerobacter sp. X514 in minimal glucose medium 
(symbol: ○) and rich medium (with 1g/L yeast extract) (symbol: □). (b) Glucose 
consumption and metabolite production by Thermoanaerobacter sp. X514 in 
minimal glucose medium: glucose (symbol: ■); acetate (symbol: ◊); lactate 
(symbol: □); ethanol (symbol: ○). 
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Figure 3.3.2. Proposed scheme of central metabolic pathways in 
Thermoanaerobacter sp. X514. 
13
C labeled positions in metabolites are marked 
with an asterisk (*) for the 1
st
-position labeled pyruvate experiment. The inactive 
pathways are marked with dashed lines. Based on the genome annotation in 
KEGG database, some genes that are missed in the pathways are marked by 
dashed boxes. C5P: ribulose 5-phosphate, ribose 5-phosphate and xylulose 5-
phosphate. 
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Figure 3.3.3. Proposed scheme of isoleucine biosynthesis in Thermoanaerobacter 
sp. X514 (using 1
st
-position labeled pyruvate as the carbon source). 
13
C labeled 
positions are marked with asterisks. The inactive pathway is marked by dashed 
line.  
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Figure 3.3.S1. Separation and detection of malate, citrate and citramalate in 
Thermoanaerobacter sp. X514 sample by LC-MS/MS in MRM mode. The 
multiple MRM transitions used for confident detection of the three target 
compounds in the sample are: 1) malate: 133/89, 133/71, 133/73, 133/43; 2) 
citrate: 191/129, 191/111, 191/87, 191/85; 3) citramalate: 147/87, 147/85, 147/57, 
147/43, 147/41; 4) UN: unidentified compounds. The colors represent different 
transitions used in this method.  Malate eluted at 5.6 min, citrate at 7.6 min and 
citramalate at 8.5 min. The peak at 9.0 min was an uncharacterized compound that 
shared the same MRM transitions as malate, but with different ratios. 
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Figure 3.3.S2. Comparison of CID mass spectra of authentic standards with target 
compounds in sample X514. Left panel: CID mass spectra of authentic standards. 
Right panel: corresponding CID mass spectra in sample X514 after background 
subtraction to remove background noise. 
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Figure 3.3.S3. The BLASTP (80) result of transhydrogenase
 
PntA and UdhA in 
the genome of Thermoanaerobacter sp. X514. Neither gene was annotated. 
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Figure 3.3.S4. Protein sequences of (Re)-type citrate synthase (CKL0973) were 
compared against the strain X514 genome (http://www.jgi.doe.gov) using BLAST 
search. The resulting polypeptide amino acid sequence identity was low: 27% for 
homocitrate synthase and 23% for 2-isopropylmalate synthase.   
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Table 3.3.1. BLAST searches (May, 2009) for the key genes in an alternate 
isoleucine synthesis pathway (citramalate synthase, GSU 1798), for (Si)-type 
citrate synthase (EC 2.3.3.1 from E.coli K12) and for (Re)-type citrate synthase 
(CKL 0973 from Clostridium kluyveri) in the Joint Genome Institute 
(http://img.jgi.doe.gov).  
Species 
EC 2.3.3.1 EC 2.3.3.3 (CKL 0973) EC 2.3.1.182 
(Si)-type citrate synthase  (Re)-type citrate synthase  GSU1798 
*Thermoanaerobacter sp. X514 (B)[F] 0% 27% 49% 
Anaerocellum thermophilum DSM 6725 (B)[D] 0% 68% 51% 
Caldicellulosiruptor saccharolyticus DSM 8903 (B)[F] 0% 68% 51% 
Caldivirga maquilingensis IC-167 (A)[F] 39% 41% 47% 
Candidatus Kuenenia stuttgartiensis (B)[F] 0% 55% 54% 
Clostridium acetobutylicum ATCC 824 (B)[F] 0% 65% 50% 
Clostridium botulinum A ATCC 3502 (B)[F] 0% 73% 22% 
Clostridium kluyveri DSM 555 (B)[F] 28% 100% 29% 
Clostridium cellulolyticum H10 (B)[F] 30% 60% 50% 
Clostridium thermocellum ATCC 27405 (B)[F] 30% 60% 51% 
Clostridium phytofermentans ISDg (B)[F] 30% 62% 25% 
Desulfovibrio desulfuricans G20 (B)[F] 0% 48% 55% 
Desulfovibrio vulgaris Hildenborough (B)[F] 0% 48% 55% 
Desulfovibrio vulgaris DP4 (B)[F] 0% 48% 55% 
Desulfovibrio vulgaris Miyazaki F (B)[F] 0% 49% 55% 
*Dehalococcoides ethenogenes 195 (B)[F] 0% 28% 53% 
Syntrophus aciditrophicus SB (B)[F] 0% 49% 55% 
Syntrophobacter fumaroxidans MPOB (B)[F] 32% 50% 59% 
*Pelotomaculum thermopropionicum SI (B)[F] 0% 29% 56% 
Ignicoccus hospitalis KIN4/I (A)[F] 0% 50% 45% 
 
Note:   
1. Domains: (B)acteria, (A)rchaea. 
2. Genome Completion: [F]inished, [D]raft. 
3. Both (Si)- and (Re)-type citrate synthases in the species (with “*” in front) 
may be missing due to the low identity (<30%) of polypeptide amino acid 
sequences to the documented (Si)- and (Re)-type citrate synthases.  
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Table 3.3.S1. Isotopic analysis of amino acids in Thermoanaerobacter X514  
Amino Acids Precursors Ions 
[M-57]
+ 
[1-
13
C]/[6-
13
C] 
[M-159]
+
 
[1-
13
C]/[6-
13
C] 
[f302]
+
 
[1-
13
C]/[6-
13
C] 
Ala 
 
Pyruvate 
 
M0 0.51/0.49 0.51/0.49 ND 
M1 0.47/0.50 0.45/0.47  
M2 0.01/0.01 0.04/0.03  
Gly 
 
Serine 
 
    
M0 0.95/0.96 0.97/0.97  
M1 0.05/0.03 0.03/0.03 ND 
M2 0/0   
      
Val 
 
Pyruvate 
 
M0 0.26/0.24 0.26/0.24 0.90/0.91 
M1 0.49/0.49 0.49/0.48 0.08/0.06 
M2 0.24/0.26 0.24/0.26 0.02/0.03 
      
Leu 
 
Pyruvate 
Acetyl-CoA 
 
M0 Overlap 
Peak with  
f302 
0.14/0.12  
M1 0.38/0.37 ND 
M2 0.36/0.37  
M3  0.12/0.13  
      
Ile 
 
Pyruvate 
Acetyl-CoA 
 
M0 
Overlap 
Peak with 
f302 
0.18/0.17  
M1 0.41/0.41 ND 
M2 0.32/0.33  
M3 0.08/0.09  
      
Met 
 
Aspartate 
Methy-THF 
 
M0 0.35/0.32 0.35/0.36  
M1 0.48/0.51 0.49/0.48 ND 
M2 0.16/0.16 0.15/0.14  
M3 0/0.01 0.01/0.02  
      
Ser 
 
G3P 
 
M0 0.54/0.52 0.55/0.53 0.96/0.99 
M1 0.44/0.48 0.45/0.47 0.04/0 
M2 0.02/0 0.01/0 0/0.01 
      
Thr 
 
Aspartate 
 
M0 0.51/0.47 0.52/0.46 
 
 
M1 0.47/0.52 0.48/0.51  
M2 0.02/0 0/0.02  
      
Phe 
 
PEP 
E4P 
 
M0 0.19/0.05 0.20/0.06 0.97/0.98 
M1 0.42/0.29 0.42/0.29 0.03/0.02 
M2 0.30/0.44 0.30/0.43 0/0 
M3 0.08/0.21 0.08/0.21  
M4 0.01/0.01 0/0.01  
      
Asp/Asn OAA M0 0.50/0.47 0.50/0.48 0.97/0.98 
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  M1 0.48/0.52 0.48/0.49 0.03/0.02 
M2 0.02/0.01 0.01/0.02 0/0 
      
Glu/Gln 
 
OXO 
 
M0 0.26/0.24 0.27/0.24 ND 
M1 0.49/0.49 0.49/0.49  
M2 0.25/0.26 0.23/0.26  
M3 0.01/0.01 0/0  
      
Tyr 
 
 
PEP 
E4P 
 
M0 0.19/0.05 0.20/0.08 0.97/0.97 
M1 0.42/0.32 0.41/0.31     0.03/0.03 
M2 0.30/0.41 0.310.38 0/0 
M3 0.08/0.21 0.08/0.21  
M4 0.01/0.01 0.01/0.02  
 
Notes for Table 3.3.S1 ~ 2:  
1. Ion mass values represent amino acid molecules with specific 
fragmentation patterns: ([M-57]
+
: No loss); ([M-159]
+: Loss of α carboxyl 
group); ([f302]
+
: 1
st
 and 2
nd
 carbons in amino acids). ([M-159]
+: Loss of α 
carboxyl group) of threonine was replaced by ([M-85]
+: Loss of α 
carboxyl group) because the later ion had clearer signals.  
2. [f302]+ peaks of some amino acids overlapped with other peaks, so [f302]+ 
only qualitatively reflects the labeling status in amino acids. 
3. Asparagine and glutamate were converted into aspartate and glutamine 
during the protein hydrolysis.  
4. Abbreviations: E4P, erythrose-4-phosphate; OAA, oxaloacetate; OXO, 2-
ketoglutarate; PEP, phosphoenolpyruvate; G3P, 3-phosphoglycerate. 
5. The standard deviations for measurement (n=2) of mass fractions are 
below 2%. 
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Table 3.3.S2. Isotopic analysis of amino acids in Thermoanaerobacter sp. X514 
and their labeling positions ([1-
13
C] pyruvate) 
Amino 
Acids 
Precursors Ions [M-57]+ [M-159]+ [f302]+ 
Proposed 13C enriched 
positions 
Ala 
 
Pyruvate 
 
M0 0.02 0.93 0.03 
C-C-*COOH 
 M1 0.96 0.02 0.95 
M2 0.02 0.04 0.02 
       
Gly 
 
Serine 
 
M0 0.03 0.99  
C-*COOH 
 M1 0.96 0.01 ND 
M2 0.01   
       
Val 
 
Pyruvate 
 
M0 0.01 0.95 0.12 
C-C-C-C-*COOH 
 M1 0.94 0.04 0.87 
M2 0.04 0 0.01 
       
Leu 
 
Pyruvate 
Acetyl-
CoA 
 
M0  0.93  
C-C-C-C-C-COOH 
C2~C6 were not labeled. 
M1 Overlap 0.06 ND 
M2 
Peak 
with f302 0.01  
M3  0.00  
       
Ile 
 
Pyruvate 
Acetyl-
CoA 
 
M0  0.91 ND 
C-C-C-C-C-COOH 
C2 ~C6 were not labeled 
M1 Overlap 
Peak 
with f302 
0.08  
M2 0.01  
M3 0  
       
Met 
 
Aspartate 
Methy-
THF 
 
M0 0 0.03  
C-S-*C-C-C-*COOH 
 
M1 0.03 0.93 ND 
M2 0.92 0.03  
M3 0.04 0  
       
Ser 
 
G3P 
 
M0 0.02 0.97 0.03 
C-C-*COOH 
 M1 0.96 0.02 0.95 
M2 0.01 0 0.02 
       
Thr 
 
Aspartate 
 
M0 0.01 0.03  
*C-C-C-*COOH 
 M1 0.02 0.95 ND 
M2 0.93 0  
       
Phe 
 
PEP 
E4P 
 
M0 0.01 0.01 0.02 
C-C-C-C-C-C-C-C-*COOH 
1st carbon was labeled. The other 
two carbons’ labeling positions 
could not be determined. 
M1 0.01 0.37 0.97 
M2 0.38 0.56 0.01 
M3 0.56 0.05  
M4 0.04 0.01  
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Asp/Asn 
 
OAA 
 
M0 0 0.02 0.02 
*C-C-C-*COOH M1 0.03 0.95 0.98 
M2 0.96 0.02 0 
       
Glu/Gln 
 
OXO 
 
M0 0.02 0.02 0.82 
*C-C-C-C-COOH 
M1 0.93 0.94 0.18 
M2 0.05 0.03 0 
M3 0 0  
       
Tyr 
 
 
 
PEP 
E4P 
 
 
M0 0 0.02 0.02 
C-C-C-C-C-C-C-C-*COOH 
1st carbon was labeled. The other 
two carbons’ labeling positions 
could not be determined 
M1 0.02 0.37 0.98 
M2 0.37 0.54 0 
M3 0.56 0.05  
M4 0.04 0.01  
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3.4 
13
C-pathway analysis of environmental microorganisms 
13
C-pathway analysis has been applied to a number of environmental 
microorganisms, including 1) Cyanothece 51142, a unicellular diazotrophic 
cyanobacterium (81); 2) Heliobacterium modesticaldum, a Gram-positive 
photosynthetic bacterium (82); 3) Roseobacter denitrificans OCh114, an aerobic 
anoxygenic phototrophic bacterium (83); 4) Dehalococcoides ethenogenes Strain 
195, an important member of bioremediation communities to detoxify 
chloroethenes into the benign end product ethane (84); and 5) Mycobacterium 
smegmatis, a non-virulent bacterium that is often used to study the metabolism of 
a pathogenic bacterium, Mycobacterium tuberculosis (85). Novel metabolic 
features have been uncovered for the aforementioned environmental 
microorganisms via 
13
C-pathway analysis. Diverse analytical methods were 
utilized to confirm the discoveries from 
13
C-pathway analysis, including 
biochemical assays to detect in vitro enzyme activities, quantitative RT-PCR to 
profile the gene expressions, and LC-MS/MS to measure fast-turnover 
metabolites.    
3.4.1 Cyanothece 51142 
Based on the identical labeling patterns of isoleucine and leucine in [2-
13
C] glycerol cultures, an alternative isoleucine biosynthesis pathway via 
citramalate synthase was discovered in Cyanothece 51142. Instead of using 
threonine as the precursor, Cyanothece 51142 applied the citramalate pathway to 
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induce isoleucine biosynthesis by using the same precursors (i.e., pyruvate and 
acetyl-CoA) as those used in leucine biosynthesis pathway. The presence of 
citramalate pathway was confirmed by measuring the in vitro enzymatic activity 
of citramalate synthase via biochemical assays and by detecting the key 
intermediate in citramalate pathway, citramalte, via LC-MS/MS. A report about 
applications of 
13
C-pathway analysis to identify citramalate pathway in 
Cyanothece 51142 is attached in Appendix 2. 
3.4.2 Heliobacterium modesticaldum 
Heliobacteria are the only cultured Gram-positive photosynthetic bacteria. 
The isotopomer data from proteinogenic amino acids was collected to probe the 
central carbon metabolism of Heliobacterium modesticaldum. The CO2-
anaplerotic pathway was found to be active during phototrophic growth and the 
citramalate pathway was employed by Heliobacterium modesticaldum for 
isoleucine biosynthesis. Furthermore, the oxidative TCA cycle was operative by 
using a putative (Re)-citrate synthase to produce citrate. The presence of (Re)-
citrate synthase was confirmed by measuring activity of citrate synthase via an 
activity assay. The report of 
13
C-pathway analysis for Heliobacterium 
modesticaldum is attached in Appendix 3. 
3.4.3 Roseobacter denitrificans OCh114 
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Roseobacter denitrificans OCh114 is a model organism to study aerobic 
anoxygenic photosynthesis in bacteria. Through measurements of 
13
C-isotopomer 
labeling patterns of proteinogenic amino acids in a series of tracer experiments, 
the metabolic routes for carbohydrate utilization, CO2 assimilation, and amino 
acid biosynthesis were studied in Roseobacter denitrificans OCh114. The 
anaplerotic pathways, mainly via the malic enzyme, were used to fix CO2 by R. 
denitrificans. The Entner-Doudoroff (ED) pathway and the non-oxidative pentose 
phosphate pathway were employed by R. denitrificans in carbohydrate 
metabolism. The Embden-Meyerhof-Parnas (EMP, glycolysis) pathway was 
found to be inactive, which was confirmed by the absence of in vitro enzyme 
activity of 6-phosphofructokinase (PFK). In addition, isoleucine synthesis in R. 
denitrificans used both threonine-dependent (20% total flux) and citramalate 
pathway (80% total flux). The report of 
13
C-pathway analysis for Roseobacter 
denitrificans OCh114 is attached in Appendix 4. 
3.4.4 Dehalococcoides ethenogenes Strain 195 
Dehalococcoides ethenogenes 195 is the only known bacteria that can 
fully degrade PCE to ethane (86,87). Isotopomer-based dilution analysis was 
applied to differentiate the amino acids in Dehalococcoides ethenogenes from two 
pathways: de novo synthesis from acetate, and amino acids import from 
environment. It was found that glutamate/glutamine and aspartate/asparagine 
were almost exclusively synthesized by Dehalococcoides ethenogenes, even when 
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provided in excess in the medium. In contrast, phenylalanine, isoleucine, leucine, 
and methionine were identified as the four amino acids that were most highly 
imported from environment. Adding either phenylalanine or the four highly 
imported amino acids to the defined mineral medium enhanced the growth rates, 
dechlorination activities, and yields of strain 195 in a similar level to 
supplementation with 20 amino acids. The transcriptional regulations of ABC-
type amino acids transporters were also analyzed by qRT-PCR. The report of 
13
C-
pathway analysis for Dehalococcoides ethenogenes Strain 195 is attached in 
Appendix 5. 
3.4.5 Mycobacterium smegmatis  
Mycobacterium smegmatis is phylogenetically related to Mycobacterium 
tuberculosis (MTB) and is often used as a model for studying MTB metabolism 
since it is non-virulent. Isotopomer-assisted metabolite analysis was used to 
investigate the metabolic transition from normal growth to a non-replicating state 
under a hypoxic environment. The glyoxylate pathway and glycine 
dehydrogenase were induced as the bacillus encountered hypoxic stress. 
Meanwhile, the relative amount of acetyl-CoA entering the TCA cycle was 
doubled, whereas little entered the glycolytic and pentose phosphate pathways. 
The report of 
13
C-pathway analysis for Mycobacterium smegmatis is attached in 
Appendix 6. 
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Chapter 4 
13
C-Metabolic Flux Analysis of Central Carbon Metabolisms  
4.1 
13
C-metabolic flux analysis (
13
C-MFA) protocol 
13
C-MFA integrates the isotopomer measurements and the computational 
optimization to quantify fluxes through a metabolic network. In general, 
13
C-MFA 
is formulated as a nonlinear inverse problem, in which mass balance equations 
and isotopomer balance equations are used to find an optimal set of metabolic 
fluxes that has the smallest lack-of-fit between the simulated and measured 
isotopomer labeling patterns in proteinogenic amino acids (1). 
13
C-MFA is 
usually applied to quantify the flux distributions in central metabolic network, 
including glycolysis, Entner–Doudoroff pathway, pentose phosphate pathway, the 
TCA cycle, futile pathways, and the glyoxylate shunt. At metabolic and isotopic 
steady state, labeling information of proteinogenic amino acids that are 
synthesized from these central metabolic pathways is collected for 
13
C-MFA. The 
substrate uptake rates and products secretion rates are measured as the inflow and 
outflow fluxes in 
13
C-MFA. 
To quantify the intracellular metabolic fluxes, both mass and isotopomer 
balance equations are applied. At metabolic steady state, there is no net 
accumulation of the intracellular metabolites in the metabolic network. The mass 
balance in the given metabolic network is hence represented as S ∙ v = 0, where S 
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is the stoichiometric coefficients matrix and v is the flux distribution vector. For 
an intracellular metabolite synthesized from two reactant molecules at isotopic 
steady state, i.e. A+B→C, the isotopomer distribution of the product molecule can 
be represented as IDVC = (IMMA→C ∙ IDVA)  (IMMB→C ∙ IDVB); where IDV is 
the isotopomer distribution vector for a metabolite,  represents element-wise 
multiplication, and IMMA→C represents the isotopic mapping matrix that 
describes the isotopomer transitions from the precursor to the product. The 
isotopomer balance equations can be derived as 
n
j
n
j
jjj IDVvvIDV
1 1
; 
where IDV are the isotopomer distributions for the target metabolite, vj is the jth 
reaction that produces the target metabolite, and IDVj are the isotopomer 
distributions of the target metabolites synthesized from vj. 
To simulate the isotopomer labeling patterns of amino acids that are 
measured by GC/MS, the isotopomer distributions are converted to mass 
distribution vectors (MDV) by the following MDV = M ∙ IDV equation, where M 
is the conversion matrix. The difference between the simulated and measured 
MDV in proteinogenic amino acids is minimized by using a series of 
computational optimization algorithm, such as simulated annealing and 
evolutionary algorithms. Multiple sets of metabolic fluxes are tested and the flux 
distribution that best match the simulated data with the experimental data is 
provided by 
13
C-MFA. The flowchart of 
13
C-MFA is illustrated in Figure 4.1. 
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Figure 4.1. Framework for 
13
C-metabolic flux analysis. 
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4.2.1 Abstract 
The photosynthetic green sulfur bacterium, Chlorobaculum (Cba.) 
tepidum, assimilates CO2 and organic carbon sources (acetate or pyruvate) during 
mixotrophic growth conditions through a unique carbon and energy metabolism. 
Using a 
13
C-labeling approach, this study examined biosynthetic pathways and 
flux distributions in the central metabolism of Cba. tepidum. The isotopomer 
patterns of proteinogenic amino acids revealed an alternate pathway for isoleucine 
synthesis (via citramalate synthase, CimA, CT0612). 
13
C-based flux analysis 
indicated that carbons in biomass were mostly derived from CO2 fixation via three 
key routes: the reductive tricarboxylic acid (RTCA) cycle, the pyruvate synthesis 
pathway via pyruvate:ferredoxin oxidoreductase (PFOR), and the CO2-anaplerotic 
pathway via phosphoenolpyruvate carboxylase. During mixotrophic growth with 
acetate or pyruvate as carbon sources, acetyl-CoA was mainly produced from 
acetate (via acetyl-CoA synthetase) or citrate (via ATP citrate lyase). PFOR 
converted acetyl-CoA and CO2 to pyruvate, and this growth-rate-control reaction 
is driven by reduced ferredoxin generated during phototrophic growth. Most 
reactions in the RTCA cycle were reversible. The relative fluxes through the 
RTCA cycle were 80~100 units for mixotrophic cultures grown on acetate and 
200~230 units for cultures grown on pyruvate. Under the same light conditions, 
the flux results suggested a trade-off between energy-demanding CO2 fixation and 
biomass growth rate: Cba. tepidum fixed more CO2 and had higher biomass yield 
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(YX/S: mole carbon in biomass/mole substrate) in pyruvate culture (YX/S=9.2) than 
in acetate culture (YX/S=6.4), but the biomass growth rate was slower in pyruvate 
culture than in acetate culture. 
Key words: 
13
C, citramalate, CO2 fixation, ferredoxin, RTCA, light-harvesting  
4.2.2 Introduction 
Chlorobaculum tepidum (Cba. tepidum) is a representative green sulfur 
bacterium that is ecologically significant in global cycling of carbon, nitrogen and 
sulfur (2,3). The Cba. tepidum genome has been sequenced, and the genetic tools 
for creating Cba. tepidum mutant strains have been developed to make 
transposon-based mutations or targeted gene disruptions, which offer great 
potential to engineer Cba. tepidum for future applications (4). The annotated 
genome reveals unique aspects in carbon and energy metabolism in Cba. tepidum. 
Instead of using the Calvin-Benson Cycle for CO2-assimilation as in most 
photosynthetic organisms, Cba. tepidum captures energy from light and uses it 
along with electrons, primarily derived from oxidation of sulfur compounds, to 
drive the reductive tricarboxylic acid cycle (RTCA) for synthesis of building 
block molecules (4). Cba. tepidum can grow mixotrophically with acetate or 
pyruvate as the organic carbon source (3). Although recent research has been 
performed on the carbon and energy metabolism of Cba. tepidum (5,6), rigorous 
quantification of the metabolic pathway activities has not yet been achieved. To 
provide quantitative readout of the metabolic functions and regulatory 
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mechanisms, this study has performed 
13
C-based metabolic flux analysis of Cba. 
tepidum in the following steps: 1) growing cultures of Cba. tepidum with 
13
C-
labeled acetate or pyruvate, 2) using gas chromatography-mass spectrometry (GC-
MS) to measure the resulting labeling pattern in key metabolites, and 3) 
deciphering in vivo metabolisms via a flux model (7). Isotopic labeling and 
metabolic flux analysis have been developed to identify the active biosynthesis 
pathways (8,9,10,11) and measure the global enzymatic reaction rates (12,13). 
Such a fluxomics approach can bridge the gap between genome annotations and 
final metabolic outputs, and has been applied for characterizing numerous 
environmental microorganisms, including E. coli (14,15), Saccharomyces 
cerevisiae (16,17), Bacillus subtilis (18), Geobacter metallireducens (19), 
Shewanella oneidensis (20),  Synechocystis sp. (21), etc. This paper reports on the 
first studies of the fluxomics of mixotrophic metabolism in the green sulfur 
bacteria, and provides complementary information to previous genomic and 
proteomic studies.  
4.2.3 Experimental procedure 
13
C-labeled experiments. Cba. tepidum cultures were grown 
anaerobically at temperatures ranging from 46–50 °C in low-intensity light (10 ± 1 
W/m
2
). The medium composition (1L) was Na2EDTA-2H2O (0.015 g), MgSO4-
7H2O (0.22 g), CaCl2-2H2O (0.08 g), NaCl (0.45 g), NH4Cl (0.45 g), Na2S2O3-
5H2O (2.6 g), KH2PO4 (0.57 g), MOPS buffer (2.4 g), trace element stock (1.2 
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mL), vitamin B12 stock (0.08 mg), NaHCO3 (0.23 g), and Na2S-9H2O (0.07 g). All 
chemicals were purchased from Sigma-Aldrich. The carbon source for the trace 
experiments was [1-
13
C] acetate (purity > 98%, 0.83g/L) or [2-
13
C] acetate (purity 
> 98%, 0.83g/L) for cultures growing on acetate, or [3-
13
C] pyruvate (purity > 
98%, 1.1 g/L) for cultures growing on pyruvate. The 
13
C-labeled acetate and 
pyruvate were purchased from Cambridge Isotope Laboratories 
(www.isotope.com). Cell growth was monitored at OD625. 1% cultures (100-fold 
dilution) in the exponential growth phase were used to inoculate fresh media with 
13
C-labeled substrates. To reduce the effect of non-labeled carbon from the initial 
stock, cells were sub-cultured twice in the same labeled medium. Biomass was 
sampled at two time points (4 hr interval) in the middle-exponential growth phase, 
and the labeling patterns of proteinogenic amino acids in the biomass were 
measured.  The invariability of amino acid labeling during the two time points 
confirmed the pseudo-steady-state metabolism in tracer experiments.  
Metabolites and isotopomer analysis. The amount of pyruvate and 
acetate during the growth period was determined by enzymatic assays (22,23,24). 
For GC-MS measurement of amino acid labeling, the biomass was harvested by 
centrifugation and hydrolyzed using 6M HCl (24 hrs at 100 
°
C) (20,25). The 
amino acids were derivatized in 0.2 mL tetrahydrofuran and 0.2 mL N-(tert-butyl 
dimethylsilyl)-N-methyl-trifluoroacetamide (Sigma-Aldrich, St. Louis, MO). A 
gas chromatograph (Hewlett-Packard model 7890A; Agilent Technologies, CA) 
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equipped with a DB5-MS column (J&W Scientific, Folsom, CA) and a mass 
spectrometer (model 5975C; Agilent Technologies, CA) were used for analyzing 
metabolite labeling profiles. Four types of charged fragments were detected by 
gas chromatography-mass spectrometry (GC-MS) for all the amino acids (Table 
4.2.1 and Figure 4.2.1): the [M-57]
+
 or [M-15]
+
 group (containing unfragmented 
amino acids); the [M-159]
+
 or [M-85]
+
 group (containing amino acids that had 
lost an α-carboxyl group). For each type of fragments, the labeling patterns were 
represented by M0, M1, M2, etc, which were fractions of unlabeled, singly labeled, 
and doubly labeled amino acids. The effects of natural isotopes on isotopomer 
labeling patterns were corrected by previously reported algorithms (26).  
To compare the relative contributions of carbon substrates and CO2 to 
mixotrophic biomass synthesis, the substrate utilization ratio R was calculated 
based on the labeling patterns of unfragmented amino acid X (e.g., alanine) (8):  
0.98 n Vsub 0.01 VCO2
m Vsub VCO2
( i Mi)
i 1
C
C
 andR
mVsub
VCO2     
             (Equation 1)  
where R ratio reflects the carbon flux ratio of labeled carbon substrate to 
unlabeled CO2 for producing the corresponding amino acid X (mol carbon from 
substrate / mol carbon from CO2); Mi is the GC-MS isotopomer fraction for a 
given amino acid. C is the total number of carbon atoms in the amino acid 
molecule. Vsub is the uptake of 
13
C-labeled organic substrates, VCO2 is the uptake 
. 
146 
 
of CO2; 0.98 is the purity of the labeled carbon substrate; 0.01 is the natural 
abundance of 
13
C, m is the total number of carbons in the substrate molecule, and 
n is the total number of labeled carbons in the substrate molecule.  
Metabolic flux analysis. The pathway map of Cba. tepidum was 
generated based on genome annotation from the KEGG database 
(http://www.genome.jp/kegg/) and transcription analysis of several key pathways 
(27). The simplified pathway map includes the reductive tricarboxylic acid cycle, 
CO2-anaplerotic pathway, gluconeogenesis pathway, and pentose phosphate 
pathway (Supplementary Figure 4.2.S1 and Table 4.2.S1). The development of a 
pseudo-steady-state flux model has been discussed before (20,28,29). In brief, the 
substrate (acetate or pyruvate) uptake rate was measured and normalized to 100 
units. The biomass production was determined based on our previous paper (27). 
The biomass composition for macromolecules such as protein and fatty acids was 
assigned based on that of E. coli (14). The fluxes to biomass pools were loosely 
constrained by the estimated dry cell weight (DCW) and biomass compositions. 
These fluxes were used as initial inputs to the isotopomer model and optimized by 
isotopomer labeling information (Table 4.2.1 and Supplementary Table 4.2.S2). 
The remaining unknown intracellular fluxes were determined by reaction 
stoichiometry and atom/isotopomer mapping matrices in an iterative scheme 
(Supplementary Table 4.2.S3). The reaction reversibility was calculated using the 
exchange coefficient (19):  
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exch i
i
i
exch
v
1 exch
                       
(Equation 2) 
where vi
exch
 is the exchange flux defined as the smaller of the forward and 
backward fluxes, and  exchi is the exchange coefficient with the range of [0,1] (If 
the reaction is irreversible, exchi is 0; if the reaction is “freely” reversible, exchi is 
close to 1). The flux combinations were searched to minimize of the objective 
function (20):  
             (Equation 3) 
where vn are the unknown fluxes to be optimized in the program, Mi is the 
measured MS data, Ni is the corresponding model-simulated MS data, and δi is the 
corresponding standard deviation in the GC-MS data (1~2%). The unknown 
metabolic fluxes were searched to minimize ε. The model was solved by IPOPT 
(Interior Point Optimizer, https://projects.coin-or.org/Ipopt), which is a software 
package for large-scale nonlinear optimization. To avoid getting trapped in a local 
optimal minimum, multiple initial guesses (>100) were used for model calculation 
to obtain the global solution.  
To estimate the confidence interval for the calculated fluxes, a Monte 
Carlo approach was employed (15). In brief, the isotopomer concentration data 
sets were generated by adding 2% of normally distributed measurement noise to 
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actual measured isotopomer data. The same optimization routine was used to 
estimate flux distribution from these data sets.  Confidence limits for each flux 
value were obtained from the probability distribution of calculated fluxes 
resulting from the simulated data sets (n=100). To determine the cellular 
metabolism’s requirements for energy and reducing power, the relative 
consumption rates of ATP, NADH, NADPH and ferredoxin were quantified based 
on the flux distributions in the central metabolic pathways and biomass synthesis 
rates.  
Calculation of biomass yield. The biomass yield (moles of carbon in 
biomass/moles of substrate) was calculated based on the substrate uptake rates 
(moles of substrate/L/hr) and biomass growth rates (g DCW/L/hr). The molecular 
formula for Cba. tepidum was assumed to be CH1.8O0.5N0.2P0.02 (molecular weight 
MW ≈ 25.5) (30). The biomass yield was calculated by: 
biomass growth rate (g/L/hr)
MW of biomass (g/mol)
Yield=
substrate uptake rate (mol/L/hr)
 
4.2.4 Results and discussion 
Carbon utilization during mixotrophic growth. During exponential-
growth with pyruvate and acetate, Cba. tepidum had the growth rates of 0.12 h
-1 
and 0.17 h
-1
, respectively. In the trace experiments, the labeled carbons were 
detected in all amino acids (Table 4.2.1), suggesting utilization of acetate or 
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pyruvate to synthesize all building blocks. Table 4.2.2 shows the ratio of carbon 
utilization (organic carbon vs. CO2) for mixotrophic synthesis of proteinogenic 
amino acids. For acetate culture, the substrate utilization ratio for Ala (precursor: 
pyruvate) was 0.60, which indicated that carbons in pyruvate were mainly derived 
from labeled acetate. Pyruvate is the precursor for both the gluconeogenesis 
pathway and the pentose phosphate pathway, so the R ratios (Equation 1) of Ser 
and Phe are similar to that of alanine. The substrate utilization ratio of His was 
high (0.96) for culture with [2-
13
C]acetate because the His precursor C1 pool (N
5
, 
N
10
-methylene-tetrahydrofolate) was highly labeled. This carbon was derived 
from acetate by following route: 
[2-
13
C]acetate[3-13C]pyruvate[3-13C]Ser[13C] C1 pool. 
In the mixotrophic culture with acetate, the R ratios for aspartate and 
glutamate (~0.2) were significantly lower than the other amino acids. Aspartate 
and glutamate were synthesized from the RTCA cycle, so the small R values 
indicated that the unlabeled CO2 was the dominant carbon source for synthesizing 
metabolites in the RTCA cycle. In pyruvate culture, the substrate utilization ratios 
of amino acids (Ala, Phe, Ser, and Asp) were all lower than in acetate culture, 
indicating a higher contribution of CO2 to synthesize building blocks.  
Analysis of amino acid biosynthesis pathways. Growing in a completely 
defined medium, Cba. tepidum was able to synthesize all amino acids from CO2 
and organic carbon sources using the annotated pathways. Interestingly, the 
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labeling patterns of Leu and Ile from tracer experiments were found to be 
identical, which indicated that the two amino acids shared the same precursors. Ile 
is commonly synthesized via threonine ammonia-lyase, with Thr and pyruvate as 
the precursors, while Leu is synthesized from pyruvate and acetyl-CoA. In the [2-
13
C] acetate trace experiment, both Thr and pyruvate are singly labeled, which 
could lead only to doubly labeled Ile, instead of the triply labeled Ile detected by 
GC-MS. Such an observation is consistent with the fact that a gene encoding 
threonine ammonia-lyase has not been annotated in the genome of Cba. tepidum. 
On the other hand, an alternative pathway for Ile biosynthesis (i.e., threonine-
independent pathway) has been recently identified in several bacteria 
(9,10,25,31), where Ile is synthesized from acetyl-CoA and pyruvate (i.e., using 
the same precursors as Leu) through the formation of citramalate as the 
intermediate (Figure 4.2.1). A search in the genome of Cba. tepidum for the gene 
for citramalate synthase (CimA) as found in Geobacter (10) returned a high 
identity for CT0612 (~ 52%), supporting the presence of the citramalate pathway 
for Ile synthesis. 
Central carbon metabolic pathways. The genome annotation from the 
KEGG database indicates: 1) pyruvate:ferredoxin oxidoreductase (PFOR) (porA, 
CT1628) converts pyruvate to acetyl-CoA (an end-product from RTCA cycle), 2) 
phosphoenolpyruvate (PEP) is derived from pyruvate via pyruvate phosphate 
dikinase (ppd, CT1682), and 3) PEP is fed into the TCA cycle via the CO2-
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anaplerotic pathway (Figure 4.2.2). The fraction of non-labeled Asp (M0=0.64, 
Table 4.2.1) was much higher than that of Ala (M0=0.45, Table 4.2.1) in trace 
experiments with [1-
13
C] acetate, which indicated that non-labeled oxaloacetate 
was also generated through CO2 fixation via the RTCA cycle. Furthermore, 
similar labeling patterns of Ala (precursor: pyruvate) and Ser (precursor: 
glycerate-3-P) confirmed that the carbon flux through the gluconeogenesis 
pathway was mainly from pyruvate.  
The flux analysis results are shown in Figure 4.2.2. In general, predicted 
labeling patterns of all amino acids were good matches with the measured 
isotopomer data (Figure 4.2.3). Under acetate-growth conditions, acetyl-CoA 
could be generated from acetate uptake or as the end-product through the RTCA 
cycle. Fluxes through pyruvate:ferredoxin oxidoreductase (PFOR), the RTCA 
cycle, and the CO2-anaplerotic pathway were ~152, 80-100, and ~30 units, 
respectively (Figure 4.2.2). Meanwhile, the flux ratio of the gluconeogenesis 
pathway to the RTCA cycle was close to 1:1. The oxidative pentose phosphate 
pathway (G6P  6PG  Ru5P) was inactive under our experimental conditions. 
Compared to mixotrophic growth with acetate, the flux distribution during 
pyruvate growth demonstrated different patterns. In general, the fluxes into the 
RTCA cycle and CO2-anaplerotic pathway were much higher (200-230 units and 
~50 units, respectively) and thus more CO2 was fixed. The flux ratio of the 
gluconeogenesis pathway to the RTCA cycle was reduced to 1:2, while acetyl-
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CoA was generated only from the RTCA cycle. The oxidative pentose phosphate 
pathway was not active (flux<1 unit) under pyruvate mixotrophic growth (or 
acetate mixotrophic growth).  
In the mixotrophic cultures grown on acetate or pyruvate, most reactions 
in the RTCA cycle were freely reversible (exchange coefficient close to 1). The 
reversibility is consistent with the physiological free energy changes in the RTCA 
cycle, where the standard Gibbs free energy for most reactions of the TCA cycle 
is positive so that the magnitude of the reaction equilibrium constants is small 
(32). Furthermore, PFOR catalyzes a reversible reaction between pyruvate and 
acetyl-CoA (pyruvate + CoA + 2 Fdox ↔ acetyl-CoA + CO2 + 2 Fdred + 2 H
+
). 
However, metabolic flux analysis of the mixotrophic metabolism indicates that 
the net flux of this enzymatic reaction was from acetyl-CoA to pyruvate (33). The 
direction of the PFOR pathway indicates that the reduced ferredoxin from 
phototrophic processes made the reaction for pyruvate synthesis 
thermodynamically favorable. 
Energy metabolism of Chlorobaculum tepidum. The mixotrophic 
metabolism of Cba. tepidum consumes energy harvested from light.  Since the 
oxidative pentose phosphate pathway and normal TCA cycle are not fully 
functional, the energy (NADPH and NADH) generation mainly depends on the 
light reactions. Based on the metabolic flux distribution and previous 
measurement of the absolute uptake rates of carbon substrates and biomass 
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growth (27), the light-energy harvested for central metabolism and biomass 
growth was approximately quantified (Figure 4.2.4). In general, the photons 
absorbed by pigments (e.g. bacteriochlorophylls) initiate the electron flow and 
oxidize sulfide. The electrons are used to reduce ferredoxin and generate 
NAD(P)H (3,4). Concomitant with the oxidation of the reduced ferredoxin, the 
essential cofactors for energy metabolism (i.e., NADPH and NADH) are mainly 
generated by ferredoxin-NAD(P)
+
 reductase (3,34). Meanwhile, the oxidation of 
sulfide also creates a proton motive force for ATP production. The generated 
ATP, cofactors, and reduced ferredoxin then become the “driver” for the 
mixotrophic metabolism and the RTCA cycle for energy-demanding CO2 fixation. 
Figure 4.2.4 shows that the ATP, NADH and NADPH fluxes into biomass and the 
RTCA cycle are stronger in acetate-grown cultures than in pyruvate-grown 
cultures, supporting a higher growth rate during mixotrophic growth with acetate. 
On the other hand, the calculated biomass yield (moles of carbon in 
biomass/moles of substrate) was higher for pyruvate culture (YX/S=9.2) than for 
acetate (YX/S=6.4), based on our previous experiments (27), which is consistent 
with the fact that the normalized fluxes through RTCA are higher in pyruvate 
culture than acetate culture. Accordingly, pyruvate metabolism has more CO2 
fixation (but slower growth rate).  
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Figure 4.2.1. Citramalate pathway for isoleucine biosynthesis in Cba. tepidum 
(using [2-
13
C] acetate and NaHCO3 as the carbon sources). The asterisks indicate 
the positions of labeled carbon. The dashed lines indicate inactive pathways. 
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Figure 4.2.2. Metabolic flux distribution in Cba. tepidum. (A) Net flux 
distribution in acetate growth conditions (based on [2-
13
C] acetate culture); (B) 
net flux distribution in pyruvate growth conditions. The standard derivation (std) 
and exchange coefficients are marked by flux +/- std and < exchange coefficient > 
respectively. The inactive pathways are marked with dashed lines. The calculated 
biomass yield (moles of carbon in biomass/moles of substrate): pyruvate culture 
(YX/S=9.2); acetate culture (YX/S=6.4). Abbreviations: 3PG, 3-phosphoglycerate; 
6PG, 6-phosphogluconate; AC.ext, extracellular acetate; AC, intracellular acetate; 
ACCOA, acetyl-coenzyme A; AKG, α-ketoglutarate; CIT, citrate; DCW, dry cell 
weight; E4P, erythrose-4-phosphate; F6P, fructose-6-phosphate; FBP, Fructose 
1,6-bisphosphate; Fdred, reduced ferredoxin; Fdox, oxidized ferredoxin; FNR, 
ferredoxin-NAD(P)
+
 reductase; FUM, fumarate; G6P, glucose-6-phosphate; GAP, 
glyceraldehyde 3-phosphate; ICIT, isocitrate; KGOR, 2-ketoglutarate ferredoxin 
oxidoreductase; MAL, malate; OAC, oxaloacetate; PEP, phosphoenolpyruvate; 
PFOR, pyruvate:ferredoxin oxidoreductase; PYR, intracellular pyruvate; PYR.ext, 
extracellular pyruvate; R5P, ribose-5-phosphate; Ru5P, ribulose-5-phosphate; 
RTCA, the reductive tricarboxylic acid; S7P, sedoheptulose-7-phosphate; SUCC, 
succinate; SUCCoA, Succinyl-CoA; Xu5P, xylulose-5-phosphate.  
 156 
 
 
 
A 
 157 
 
 
 
 
 
 
B 
 158 
 
Figure 4.2.3. Model quality test for (A) acetate metabolism; (B) pyruvate 
metabolism. ● alanine data, ○ serine data, ▼ aspartate data, Δ glutamate data, ■ 
leucine data, □ histidine data, ◊ phenylalanine data, and ♦ glycine data. 
 
 
 159 
 
Figure 4.2.4. Proposed energy metabolism in Cba. tepidum. (A) energy 
requirement (mmol/gDCW/hr) in acetate growth conditions; (B) energy 
requirement (mmol/gDCW/hr) in pyruvate growth conditions. The intracellular 
energy metabolism was quantified in the framed figures based on the relative flux 
distributions (The detailed calculations are in Supplementary Tables 4.2.S4A and 
S4B). Arrows pointing to the framed figure indicated the energy demand of 
intracellular metabolism. Arrows pointing to biomass indicate the energy demand 
of biomass accumulation. Arrows pointing from light indicated the entire energy 
harvested by Cba. tepidum. The light reaction produces reduced ferredoxin and 
ATP. NADPH and NADH are mainly generated by ferredoxin-NAD(P)
+
 
reductase. Biomass (protein) synthesis can also generate a small amount of 
NADH, as indicated in the figure. 
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Figure 4.2.S1. Pathway map for mixotrophic metabolism of Chlorobaculum 
tepidum 
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Table 4.2.1. Isotopic labeling patterns in amino acids from Chlorobaculum 
tepidum
a
 
Carbon source Amino acids Fragments M0 M1 M2 
[1-
13
C] acetate 
Ala 
[M-57]
+
 0.45 0.54 0.01 
[M-159]
+
 0.44 0.53 0.03 
Gly 
[M-57]
+
 0.54 0.46 0.00 
[M-85]
+
 0.54 0.46  
Ser 
[M-57]
+
 0.46 0.52 0.02 
[M-159]
+
 0.47 0.53 0.00 
Leu [M-159]
+
 0.21 0.43 0.33 
Ile [M-159]
+
 0.21 0.43 0.33 
Asp 
[M-57]
+
 0.64 0.35 0.01 
[M-159]
+
 0.65 0.34 0.01 
Glu 
[M-57]
+
 0.63 0.33 0.04 
[M-159]
+
 0.63 0.33 0.04 
Phe 
[M-57]
+
 0.11 0.29 0.36 
[M-159]
+
 0.12 0.30 0.36 
[2-
13
C] acetate 
Ala 
[M-57]
+
 0.43 0.56 0.01 
[M-159]
+
 0.42 0.54 0.04 
Gly 
[M-57]
+
 0.94 0.06 0.00 
[M-85]
+
 0.95 0.05  
Ser 
[M-57]
+
 0.44 0.55 0.01 
[M-159]
+
 0.45 0.55 0.00 
Leu [M-159]
+
 0.13 0.25 0.36 
Ile [M-159]
+
 0.14 0.25 0.36 
Asp 
[M-57]
+
 0.61 0.38 0.00 
[M-159]
+
 0.62 0.37 0.00 
Glu 
[M-57]
+
 0.62 0.35 0.03 
[M-159]
+
 0.63 0.34 0.03 
Phe 
[M-57]
+
 0.13 0.26 0.36 
[M-159]
+
 0.14 0.26 0.35 
His 
[M-57]
+
 0.16 0.35 0.36 
[M-159]
+
 0.28 0.48 0.22 
[3-
13
C] pyruvate 
Ala 
[M-57]
+
 0.67 0.32 0.01 
[M-159]
+
 0.65 0.30 0.05 
Gly 
[M-57]
+
 0.96 0.04 0.00 
[M-85]
+
 0.97 0.03  
Ser 
[M-57]
+
 0.71 0.28 0.01 
[M-159]
+
 0.71 0.28 0.01 
Leu [M-159]
+
 0.47 0.38 0.12 
Ile [M-159]
+
 0.47 0.39 0.12 
Asp 
[M-57]
+
 0.82 0.17 0.00 
[M-159]
+
 0.83 0.15 0.01 
Glu 
[M-57]
+
 0.75 0.20 0.05 
[M-159]
+
 0.76 0.20 0.04 
Phe [M-57]
+
 0.38 0.41 0.17 
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[M-159]
+
 0.38 0.40 0.18 
His 
[M-57]
+
 0.46 0.41 0.11 
[M-159]
+
 0.56 0.34 0.08 
a. the standard deviations for GC-MS measurement were based on the 
duplicate experiments (n=2), with the standard deviation below 2%. 
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Table 4.2.2. Carbon substrate utilization ratios
a
 in amino acids from 
Chlorobaculum tepidum 
Amino 
acids 
Carbon sources 
[1-
13
C] acetate + 
NaHCO3 
[2-
13
C] acetate + 
NaHCO3 
[3-
13
C] pyruvate + 
NaHCO3 
Ala 0.60 0.60 0.48 
Ser 0.58 0.58 0.42 
Asp 0.20 0.22 0.12 
Glu 0.18 0.18 0.21 
His NA
b
 0.96 0.38 
Phe 0.62 0.64 0.26 
a. the carbon source utilization ratio (organic substrate/CO2 fixation) for amino 
acid synthesis was calculated according to Equation (1); b. isotopomer labeling 
pattern for histidine was not detected under [1-
13
C] acetate + NaHCO3 due to the 
weak signal to noise ratio in GC-MS. 
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Table 4.2.S1. Metabolic pathways in mixotrophic metabolism of Chlorobaculum 
tepidum 
Pathway 
ID 
Reactions Notes 
v1_ACT 
Extracellular acetate→Intracellular 
acetate 
Confirmed by qRT-PCR (acsA, ackA) 
v1_PYR 
Extracellular pyruvate→Intracellular 
pyruvate 
 
v2 Acetate→Acetyl-CoA (-ATP)  
v3 Acetyl-CoA+CO2↔Pyruvate (-2 Fdred) Confirmed by qRT-PCR (porA) 
v4 PEP/Pyruvate+CO2↔OAC (+ATP) Confirmed by qRT-PCR (ppc, pckA) 
v5 OAC↔MAL (-NADH)  
v6 MAL↔FUM  
v7 FUM↔SUCC (-2[H])  
v8 SUCC↔SUCCoA (-ATP)  
v9 SUCCoA+CO2↔AKG (-2 Fdred) Confirmed by qRT-PCR (korA, korB) 
v10 AKG+CO2↔ICIT (-NADPH) Confirmed by qRT-PCR (icd) 
v11 ICIT↔CIT Confirmed by qRT-PCR (acn) 
v12 CIT↔ACCOA+OAC 
Confirmed by qRT-PCR (gltA, aclA, 
aclB) 
v13 PYR↔PEP (-ATP) Confirmed by qRT-PCR (ppd) 
v14 PEP↔3PG  
v15 3PG→GAP (-ATP) (-NADH)  
v16 2 GAP→FBP  
v17 FBP→F6P (+ATP)  
v18 F6P→GAP  
v19 GAP→6PG (+NADPH)  
v20 6PG→C5P+CO2 (+NADPH)  
v21 F6P+GAP↔XU5P+E4P  
v22 E4P+F6P↔S7P+GAP  
v23 S7P+GAP↔XU5P+R5P  
v24 R5P→Biomass Energy cost is listed in Table.S2 
v25 E4P→Biomass Energy cost is listed in Table.S2 
v26 F6P→Biomass Energy cost is listed in Table.S2 
v27 G6P→Biomass Energy cost is listed in Table.S2 
v28 GAP→Biomass Energy cost is listed in Table.S2 
v29 3PG→Biomass Energy cost is listed in Table.S2 
v30 PEP→Biomass Energy cost is listed in Table.S2 
v31 PYR→Biomass Energy cost is listed in Table.S2 
v32 ACCOA→Biomass Energy cost is listed in Table.S2 
v33 OAC→Biomass Energy cost is listed in Table.S2 
v34 AKG→Biomass Energy cost is listed in Table.S2 
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Table 4.2.S2. Precursors for building blocks synthesis in Chlorobaculum tepidum 
Building block  
 
 
Cost of making 1 mol of each of these building blocks 
(mol/mol) 
Precursors 
Protein amino acids  
Alanine 1 PYR 
Arginine 1 AKG, (-5 ATP) (-1 NADPH) 
Asparagine 1 Asp, (-2 ATP) 
Aspartate 1 OAC 
Cysteine 1 Ser (-3 ATP) (-4 NADPH) 
Glutamate 1 AKG (-1 NADPH) 
Glutamine 1 Glu (-1 ATP) 
Glycine 1 Ser 
Histidine 1 C5P, 1 C1 unit (-5 ATP) (+2 NADH) 
Isoleucine 2 PYR, 1 ACCOA (-1 NADPH) (+1 NADH) 
Leucine 2 PYR, 1 ACCOA (-1 NADPH) (+1 NADH) 
Lysine 1 OAC, 1 PYR (-1 NADPH) 
Methionine 1 Asp,1 C1 unit (-1 ATP) (-2 NADPH) 
Phenylalanine 1 E4P, 2 PEP (-1 ATP) (-1 NADPH) 
Proline 1 Glu (-1 ATP) (-2 NADPH) 
Serine 1 3PG (+1 NADH) 
Threonine 1 OAC (-2 ATP) (-2 NADPH) 
Tryptophan 1 C5P, 1 E4P,1 PEP (-3 ATP) (-1 NADPH) 
Tyrosine 1 E4P, 2 PEP (-1 ATP) (-1 NADPH) (+1 NADH) 
Valine 2 PYR (-1 NADPH) 
RNA nucleotides  
ATP 1 C5P, 1 3PG 
GTP 1 C5P, 1 3PG 
CTP 1 C5P, 1 OAC 
UTP 1 C5P, 1 OAC 
DNA nucleotides  
dATP 1 C5P, 1 3PG 
dGTP 1 C5P, 1 3PG 
dCTP 1 C5P, 1 OAC 
dTTP 1 C5P, 1 OAC 
Average fatty acid 8.2 ACCOA 
Average 
carbohydrate 
1 G6P 
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Table 4.2.S3.  Atom mapping matrices for metabolic reactions 
PyrPEP 
  1  0  0 
  0  1  0 
  0  0  1 
PEP3PG 
  1  0  0 
  0  1  0 
  0  0  1 
3PGGAP 
  1  0  0 
  0  1  0 
  0  0  1 
Acetate 
ACCOA 
  1  0 
  0  1 
 
C1GLY 
  0 
  1 
 
ICITCO2 
 0  0  0  0  0  1 
 
ACCOAPyruvate 
  0     0 
  1     0 
  0     1 
AKGCO2 
  1  0  0  0  0 
 
AKG GLU 
  1  0  0  0  0 
  0  1  0  0  0 
  0  0  1  0  0 
  0  0  0  1  0 
  0  0  0  0  1 
AKGSUCC 
  0  1  0  0  0 
  0  0  1  0  0 
  0  0  0  1  0 
  0  0  0  0  1 
 
ASPMET 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
  0  0  0  0 
 
ACCOA  LEU 
  1  0 
  0  1 
  0  0 
  0  0 
  0  0 
  0  0 
PYR LEU 
  0  0  0 
  0  0  0 
  0  1  0 
  0  1  0 
  0  0  1 
  0  0  1 
C1MET 
  0 
  0 
  0 
  0 
  1 
 
C1HIS 
  0 
  0 
  0 
  0 
  0 
  1 
E4PTYR 
  0  0  0  0 
  0  0  0  0 
  0  0  0  0 
  0  0  0  0 
  0  0  0  0 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
E4PF6P 
  0  0  0  0 
  0  0  0  0 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
 
E4PPHE 
  0  0  0  0 
  0  0  0  0 
  0  0  0  0 
  0  0  0  0 
  0  0  0  0 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
E4PS7P 
  0  0  0  0 
  0  0  0  0 
  0  0  0  0 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
 
E4PGAP 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
 
CO2OAA 
  0 
  0 
  0 
  1 
 
F6PE4P 
  0  0  1  0  0  0 
  0  0  0  1  0  0 
  0  0  0  0  1  0 
  0  0  0  0  0  1 
 
F6PG6P 
  1  0  0  0  0  0 
  0  1  0  0  0  0 
  0  0  1  0  0  0 
  0  0  0  1  0  0 
  0  0  0  0  1  0 
  0  0  0  0  0  1 
F6PS7P 
  1  0  0  0  0  
0 
  0  1  0  0  0  
0 
  0  0  1  0  0  
0 
  0  0  0  0  0  
0 
  0  0  0  0  0  
0 
  0  0  0  0  0  
0 
  0  0  0  0  0  
0 
GAPF6P 
  0  0  1   
  0  1  0  
  1  0  0   
  1  0  0   
  0  1  0  
  0  0  1   
 
F6PC5P 
  1  0  0  0  0  0 
  0  1  0  0  0  0 
  0  0  0  0  0  0 
  0  0  0  0  0  0 
  0  0  0  0  0  0 
 
ICITAKG 
  1  0  0  0  0  0 
  0  1  0  0  0  0 
  0  0  1  0  0  0 
  0  0  0  1  0  0 
  0  0  0  0  1  0 
 
F6PG6P 
  1  0  0  0  0  0 
  0  1  0  0  0  0 
  0  0  1  0  0  0 
  0  0  0  1  0  0 
  0  0  0  0  1  0 
  0  0  0  0  0  1 
G6PC5P 
  0  1  0  0  0  
0 
  0  0  1  0  0  
0 
  0  0  0  1  0  
0 
OACMAL 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
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  0  0  0  0  1  
0 
  0  0  0  0  0  
1 
 
MALFUM 
  0.5  0  0  0.5 
  0  0.5  0.5  0 
  0  0.5  0.5  0 
  0.5  0  0  0.5 
FUMSUCC 
  0.5  0  0  0.5 
  0  0.5  0.5  0 
  0  0.5  0.5  0 
  0.5  0  0  0.5 
SUCCSUCCoA 
  0.5  0  0  0.5 
  0  0.5  0.5  0 
  0  0.5  0.5  0 
  0.5  0  0  0.5 
PYRCO2 
  1  0  0 
 
PYRACCOA 
  0  1  0 
  0  0  1 
 
SUCCoASUCC 
  0.5  0  0  0.5 
  0  0.5  0.5  0 
  0  0.5  0.5  0 
  0.5  0  0  0.5 
CO2 MAL 
  0 
  0 
  0 
  1 
PYROAA 
  1  0  0  
  0  1  0   
  0  0  1   
  0  0  0 
SUCCFUM 
  0.5  0  0  0.5 
  0  0.5  0.5  0 
  0  0.5  0.5  0 
  0.5  0  0  0.5 
FUMMAL 
  0.5  0  0  0.5 
  0  0.5  0.5  0 
  0  0.5  0.5  0 
  0.5  0  0  0.5 
AKGSUCCoA 
  0   1     0     0     0 
  0   0     1     0     0 
  0   0     0     1     0 
  0   0     0     0     1 
SUCCoA 
AKG 
  0  0  0  0 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
MAL(OAA)CO2 
  0  0  0  1 
 
MALOAC 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
PYRMAL 
  1  0  0  
  0  1  0   
  0  0  1   
  0  0  0 
CIT  ACCOA 
 
 
0.5  0  0   0   0.5   0      
0   0.5   0   0.5 0   0 
ACCOA  CIT 
  0.5  0 
  0     0.5 
 0     0 
  0     0.5 
  0.5  0 
  0     0 
CITOAC 
 0    0    0   0     0     1 
 0    0    1   0     0     0 
 0    0.5 0  0.5   0     0 
 0.5  0   0   0   0.5     0 
OACCIT  
  0  0  0    0.5 
  0  0  0.5  0 
  0  1  0     0 
  0  0  0.5  0 
  0  0  0     0.5 
  1  0  0      0 
PYRALA 
  1  0  0 
  0  1  0 
  0  0  1 
 
OACASP 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
  0  0  0  1 
OACCO2 
  0  0  0  1 
 
PEPOAA 
  1  0  0 
  0  1  0 
  0  0  1 
  0  0  0 
OACPEP 
  1  0  0  0 
  0  1  0  0 
  0  0  1  0 
PEPPYR 
  1  0  0 
  0  1  0 
  0  0  1 
 
C5PF6P 
  1  0  0  0  0 
  0  1  0  0  0 
  0  0  0  0  0 
  0  0  0  0  0 
  0  0  0  0  0 
  0  0  0  0  0 
 
C5PS7P  
  1  0  0  0  0 
  0  1  0  0  0 
  1  0  0  0  0 
  0  1  0  0  0 
  0  0  1  0  0 
  0  0  0  1  0 
  0  0  0  0  1 
 
G6PCO2 
  1  0  0  0  0  0 
 
PEPTYR 
  1  0  0 
  0  1  0 
  0  0  1 
  0  1  0 
  0  0  1 
  0  0  0 
  0  0  0 
  0  0  0 
  0  0  0 
PEPPHE 
  1  0  0 
  0  1  0 
  0  0  1 
  0  1  0 
  0  0  1 
  0  0  0 
  0  0  0 
  0  0  0 
  0  0  0 
GAPC5P 
  0  0  0 
  0  0  0 
  1  0  0 
  0  1  0 
  0  0  1 
 
PYRLEU 
  0  0  0 
  0  0  0 
  0  1  0 
  0  2  0 
  0  0  2 
  0  0  1 
PYRLys 
  0  0  0 
  0  0  0 
  0  0  0 
  0  0  0 
  0  1  0 
  0  0  1 
PYRVal 
  1  0  0 
  0  1  0 
  0  2  0 
  0  0  2 
  0  0  1 
C5PHis 
  1  0  0  0  0 
  0  1  0  0  0 
  0  0  1  0  0 
  0  0  0  1  0 
  0  0  0  0  1 
  0  0  0  0  0 
C5PS7P  
  1  0  0  0  0 
C5PGAP 
  0  0  1  0  0 
S7PE4P 
 0  0  0  1  0  0  0 
S7PF6P 
  1  0  0  0  0  0  0 
S7P C5P  
  1  0  1  0  0  0  0 
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  0  1  0  0  0 
  1  0  0  0  0 
  0  1  0  0  0 
  0  0  1  0  0 
  0  0  0  1  0 
  0  0  0  0  1 
  0  0  0  1  0 
  0  0  0  0  1 
 
 0  0  0  0  1  0  0 
 0  0  0  0  0  1  0 
 0  0  0  0  0  0  1 
 
  0  1  0  0  0  0  0 
  0  0  1  0  0  0  0 
  0  0  0  0  0  0  0 
  0  0  0  0  0  0  0 
  0  0  0  0  0  0  0 
 
  0  1  0  1  0  0  0 
  0  0  0  0  1  0  0 
  0  0  0  0  0  1  0 
  0  0  0  0  0  0  1 
 
SERC1 
  0  0  1 
 
SERGLY 
  1  0  0 
  0  1  0 
 
ICITAKG 
  1  0  0  0  0  0   
  0  1  0  0  0  0 
  0  0  1  0  0  0 
  0  0  0  1  0  0 
  0  0  0  0  1  0 
AKGICIT 
  1  0  0  0  0 
  0  1  0  0  0 
  0  0  1  0  0 
  0  0  0  1  0 
  0  0  0  0  1  
  0  0  0  0  0 
GAPE4P 
  0  0  0 
  1  0  0 
  0  1  0 
  0  0  1 
CITICIT 
  0.5  0  0  0  0.5  0 
  0  0.5  0  0.5  0  0 
  0  0  1  0  0  0 
  0  0.5  0  0.5  0  0 
  0.5 0  0  0  0.5  0 
  0  0  0  0  0  1 
ICITCIT 
   0.5  0  0  0  0.5  
0 
  0  0.5  0  0.5  0  
0 
  0  0  1  0  0  0 
  0  0.5  0  0.5  0  
0 
  0.5 0  0  0  0.5  
0 
  0  0  0  0  0  1 
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Table 4.2.S4A. Energy demand of Chlorobaculum tepidum in acetate growth 
conditions 
Acetate Metabolism 
Flux ID Flux (units) 
Flux 
(mmol/g/hr) 
ATP NADH NADPH 2[H] Fdred 
v1_ACT 100.0±0.0 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v2 100.0±0.0 1.0±0.1 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v3 152.4±11.4 1.5±1.2 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 3.0±0.2 
v4 33.1±2.3 0.3±0.0 -0.3±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v5 98.1±11.3 1.0±0.1 0.0±0.0 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 
v6 98.1±11.3 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v7 98.1±11.3 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 1.0±0.1 0.0±0.0 
v8 98.1±11.3 1.0±0.1 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v9 98.1±11.3 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 2.0±0.2 
v10 81.4±9.4 0.8±0.1 0.0±0.0 0.0±0.0 0.8±0.1 0.0±0.0 0.0±0.0 
v11 81.4±9.4 0.8±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v12 81.4±9.4 0.8±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v13 124.2±10.4 1.2±0.1 1.2±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v14 81.1±15.0 0.8±0.2 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v15 51.1±7.8 0.5±0.1 0.5±0.1 0.5±0.1 0.0±0.0 0.0±0.0 0.0±0.0 
v16 18.5±2.4 0.2±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v17 18.5±2.4 0.2±0.0 -0.2±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v18 1.7±0.2 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v19 0.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v20 0.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v21 10.9±1.8 0.1±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v22 4.2±0.2 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v23 4.2±0.2 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
Sum - - 3.2±0.4 1.5±0.2 0.8±0.1 1.0±0.1 5.0±0.5 
Biomass - 
μ=0.17 hr-1 
±0.02 hr-1 
40.86∙0.17 
=6.9±0.7 
-3.55∙0.17 
=0.6±0.1 
16.87∙0.17 
=2.9±0.3 
0.00∙0.17 
=0.0±0.0 
0.00∙0.17 
=0.0±0.0 
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Table 4.2.S4B. Energy demand of Chlorobaculum tepidum in pyruvate growth 
conditions 
Pyruvate Metabolism 
Flux ID Flux (units) 
Flux 
(mmol/g/hr) 
ATP NADH NADPH 2[H] Fdred 
v1_PYR 100.0±0.0 0.4±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v2 100.0±0.0 0.4±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v3 138.1±10.2 0.6±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 1.2±0.1 
v4 48.1±5.6 0.2±0.0 -0.2±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v5 230.4±26.6 1.0±0.1 0.0±0.0 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 
v6 230.4±26.6 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v7 230.4±26.6 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 1.0±0.1 0.0±0.0 
v8 230.4±26.6 1.0±0.1 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v9 230.4±26.6 1.0±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 2.0±0.2 
v10 207.3±21.0 0.9±0.1 0.0±0.0 0.0±0.0 0.9±0.1 0.0±0.0 0.0±0.0 
v11 207.3±21.0 0.9±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v12 207.3±21.0 0.9±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v13 161.1±4.9 0.7±0.0 0.7±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v14 100.0±11.8 0.4±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v15 70.1±9.5 0.3±0.0 0.3±0.0 0.3±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v16 25.4±10.9 0.1±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v17 25.4±10.9 0.1±0.0 -0.1±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v18 2.9±1.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v19 0.4±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v20 0.4±0.1 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v21 14.6±6.2 0.1±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v22 5.5±2.6 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
v23 5.5±2.6 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 
Sum - - 1.7±0.2 1.3±0.1 0.9±0.1 1.0±0.1 3.2±0.3 
Biomass - 
μ=0.12 hr-1 
±0.01 hr-1 
40.86∙0.12 
=4.9±0.5 
-3.55∙0.12 
=-0.4±0.1 
16.87∙0.12 
=2.0±0.2 
0.00∙0.12 
=0.0±0.0 
0.00∙0.12 
=0.0±0.0 
 
Biomass formation: 2.833 PYR+ 1.078 AKG+1.787 OAC+1.493 3PG+0.898 
R5P+2.938 ACCOA+0.719 PEP+0.361 E4P+0.205 G6P+0.071 F6P+0.129 GAP 
+16.866 NADPH+ 40.860 ATP→39.68 Biomass+3.547 NADH 
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4.3 
13
C-metabolic flux analyses of Thermoanaerobacter species  
13
C-MFA has been applied to quantify and compare metabolic flux 
distributions in two Thermoanaerobacter species: Thermoanaerobacter sp. X514 
and Thermoanaerobacter pseudethanolicus 39E (35). Both species were cultured 
anaerobically with 2 g/L of [1-
13
C] glucose or 2 g/L of [1-
13
C] xylose. The 
metabolic network of Thermoanaerobacter species included pentose phosphate 
pathway, glycolysis, the branched TCA cycle, and the futile pathways.  
When using glucose as the carbon substrate, the flux through the oxidative 
pentose phosphate pathway, which was often used for NADPH production, was 
moderately higher in 39E than that in X514. In spite of very different growth rates 
between X514 and 39E in glucose and xylose cultures, the intracellular carbon 
flux distributions, after normalization by carbon substrate consumption rates, 
were not significantly different between these two strains. This suggested a 
similar regulation of central metabolic pathways in these two phylogenetically 
closely related strains. The report of 
13
C-MFA of Thermoanaerobacter species is 
attached in Appendix 7. Beside, 
13
C-MFA has also been used in investigating the 
metabolic robustness of Shewanella oneidensis MR-1 (36) (Appendix 8). 
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4.4.1 Abstract 
In a 
13
C-experiment for metabolic flux analysis (
13
C-MFA), we examined 
isotope discrimination by measuring the labeling of glucose, amino acids and 
hexose monophosphates via mass spectrometry. When Escherichia coli grew in a 
mix of 20% fully labeled and 80% naturally labeled glucose medium, the cell 
metabolism favored light isotopes, and the measured isotopic ratios (δ13C) were in 
the range of -35 to -92. Glucose transporters might play an important role in such 
isotopic fractionation. Flux analysis showed that both isotopic discrimination and 
isotopic impurities in labeled substrates could impact the accuracy and precision 
of 
13
C-MFA. 
Key words: amino acid, glucose transporter, δ13C, mass spectrometer, isotopic 
impurity 
4.4.2 Methods and results 
13
C-metabolic flux analysis (
13
C-MFA) experiments consist of feeding 
microbes with enriched 
13
C-labeled substrate, then measuring the isotopic 
distribution in the resulting metabolites (often amino acids) to quantify absolute 
fluxes through the metabolic network. In a typical 
13
C-MFA experiment, 
uniformly 
13
C-labeled substrates are often used in a mixture with the non-labeled 
form to create efficient scrambling of labeled carbons in the backbone of all 
metabolites (37,38). Such an experiment assumes that the microbial activity is 
equal for all isotopomers, and that 
13
C tracing will not change the metabolic 
 175 
 
kinetics.  However, a kinetic isotopic effect may be present in all bio-reactions, 
wherein light isotopes react faster than heavy isotopes due to the lower activation 
energies for enzymatic breaking of the 
12
C-
12
C bond than the 
13
C-
13
C bond 
(39,40,41). In the microbial process, the isotopic effect depends on isotopomer 
diffusion kinetics, intrinsic enzyme characteristics, and microbial growth 
conditions (such as pH, micronutrients, and growth factors) (41,42). However, 
most isotopic effect studies are in the fields of biogeochemistry and ecology, 
where the 
13
C is naturally labeled (around 1.1%).  
This study investigated the isotopic effect in 
13
C-MFA experiments when 
highly enriched 
13
C-susbtrate was used. E.coli BL21 (DE3) was first grown in M9 
medium with 22.2 mM of glucose (shaking flasks, 150 rpm, 37°C), which 
contained  non-labeled glucose (Sigma-Aldrich, USA) and fully labeled glucose 
(99% purity, Cambridge Isotope, USA) in approximately a 4:1 molar ratio. To 
reduce the non-labeled carbon from the initial stock, cells were then sub-cultured 
(0.1% inoculation ratio) in the same 
13
C-labeled medium. All sub-cultured 
samples from the 
13
C-MFA experiments were harvested at the mid-log phase (8 
hrs) for isotopomer analysis.   
We first employed an isotope ratio mass spectrometer and a gas 
chromatograph-mass spectrometer (GC-MS) to analyze isotopic fractionation in 
cell metabolism. The exact ratio of 
13
C/
12
C (i.e. 
13
C/
12
C=0.2497) in the initial 
carbon substrate (glucose) of 
13
C-MFA experiments was determined using an 
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isotope ratio mass spectrometer after combustion of glucose to CO2 (performed 
by the Stable Isotope Biogeochemistry Laboratory, Washington University). 
Since the mass detector could be saturated for 
13
C enriched compounds (
13
C >5%) 
(43), we made a tenfold dilution of the samples with naturally labeled glucose 
before measurement (39,40). To determine the ratio of 
13
C/
12
C in the biomass 
(reflected by proteinogenic amino acids), a gas chromatograph (Hewlett-Packard 
model 7890A; Agilent Technologies, CA) and a mass spectrometer (model 
5975C; Agilent Technologies, CA) were employed. The sample preparation and 
isotopic analysis of proteinogenic amino acids were performed as previously 
described (20,25). The GC-MS was carefully tuned and the measurement errors 
were determined using naturally labeled amino acids (Supplementary Table 
4.4.S1)(44). In a separate 
13
C-MFA experiment, we used a liquid chromatograph-
mass spectrometer (LC-MS) to investigate the isotopic effect. The first metabolite 
in the glycolysis, hexose monophosphate (mainly glucose 6-phosphate, G6P), was 
extracted by cold methanol. The labeling pattern was determined using ion pair 
reverse phase LC-TOF(a Quadrupole Time-of-Flight, Agilent) with electrospray 
ionization (ESI) in negative mode. The measurement was performed by the 
Proteomics & Mass Spectrometry Facility at the Donald Danforth Plant Science 
Center) (45).  
The isotopic ratio (δ13C) is a standard parameter for isotopic fractionation 
and was calculated as: 
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1000
glucose/
)glucose/()metabolite/(
1213
12131213
13
CC
CCCC
C
            (Equation 1) 
The 
13
C/
12
C ratio of glucose used in 
13
C-MFA experiments can be determined by 
an isotope ratio mass spectrometer or LC-TOF. In this work, the 
13
C/
12
C ratios in 
metabolites were calculated from the labeling patterns of metabolites. Due to their 
associated pathways, each metabolite has a different value for 
13
C/
12
C, given 
below: 
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i
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C
i
i
MiC
Mi
1
1
)(
         (Equation 2) 
where Mi is the isotopomer fraction for a given metabolite (i.e., M0 is the non-
labeled fraction, M1 is the singly labeled fraction, M2 is the doubly labeled 
fraction, , etc). C is the total number of carbon atoms in the molecule.  
Previous research has reported that when a naturally labeled carbon source 
was digested, the isotopic ratio for key metabolites (including amino acids) 
resulting from enzymatic conversion of glucose was around -20 (46). When E. 
coli was grown with 20% [U-
13
C] glucose and 80% non-labeled glucose, the 
growth curve was similar to that for non-labeled glucose (supplementary Figure 
4.4.S1). Based on GC-MS measurement, δ13C values from key amino acids were 
all negative (i.e., light isotopes were favored) and significantly above the 
instrument errors (Figure 4.4.1). The δ13C values also suggest that pathways may 
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have different isotope discrimination. Phenylalanine and histidine are derived 
from the pentose phosphate pathway. Their δ13C values were between -47 and -
45, similar to the δ13C values of serine and alanine (both of which are derived 
from glycolysis). On the other hand, leucine has acetyl-CoA as one of its 
precursors.  The oxidation of pyruvate to acetyl-CoA has been reported to have a 
strong isotopic effect (47), so the leucine synthesis route showed a higher 
microbial isotopic effect (δ13C = -79) than that of alanine (converted from 
pyruvate). Besides, aspartate had the highest isotopic ratio (δ13C = -92) among all 
amino acids, because the anaplerotic reaction (PEP + CO2  Oxaloacetate) used 
non-labeled CO2 for oxaloacetate (the precursor of aspartate) synthesis, leading to 
additional dilution of the 
13
C pool of aspartate.  
To confirm the GC-MS results, we performed independent 
13
C 
experiments and examined the labeling patterns of G6P and glucose in the 
13
C 
culture medium. Table 4.4.1 gives the LC-MS-based labeling fraction data for 
G6P (M0~M6, ion m/z=259~265) and glucose (M0~M6, ion m/z=179~185). These 
results indicate that cells selectively metabolize more light glucose than heavy 
glucose (δ13C=-77±27) during the middle-log phase. The LC-MS-based δ13C 
values were close to the δ13C values obtained by GC-MS (via analysis of amino 
acid labeling). The G6P data suggests that the selectivity of glucose uptake may 
also be a reason for isotopic fractionation. In general, heavy glucose (fully 
labeled, molecular weight=186 Da) has a slower diffusion rate than 
12
C glucose 
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(non-labeled, molecular weight=180 Da). Thus the glucose transporter may favor 
light glucose and cause isotopic fractionation during the glucose uptake process.  
Finally, a 
13
C-MFA model estimated the impact of the isotopic effect on 
the accuracy of flux calculations. The pathway map of E. coli BL21 (DE3) 
includes the glycolysis, citric acid cycle, pentose phosphate, and anaplerotic 
pathways (supplementary Fig 4.4.S2). The development of the 
13
C-MFA has been 
discussed previously (20). In brief, glucose, acetate, and biomass pools were 
measured, and glucose uptake rates were normalized to 100 units. The unknown 
fluxes were determined in an iterative scheme based on the reaction stoichiometry 
and atom transition routes through the defined metabolic network. The flux 
optimization was performed using the “fmincon” function in MATLAB 
(MathWorks). Because local solutions may be found, the model was run 50 times 
from different initial guesses to generate the solution space for each flux. By 
using the amino acid labeling data (supplementary Table 4.4.S2), the flux 
distributions were estimated with three sets of initial glucose-labeling patterns. 
The first glucose set (case 1) was comprised of 20% fully labeled glucose mixed 
with 80% non-labeled glucose, which represented the traditional approach for 
13
C-MFA. The second glucose set (case 2) was adjusted to 19.2% universally 
labeled glucose mixed with 80.8% non-labeled glucose, which corrected for bias 
in glucose utilization (i.e., assuming that E. coli utilizes relatively more 
12
C-
glucose than 
13
C-glucose). Such reduced labeling was based on a microbial 
isotopic fractionation ratio (δ13C = -47). The third glucose set (case 3) was based 
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on Table 4.4.1, and the labeling distribution was M0=74%, M1=5%, M2=1%, 
M5=1% and M6=18%. Since commercial labeled glucose is not perfectly pure 
(M0≠80%, M6≠20%), the differences in fluxes from case 1 and case 3 represent a 
common error in conventional GC-MS-based 
13
C-MFA analysis. The estimated 
global net flux distributions in the three sets of labeling data showed that the 
isotopic effect slightly changed the relative fluxes in the central pathways (~1 
units) (Supplementary Fig. 4.4.S3). Beside, consideration of the isotopic impurity 
of glucose improved the precision of the flux calculation (i.e. smaller solution 
space on case 3 than that on case 1). The flux difference in key pathways between 
case 1 and 3 could be up to 5 units. Therefore, the isotopic impurity, rather than 
isotopic fractionation, should be the concern for flux estimation in conventional 
labeling experiments.  
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Figure 4.4.1. Isotopic effect in E. coli BL21 (DE3) with 20% [U-
13
C] glucose and 
80% non-labeled glucose. The biased isotopic ratio is defined as - δ13C, based on 
GC-MS measurement. The higher the biased isotopic ratio, the more 
12
C atoms 
are preferred in the amino acids synthesis.   
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Figure 4.4.S1. Growth curve of E. coli BL21 (DE3) with non-labeled glucose (●, 
solid line) or 20% [U-
13
C] glucose and 80% non-labeled glucose (○, dot-dashed 
line). 
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Figure 4.4.S2. Flux analysis of central metabolism in E. coli BL21 (DE3). The 
grey arrows indicate fluxes to biomass. Abbreviations: 6PG, 6-phosphogluconate; 
ACCOA, acetyl-coenzyme A; E4P, erythrose-4-phosphate; F6P, fructose-6-
phosphate; G6P, glucose-6-phosphate; GAP, glyceraldehyde 3-phosphate; 3PG, 
3-phosphoglycerate; CIT, citrate/isocitrate; MAL, malate; OAA, oxaloacetate; 
AKG, 2-oxoglutarate; PEP, phosphoenolpyruvate; PYR, pyruvate; P5P, ribose-5-
phosphate (or xylulose-5-phosphate, or ribulose-5-phosphate); S7P, 
sedoheptulose-7-phosphate.  
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Figure 4.4.S3. Boxplot of metabolic flux results from MATLAB fmincon 
optimization using 50 random guesses of initial fluxes. Three sets of glucose-
labeling patterns were used for flux calculations. 1) not biased: 20% [U-
13
C] 
glucose mixed with 80% non-labeled glucose; 2) biased: 19.2% [U-
13
C] labeled 
glucose mixed with 80.8% non-labeled glucose; 3) actual: glucose labeling 
patterns obtained from LC-MS measurement as listed in Table 4.4.1. All the 
fluxes were normalized by taking the glucose uptake flux as 100 units, while the 
optimal flux values were marked in the Figure. 
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Table 4.4.1. Calculation of δ13C for G6P derived from LC-MS 
Fragmentations 
G6P in E. coli  Glucose in medium 
Replicate 1 Replicate 2 Replicate 1 Replicate 2 
M0  0.663 0.655 0.743 0.743 
M1  0.091 0.095 0.051 0.049 
M2  0.054 0.056 0.008 0.012 
M3  0.059 0.066 0.000 0.000 
M4  0.014 0.000 0.000 0.000 
M5  0.000 0.000 0.015 0.013 
M6  0.119 0.128 0.183 0.183 
(
13
C/
12
C) 
0.236 0.243 0.260 0.260 
0.240±0.005 0.260±0.000 
(δ13C) -77 
 
Note: Two independent culture experiments were performed with five technical 
repeated measurements. The instrument error was 0.4%. 
13
C/
12
C was calculated 
by equation 2; δ13C was calculated by equation 1.  
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Table 4.4.S1. GC/MS calibration for eight amino acids fragments. 
 
Ala 260 (C11H26O2NSi2); δ
13
C=-20.4  
m/z theory data difference 
260 100 100 0.0 
261 23.2 22.6 -0.6 
262 9.5 9.4 -0.1 
263 1.5 1.4 -0.1 
264 0.3 0.2 -0.1 
265 0.0 0.0 0.0 
266 0.0 0.0 0.0 
267 0.0 0.0 0.0 
268 0.0 0.0 0.0 
 
Gly 246 (C10H24O2NSi2); δ
13
C=-19.2  
m/z theory data difference 
246 100 100 0.0 
247 22.0 21.4 -0.6 
248 9.2 9.1 -0.1 
249 1.3 1.3 0.0 
250 0.2 0.2 0.0 
251 0.0 0.0 0.0 
252 0.0 0.0 0.0 
253 0.0 0.0 0.0 
254 0.0 0.0 0.0 
 
Leu 344 (C17H38O2NSi2); δ
13
C=-27.6 
m/z theory data difference 
344 100 100 0.0 
345 30.0 29.3 -0.7 
346 11.3 11.2 -0.1 
347 2.1 2.0 -0.1 
348 0.4 0.3 -0.1 
349 0.0 0.1 0.0 
350 0.0 0.0 0.0 
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Ser 390 (C17H40O3NSi3); δ
13
C=-20.4  
m/z theory data difference 
390 100 100 0.0 
391 35.1 34.3 -0.8 
392 16.3 15.9 -0.4 
393 3.8 3.7 -0.1 
394 0.9 0.9 0.0 
395 0.1 0.1 0.0 
396 0.0 0.0 0.0 
397 0.0 0.0 0.0 
398 0.0 0.0 0.0 
399 0.0 0.0 0.0 
400 0.0 0.0 0.0 
 
Phe 336 (C17H30O2NSi2); δ
13
C=-14.6  
m/z theory data difference 
336 100 100 0.0 
337 29.9 29.3 -0.6 
338 11.2 11.0 -0.2 
339 2.1 2.1 0.0 
340 0.4 0.4 0.0 
341 0.0 0.0 0.0 
342 0.0 0.0 0.0 
343 0.0 0.0 0.0 
344 0.0 0.0 0.0 
 
Asp 418 (C18H40O4NSi3); δ
13
C=-18.8  
m/z theory data difference 
418 100 100 0.0 
419 36.1 35.1 -1.0 
420 16.9 16.6 -0.3 
421 4.0 3.9 -0.1 
422 1.0 0.9 -0.1 
423 0.2 0.1 -0.1 
424 0.0 0.0 0.0 
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425 0.0 0.0 0.0 
426 0.0 0.0 0.0 
427 0.0 0.0 0.0 
428 0.0 0.0 0.0 
 
Glu 432 (C19H42O4NSi3); δ
13
C=-27.1  
m/z theory data difference 
432 100 100 0.0 
433 37.4 36.4 -1.0 
434 17.4 16.9 -0.5 
435 4.3 4.1 -0.2 
436 1.0 1.0 0.0 
437 0.2 0.1 -0.1 
438 0.0 0.0 0.0 
439 0.0 0.0 0.0 
440 0.0 0.0 0.0 
441 0.0 0.0 0.0 
442 0.0 0.0 0.0 
 
His 440 (C20H42O2N3Si3); δ
13
C=-24.3 (‰) 
m/z theory data difference 
440 100 100 0.0 
441 39.2 38.3 -0.9 
442 17.7 17.2 -0.5 
443 4.4 4.2 -0.2 
444 1.0 0.9 -0.1 
445 0.2 0.1 -0.1 
446 0.0 0.0 0.0 
447 0.0 0.0 0.0 
448 0.0 0.0 0.0 
449 0.0 0.0 0.0 
450 0.0 0.0 0.0 
Note: Table 4.4.S1 determined the instrumental errors of GC-MS using 
derivatized amino acids (naturally labeled with 
13
C, 
18
O, 
15
N and 
29,30
Si). δ13C 
values in the table represent the measurement bias for labeled amino acids during 
13
C-MFA. 
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Reference: M.R. Antoniewicz, J.K. Kelleher, and G. Stephanopoulos, Accurate 
assessment of amino acid mass isotopomer distributions for metabolic flux 
analysis. Anal. Chem. 79 (2007) 7554-9. 
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Table 4.4.S2.  Measured and model fitted isotopomer data from TBDMS-
derivatized amino acids  
Amino 
Acids 
Fragment Origin 
Isotopomer Enrichment 
M0 M1 M2 M3 M4 
Ala [M-57]
+
 
Exp 0.78 0.04 0.02 0.17  
Cal_Unbiased 0.77 0.04 0.03 0.17  
Cal_Biased 0.77 0.04 0.03 0.16  
  Cal_Actual 0.75 0.05 0.02 0.17  
Gly [M-57]
+
 
Exp 0.79 0.05 0.16   
Cal_Unbiased 0.79 0.05 0.16   
Cal_Biased 0.79 0.05 0.16   
  Cal_ Actual 0.79 0.05 0.16   
Leu [M-159]
+
 
Exp 0.51 0.15 0.24 0.06 0.03 
Cal_Unbiased 0.49 0.16 0.24 0.07 0.03 
Cal_Biased 0.51 0.15 0.24 0.06 0.03 
  Cal_ Actual 0.48 0.18 0.24 0.07 0.03 
Ser [M-57]
+
 
Exp 0.74 0.08 0.05 0.13  
Cal_Unbiased 0.74 0.07 0.06 0.14  
Cal_Biased 0.74 0.07 0.06 0.13  
  Cal_ Actual 0.73 0.08 0.05 0.14  
Asp [M-57]
+
 
Exp 0.61 0.17 0.11 0.09 0.02 
Cal_Unbiased 0.60 0.15 0.12 0.10 0.03 
Cal_Biased 0.61 0.16 0.11 0.09 0.03 
  Cal_ Actual 0.63 0.15 0.10 0.10 0.03 
Glu [M-57]
+
 
Exp 0.52 0.16 0.21 0.07 0.02 
Cal_Unbiased 0.49 0.16 0.24 0.07 0.03 
Cal_Biased 0.50 0.17 0.23 0.06 0.03 
  Cal_ Actual 0.51 0.19 0.21 0.06 0.02 
Phe [M-57]
+
 
Exp 0.45 0.09 0.12 0.16 0.10 
Cal_Unbiased 0.44 0.07 0.13 0.17 0.09 
Cal_Biased 0.45 0.08 0.13 0.17 0.09 
  Cal_ Actual 0.42 0.09 0.12 0.15 0.11 
His [M-57]
+
 
Exp 0.53 0.16 0.10 0.11 0.03 
Cal_Unbiased 0.53 0.16 0.10 0.11 0.03 
Cal_Biased 0.53 0.16 0.10 0.11 0.03 
  Cal_ Actual 0.53 0.16 0.11 0.11 0.03 
Note:  
Cal_Unbiased isotopic data are calculated by assuming δ13C= 0. 
Cal_Biased isotopic data are calculated by assuming δ13C= -47.  
Cal_ Actual isotopic data are calculated based on the labeling pattern of glucose 
detected by LC-MS. 
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5.1 Abstract 
Shewanella oneidensis MR-1 sequentially utilizes lactate and its waste 
products (pyruvate and acetate) during batch culture. To decipher MR-1 
metabolism, we integrated genome-scale flux balance analysis (FBA) into a 
multiple-substrate Monod model to perform the dynamic flux balance analysis 
(dFBA). The dFBA employed a static optimization approach (SOA) by dividing 
the batch time into small intervals (i.e., ~400 mini-FBAs), then the Monod model 
provided time-dependent inflow/outflow fluxes to constrain the mini-FBAs to 
profile the pseudo-steady-state fluxes in each time interval. The mini-FBAs used a 
dual-objective function (a weighted combination of “maximizing growth rate” 
and “minimizing overall flux”) to capture trade-offs between optimal growth and 
minimal enzyme usage. By fitting the experimental data, a bi-level optimization 
of dFBA revealed that the optimal weight in the dual-objective function was time-
dependent: the objective function was constant in the early growth stage, while 
the functional weight of minimal enzyme usage increased significantly when 
lactate became scarce. The dFBA profiled biologically meaningful dynamic MR-1 
metabolisms: 1. the oxidative TCA cycle fluxes increased initially and then 
decreased in the late growth stage; 2. fluxes in the pentose phosphate pathway and 
gluconeogenesis were stable in the exponential growth period; and 3. the 
glyoxylate shunt was up-regulated when acetate became the main carbon source 
for MR-1 growth.  
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5.2 Authors’ summary 
This study integrates two modeling approaches, a Monod kinetic model 
and genome-scale flux balance analysis, to analyze the dynamic metabolism of an 
environmentally important bacterium (S. oneidensis MR-1). The modeling results 
reveal that MR-1 metabolism is suboptimal for biomass growth, while MR-1 
continuously reprograms the intracellular flux distributions in adaption to nutrient 
conditions. This innovative dFBA framework can be widely used to investigate 
transient cell metabolisms in response to environmental variations. Furthermore, 
the dFBA is able to simulate metabolite-labeling dynamics in 
13
C-tracer 
experiments, and thus can serve as a springboard to advanced 
13
C-assisted 
dynamic metabolic flux analysis by using labeled proteinogenic amino acids to 
improve flux results. 
Key words: 
13
C, enzyme usage, genome-scale, Monod, objective functions, 
suboptimal, TCA cycle  
5.3 Introduction 
Cell metabolisms are highly dependent on environmental conditions, so 
the metabolic state often shifts during the cultivation period (1,2,3). 
Characterizing the transience of metabolic fluxes is important for understanding 
how cells responded to environmental changes. Bioprocess models (e.g., a 
Monod-based kinetic model) (4) have been widely applied to predict microbial 
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dynamics, but they cannot directly obtain the intracellular flux distributions. On 
the other hand, flux balance analysis (FBA) profiles the rates of enzymatic 
reactions based on stoichiometric mass balance, knowledge of reaction 
constraints, and measurements of inflow/outflow fluxes (5,6). As an 
underdetermined model, FBA requires an objective function (e.g., “maximizing 
growth rate”) for flux calculation. However, since cells may show suboptimal 
metabolism and reprogram their metabolic fluxes under different environmental 
conditions, the commonly used objective function is insufficient to describe cell 
physiologies (7,8,9). Furthermore, FBA assumes steady-state metabolic 
conditions, and thus is unable to directly analyze the transience of cell metabolism 
(10,11,12). 
This study developed an FBA framework that integrates Monod kinetics 
and FBA to decipher the dynamic metabolism of MR-1 (Figure 5.1). MR-1 is a 
facultative anaerobic bacterium, which not only plays an important ecological role 
in carbon cycling and metal reduction, but also has been widely used for in situ 
bioremediation and microbial fuel cell applications (13,14,15). MR-1 has a 
diverse carbon utilization capability and shifts its metabolism during batch 
cultivation (16). MR-1 uses lactate for initial growth and produces acetate and 
pyruvate. In the late growth stage, MR-1 metabolizes less energy-favorable 
pyruvate and acetate. To describe such kinetic behavior, we used unsegregated 
Monod equations to simulate cell growth, lactate utilization, and metabolite 
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secretion and reuse. The standard Monod model was incorporated into a genome-
scale FBA model, iSO783 (17), to formulate the dynamic FBA (dFBA) 
framework (11), which enabled quantitative predictions of the MR-1 metabolism. 
5.4 Results    
5.4.1 Monod model  
MR-1 growth displayed an apparent lag phase (~7.1 h) in 30 mM lactate 
medium (0.1% inoculation). By incorporating a time delay function for the lag 
growth phase, a standard Monod model consisting of four ordinary differential 
equations was built to describe the extracellular metabolite curves and growth 
kinetics (Figure 5.2). The parameters of the Monod model were estimated by 
fitting the experimental data. Table 5.1 indicates that the lactate-based biomass 
yield was higher than that for either pyruvate or acetate, confirming the 
preferential utilization of lactate as an energy-favorable carbon substrate for MR-
1. Similarly, the lactate-based growth rate (μmax) was much higher than that for 
either pyruvate or acetate, indicating that lactate was the major carbon substrate 
for biomass growth at the early growth stage. Table 5.1 lists the rate coefficients 
(kpl, kap and kal) for waste products (pyruvate and acetate) synthesis and reuse, 
which indicates that MR-1 quickly consumed lactate, producing significant 
metabolic overflows to the waste products. Such a strategy illustrates an 
advantageous ecological niche for MR-1 in competing for favorable carbon 
sources. Finally, although our standard Monod model reasonably well described 
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MR-1 growth data, its results showed some lack-of-fit with statistical analysis 
(Table 5.S1). Such a discrepancy was possibly due to the model’s simplification 
and to measurement noises. In this study, the kinetic model represents a 
compromise between complexity and practical simplicity.      
5.4.2 Link kinetic model to FBA 
To resolve the flux dynamics, the static optimization approach (SOA) 
divided the cultivation phase into numerous pseudo-steady states so that a 
conventional genome-scale MR-1 framework (iSO783, containing 774 reactions 
and 634 metabolites) was able to calculate the flux distributions (17) in each five-
minute time interval. Such dFBA model consisted of ~400 mini-FBAs. To avoid 
repeated and tedious measurements of biomass and metabolite concentrations for 
each mini-FBA, we used the Monod model to determine the inflow/outflow fluxes 
of lactate, acetate, and pyruvate in each time interval. The mini-FBAs could be 
resolved by an objective function of “maximizing growth rate”, but this function 
severely overestimated the actual biomass growth (Figure 5.3). To account for the 
suboptimal metabolic features (7,8,9), we used a dual-objective function in dFBA: 
a combination of “maximize growth rate” and “minimize overall flux”. By 
appropriately weighing both objectives, we explored the trade-offs between 
optimal cell growth and minimal enzyme usage. Specifically, the Monod model 
determined the transient growth rate for each time interval, which tuned the 
weights in the dual-objective functions for the mini-FBAs so that the biomass 
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growth curve simulated by dFBA was in agreement with experimental 
observations. Figure 5.3 showed that the optimal dual-objective function in mini-
FBAs was time-dependent. In general, these dual-objective functions were 
invariable before the carbon substrate switched from lactate to acetate/pyruvate. 
When lactate became scarce, the weight of “minimizing overall flux” in the 
objective function increased significantly, indicating an intracellular reduction of 
enzyme synthesis and minimization of intracellular fluxes.    
5.4.3 Dynamic flux distributions in MR-1 
The dynamic flux distributions in MR-1 were calculated using the bi-level 
optimization (Figure 5.4). The carbon flows to extracellular acetate and pyruvate 
were high when lactate was sufficient (~33% and ~25% of the lactate uptake flux 
before the carbon substrate switch, respectively). Fluxes into the gluconeogenesis 
pathway, reductive PP pathway, and ED pathway were mainly for biomass 
synthesis, and remained approximately constant during the exponential growth 
phase. In the middle log phase (22~25 hours), when the growth rate reached the 
maximum, fluxes in the oxidative TCA cycle reached a peak (e.g., ~6 mmol/g 
DCW/h for succinyl-CoA synthetase) to generate energy and building blocks. 
When lactate became scarce (25~30 hrs), MR-1 had to utilize its waste 
metabolites (acetate and pyruvate). During this metabolic shift, most intracellular 
fluxes started to decrease. In the late log growth phase (30~34 hrs), it was also 
observed that the glyoxylate shunt was up-regulated compared to TCA cycle 
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fluxes after acetate became the main carbon source for MR-1 growth. The 
glyoxylate shunt reduced the oxidation of carbon substrate for CO2 production by 
diverting the carbon flow into a shorter metabolic route. The glyoxylate shunt 
activity was further confirmed by in vitro enzyme assays at both the mid-log 
phase (malate synthase activity was 0.18±0.11 μmol/g DCW/min) and the late-log 
phase (malate synthase activity was 0.37±0.17 μmol/g DCW/min).  
5.4.4 Simulation of dynamic 
13
C-labeling in proteinogenic amino acids  
In 
13
C-labeled tracer experiments, dFBA can be used to predict the 
isotopomer dynamics in slow turnover metabolites, such as proteinogenic amino 
acids. During MR-1 growth with [3-
13
C] lactate, the dynamic metabolism led to 
variations of labeling patterns in intracellular metabolites (biomass precursors) so 
that the isotopic labeling in proteinogenic amino acids was continuously changing 
during cell growth (18). Here, we simulated the time-integrative labeling patterns 
in proteinogenic amino acids based on fluxes from dFBA. The predicted 
isotopomer labeling patterns of five proteinogenic amino acids (Ala, Ser, Glu, 
Asp, and Gly, at t = 24 and 30 h) are illustrated in Figure 5.5A and Figure 5.S1. 
Compared with the experimental measurements, the labeling patterns predicted by 
dFBA are consistent with the measured labeling patterns, but some lack-of-fit still 
exists. One of the limitations of the FBA model is that the intracellular pathway is 
treated as unidirectional, so the effect of exchange fluxes on isotopomer data is 
neglected. Considering that some in vivo reactions could be bi-directional, we 
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implemented exchange coefficients for four pathways (e.g., the anaplerotic 
pathway: pyruvate  malate) in the model to improve the simulation of 13C-
labeling (Table 5.2). After introduction of the exchange coefficients, the measured 
and the simulated isotopomer data for proteinogenic amino acids matched (R
2 
= 
0.9619, Figure 5.5B).  
5.5 Discussion 
dFBA models have been developed to describe the dynamic metabolism of 
E.coli (10), Saccharomyces cerevisiae (19), Lactococcus lactis (12), and even for 
a more complicated coculture system of E.coli and Saccharomyces cerevisiae 
(20). In this study, we developed dFBA for analyzing metabolic states of S. 
oneidensis MR-1. The time-dependent inflow/outflow fluxes for dFBA can be 
constrained by either a Monod model or other empirical models (such as 
polynomial-fitting to the measurement data (21)). The Monod model is suitable to 
uncover kinetic properties of a scale-up bioprocess and empowers the dFBA to 
correlate the bioprocess parameters (such as nutrient concentrations and inhibition 
coefficients) with intracellular metabolism analysis. The integration of the Monod 
model and dFBA can decipher and predict cell metabolisms in response to batch 
fermentation conditions.  
To describe biological realities, a physiologically reasonable objective 
function is important for FBA. For E.coli metabolism, 11 objective functions have 
been systemically investigated under different cultivation conditions (7). It turns 
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out that no single objective function can describe metabolic states accurately for 
all conditions. A recent study of MR-1 indicated that futile cycles may be 
operational, in which less energetically efficient enzymes are expressed at higher 
levels than their counterparts and decrease biomass yield (17). Such suboptimal 
metabolic features in MR-1 make the conventional objective functions difficult to 
use in predicting actual cell physiology. To bridge the gap between the in silico 
simulations and experimental observations, we assigned dual-objective functions 
to resolve mini-FBAs. Using dual-objective functions, dFBA accurately predicted 
the elevated flux ratio of the glyoxylate shunt (represented by malate synthase 
activity) to the oxidative TCA cycle (represented by fumarase activity) when 
acetate started to be used as the main carbon substrate (Figure 5.S2). The up-
regulation of the glyoxylate shunt and down-regulation of the oxidative TCA 
pathways were consistent with a previous 
13
C-metabolic flux analysis of MR-1 
(18). In comparison, this transient metabolic shift in the glyoxylate shunt could 
not be captured by a single objective function, such as maximal biomass growth. 
Moreover, our dFBA results showed the weight of the two objective functions 
remained relatively constant when lactate was sufficient. At the early stage of 
MR-1 growth, such a pseudo-steady state has been experimentally verified by 
previous isotopomer-based analysis (18). Under nutrient scarcity conditions, MR-
1 metabolism may reduce synthesis and usage of enzymes to achieve a 
compromise between minimization of general physiological activities and 
maintenance of essential cellular functions (22).  
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The dFBA model can also simulate time-dependent isotopomer 
enrichment in proteinogenic amino acids. In turn, the isotopomer results (Figure 
5.5) can be used to validate and improve the dFBA model predictions. For 
example, our dFBA model predicted low fluxes through malic enzyme during the 
exponential growth because these pathways may reduce biomass production, 
while the genetic analysis indicates a high functionality of malic enzyme (17). In 
the dynamic isotopomer simulations, we found that the fitting of isotopomer 
labeling patterns was significantly improved by introducing the bi-directional 
fluxes through the pathway Malate ↔ CO2 + Pyruvate, while keeping the net flux 
minimal. Such reversible reactions suggest metabolic flexibility. The activity of 
malic enzyme was also confirmed by in vitro enzyme assays at both the mid-log 
phase (malic enzyme activity was 0.90±0.18 μmol/g DCW/min) and late-log 
phase (malic enzyme activity was 1.73±0.81 μmol/g DCW/min). 
Proteinogenic amino acids
 
are abundant in biomass and can easily be 
measured by GC-MS. Complementing this instrumental data, 
13
C-metabolic flux 
analysis (MFA) offer analytic insight into the cell metabolisms in fermentation 
processes (3,23,24). However, the turnover rate of protein is much slower than 
that of intracellular metabolites, so
 13
C-MFA is useful only for analyzing the 
steady-state central metabolism. To perform 
13
C-MFA of dynamic flux 
distributions, the fast turnover metabolites have to be extracted and analyzed at 
multiple time points (1,3), which requires significant sampling efforts and high-
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sensitivity analytical measurement of low-abundance/unstable metabolites. 
Moreover, the calculation of dynamic fluxes with isotopomer data formulates an 
inverse nonlinear optimization problem, which is computationally challenging. 
Due to insufficient methods for analyzing low abundance metabolites (25), as 
well as limitations in computational algorithms, dynamic 
13
C-MFA cannot resolve 
the flux distributions in a large-scale metabolic network. To overcome these 
difficulties, this study illustrates a proof-of-concept approach that exploits the 
synergy between proteinogenic-amino-acid-based 
13
C-MFA and genome-scale 
dynamic flux balance analysis.  
In our dFBA, the Monod model is solved first independently of the FBA. 
As an alternative approach, we also tested to integrate the kinetic models with 
FBA (integrative Flux Balance Analysis, iFBA). iFBA simultaneously optimizes 
the kinetic model parameters and solves the dynamic cell metabolism in MR-1 
(Supplementary Text S1). We found that iFBA also requires a dual objective 
function, a weighted combination of “maximizing growth rate” and “minimizing 
overall flux”, to improve the model accuracy, similar to the dFBA approach 
(Figure 5.S3 and Table 5.S2). Such results indicate that it is difficult to use a 
single objective to describe the flux states under all growth conditions, while the 
time-dependent trade-off objective functions are effective for analyzing the 
dynamic suboptimal metabolism.  
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In conclusion, as in other FBA studies, the dFBA framework proposed in 
this study links macroscopic bioprocess variables (such as nutrient 
concentrations) to microscopic intracellular metabolism analysis. It predicts 
metabolic responses under dynamic culture conditions, and reveals the impact of 
the kinetic parameters (such as μmax) on intracellular flux distributions. 
Furthermore, dFBA can identify the objective functions that are possibly used by 
microorganisms in adaption to environmental variations. Finally, by simulating 
and comparing the isotopomer labeling patterns of different metabolites, the 
proposed dFBA framework can potentially improve dynamic flux resolutions by 
incorporating the isotopomer data from labeled proteinogenic amino acids. 
5.6 Materials and methods 
Culture conditions, analytical methods, and isotopomer analysis. S. 
oneidensis MR-1 (ATCC 70050) was first grown in LB medium in shake flasks 
overnight. A 0.1% inoculum volume was then cultured into modified MR-1 
defined medium (26) in shake flasks (100 mL culture for each of triplicate 
experiments, shaken at 150 rpm) at 30°C. The initial carbon source was ~30 mM 
lactate. The growth curve was monitored by dried biomass weight. The 
concentrations of lactate and acetate in the medium were measured using enzyme 
kits (r-Biopharm, Darmstadt, Germany). The concentration of pyruvate in the 
medium was measured with the enzyme assay developed by Marbach and Weli 
(27).  
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To analyze the activity of malate synthase and malic enzyme, samples 
were taken at early middle log phase (biomass of MR-1 ~0.08 g/L) and late log 
phase (biomass of MR-1 ~0.23 g/L). The harvested cells were centrifuged and re-
suspended in 100 mM Tris buffer. The samples were then ultra-sonicated for 5 
min to release the enzymes. Malate synthase activity was gauged based on the 
reaction of CoASH with DTNB (Acetyl-CoA+glyoxylateMalate+CoASH; 
CoASH+DTNBCoA-TNB+TNB), as described by Dixon and Kornberg (28). In 
general, 20 μL acetyl-CoA (5 mM), 10 μL DTNB (10 mM), 50 μL cell extract, 
and 500 μL of a solution containing 0.1 M potassium phosphate and 10 mM 
MgCl2 were mixed with water. The mixture was then added with 20 μL 100 mM 
glyoxylate. The difference in absorbance at OD412 before and after glyoxylate 
addition reflected the activity of malate synthase, in which one unit ∆OD412 
corresponded to 70.6 nmol of TNB produced (in a 1 mL reaction solution). 
Furthermore, the activity of malic enzyme was detected based on increased 
absorbance at 340 nm due to the reduction of NAD
+
 to NADH (29). In brief, 400 
μL 250 mM Tris HCl, 20 μL 50 mM MnCl2, 25 μL 40 mM NH4Cl, 100 μL 1M 
KCl, 50 μL 20 mM NAD+, 100 μL 100 mM malate, and 50 μL cell extract were 
mixed with water (1 mL reaction solution). The change in absorbance at OD340 
reflected the activity of malic enzyme. 
In the labeling experiment, MR-1 was first grown overnight in the LB 
medium in shake flasks. A 0.1% inoculum volume was then cultured into 100 mL 
 211 
 
of modified MR-1 defined medium at 30°C, with the initial carbon source as 30 
mM [3-
13
C] lactate (purity>98%) purchased from Cambridge Isotope 
Laboratories, Inc. (Andover, MA). The biomass was harvested at ~24 h (before 
lactate was depleted) and ~30 h (after the substrate had switched from lactate to 
waste products). To analyze the labeling pattern of proteinogenic amino acids, we 
hydrolyzed the biomass with 6M HCl at 100 
o
C. The isotopic analysis of 
proteinogenic amino acids was performed using a GC-MS based TBDMS 
method, as previously described (30,31,32). Ions of [M-57]
+
 (unfragmented 
amino acid) were used for the 
13
C-simulations (33). 
Monod model development. A multiple-substrate Monod model was 
developed to describe the cell growth, lactate consumption and secretion, and 
reuse of waste products (acetate and pyruvate).  
 
L
P,L A,L L
X/L
A
A,L A,P L
X/A
P
P,L A,P L
X/P
A P
XdLACT
( r r ) S(t t )                         
dt Y
XdACT
(r r ) S(t t )                            
dt Y
XdPYR
(r r ) S(t t )                          
dt Y
dX
X (
dt
L e Lk ) S(t t )                          
 
where X is biomass (g DCW/L); LACT, ACT, and PYR are lactate, acetate, and 
pyruvate concentrations (mmol/L), respectively; μL, μA, and μP are the specific 
growth rates (h
-1
) on lactate, acetate, and pyruvate, respectively; ke is the 
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endogenous metabolism rate constant (h
-1
); YX/L, YX/A, and YX/P are the biomass 
yield coefficients (g DCW/mol substrate) of lactate, acetate, and pyruvate 
respectively; rP,L and rA,L are the production rates (mmol/L/h) of acetate and 
pyruvate from lactate, respectively. rA,P is the production rates (mmol/L/h) of 
acetate from pyruvate. S(t-tL) is the dimensionless unit-step time delay function 
(S=0 when t < tL; S=1 when t= tL) which described the lag phase after inoculation.  
The specific cell growth rate was described by Monod equations: 
max,L
L
s,l
LACT
K LACT
 
max,A
A
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K ACT
 
max,P
P
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where μmax,L, μmax,A, and μmax,P are the maximal growth rates (h
-1
) for fully aerobic 
growth on lactate, acetate, and pyruvate, respectively; and Ks,l, Ks,a, and Ks,p are 
Monod constants (mmol/L) for lactate, acetate, and pyruvate, respectively. The 
acetate and pyruvate production rates are assumed to be proportional to the 
biomass (16), as expressed below: 
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where kal and kpl are rate constants of acetate and pyruvate production, 
respectively (L∙ (h∙g DCW)-1). kap is the rate constant of acetate production from 
pyruvate (L∙ (h∙g DCW)-1). 
The kinetic model (Equations 1~10) contained 14 kinetic parameters. To 
estimate the model parameters, an ordinary least squares (OLS) method (34) was 
applied to solve the inverse problem. OLS aimed to minimize the residual sum of 
the squares (R) between model simulations and experimental measurements, 
expressed as 
)];([)];([ tYtYR T                                                               (11) 
where η represents four dependent variables simulated by the kinetic model; β 
represents the vector of the parameters to be estimated; and Y is the vector of the 
measured value of the dependent variables. Since the scales of the dependent 
variables were different (e.g., the scale of the biomass measurement was < 1 g/L, 
while the lactate measurement >10 mmol/L), the direct application of OLS would 
overemphasize the fitting of dependent variables with large scales. Therefore, we 
normalized dependent variables by the corresponding maximum concentrations 
measured in the experiments.  
The “ode23” command in MATLAB (R2009a, Mathworks) was used to 
solve ODEs, and the “fmincon” command was used to find suitable settings of the 
parameters. Figure 5.S4 is the histogram of normalized model residuals. The 
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standard deviations of the parameters were derived from a bootstrap analysis, in 
which the experimental measurements were randomly re-sampled 1000 times and 
the corresponding parameters were simulated with the same parameter estimation 
approach. The 1000 re-sampling was found to be adequate since the variation of 
parameters converged to within a desired tolerance of 0.1%.  
Bi-level dFBA study. The growth phase was divided into 408 pseudo-
steady-state intervals with instantaneous transitions between the two adjacent 
intervals (11). At each pseudo-steady state (~five minutes) (35), a mini-FBA was 
formulated by a dual-objective function comprised of “maximizing the growth 
rate” and “minimizing overall flux”; and inflow/outflow fluxes (for lactate, 
acetate, and pyruvate) derived from the Monod model. The inflow/outflow fluxes 
were calculated from: 
Xv
dt
dPYR
Xv
dt
dACT
Xv
dt
dLACT
outflowpyr
outflowact
lowlac
_
_
inf_
  
where vlac_inflow, vact_outflow, and vpyr_outflow are transient lactate inflow flux, acetate 
outflow flux, and pyruvate outflow flux, respectively. 
At each pseudo steady state, the mini-FBA followed a bi-level 
optimization framework similar to ObjFind (36). The internal optimization was an 
(12) 
 
(13) 
 
(14) 
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FBA with a combined objective function in which the weighting factor of 
“minimizing overall flux” ranged from zero to one. The difference between the 
transient growth rate simulated from the FBA and that derived from the Monod 
model was minimized in the external optimization, by tuning the weighting factor 
in the combined objective function. The bi-level optimization determined a trade-
off between maximizing growth rate and maximizing enzyme efficiency under the 
specified growth conditions. The bi-level optimization was formulated as: 
10     
 model Monod  thefrom     
0  
..
]1[min 
     
 ..
)-(min 
inf
2
2
FBAMonod
w
, v, vv
ubv    lb
v  S
ts
μw)(vw
ts
wpyr_outflowact_outflolowlac_
i
FBAi
                               (15) 
where μmonod and μFBA are transient growth rates derived from the Monod model 
and the dFBA study, respectively; w is the weight of “minimizing overall flux” in 
the combined objective function; v is the vector of the intracellular fluxes; S is the 
stoichiometry matrix; lb and ub are the lower and upper boundaries for 
intracellular flux.  
The internal optimization was a typical quadratic programming (QP) 
problem and was solved using the CPLEX solver in the TOMLAB optimization 
toolbox (TOMLAB Optimization Inc, Seattle, WA) within MATLAB (R2009a). 
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The external optimization problem (i.e., search for weight) was solved by a grid 
search. Since the QP problem in this study was convex, the locally searched 
results were also the global solutions (37).  
Simulation of dynamic 
13
C-labeling in proteinogenic amino acids. Our 
previous 
13
C-MFA study of MR-1 showed that the labeling patterns in its 
proteinogenic amino acids changed during the late-stage of batch growth (18). 
Using the dynamic flux distributions from dFBA, we could now simulate 
dynamics of isotopomer labeling patterns in proteinogenic amino acids using the 
algorithm below.    
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Since FBA neglects flux reversibility, we implemented exchange 
coefficients exch to account for the reversibility of four key metabolic pathways 
(ME2, GHMT, GLYCL, and SUCOAS in iSO783, Table 5.2). In Equation 16, 
vexch is the vector of exchanged fluxes in the reversible reactions; v is the vector of 
the transient fluxes at the t’ interval, simulated from the mini-FBA; p(t) are fluxes 
to proteinogenic amino acids at each time interval; ∆t is the scale of a pseudo 
steady state (5 min); ∆X(t) is the biomass produced at each time interval;  IMM is 
the isotopomer mapping matrices describing the carbon atoms transitions from 
reactants to products in a reaction; IDV(t) are the isotopomer distribution vectors 
of transient intracellular metabolites at each time interval, which is calculated 
based on the different labeling patterns of precursors from n pathways; IDVint|t=t’ 
are the isotopomer distribution vectors in proteinogenic amino acids at the end of 
the t’ time interval; MDVi,sim and MDVi,exp are the mass distribution vectors for 
each of the five proteinogenic amino acids, as simulated and as measured by GC-
MS, respectively; M is the matrix for converting IDV to MDV; σi is the standard 
deviation of the GC-MS measurement (error ~2%), which is assumed to be 
constant in this study. The carbon transitions in the reactions involved were given 
in Supplementary Text S2.  The “fmincon” command in MATLAB was used to 
find the exchange coefficients, and the “nlparci” command in MATLAB was used 
to find the asymptotic confidence intervals of the exchange coefficients. These 
exchange coefficients significantly improved dFBA simulation of the labeling 
patterns in proteinogenic amino acids.     
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5.7 Supplementary Text S1: framework of integrative Flux Balance Analysis 
(iFBA) 
We have tested an alternative model framework: iFBA. The dynamic 
cultivation process was decomposed into numerous pseudo-steady-state time 
intervals. At each time interval, the inflow/outflow fluxes in the FBA were 
derived from the Monod equations; while the biomass increase during the time 
interval was predicted by mini-FBAs using proper objective functions. At the end 
of each time interval, the predicted biomass increase was incorporated into the 
Monod equations to estimate the metabolite and substrate concentrations at the 
next time interval. Then, we obtained the inflow/outflow fluxes of mini-FBA in 
the next time interval (t+∆t). To improve the model accuracy, iFBA employed a 
dual-objective function w(i), a weighted combination of “maximizing growth 
rate” and “minimizing overall flux”. The time-dependent weight in the dual-
objective function and the kinetic parameters in Monod equations were 
determined by minimizing the differences between iFBA predicted MR-1 growth 
kinetics and the experimentally measured data. The iFBA was formulated as 
below: 
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The new symbols introduced in iFBA are as following: num_timepoint is 
the number of time intervals decomposed during the entire cultivation process, 
which is 408; dt is the time of each time interval, which is 1/12 h. p1, p2 and p3 are 
 220 
 
three parameters used to simulate the dynamic weighting factors in the dual 
objective function. The internal dFBA problem was solved using the CPLEX 
solver in TOMLAB optimization toolbox (TOMLAB optimization Inc, Seattle, 
WA) within MATLAB (R2009a). The external optimization problem (i.e. search 
for weight) was solved by SNOPT solver in TOMLAB optimization toolbox 
within MATLAB (R2009a). The histogram of normalized residuals in growth 
kinetics simulated by iFBA was shown in Figure 5.S5. The Lack-of-fit test for 
iFBA was shown in Table 5.S3. 
5.8 Supplementary Text S2: reactions involved in 
13
C-labeling simulations  
TCA cycle and metabolites transport  
J1 (L-LACD2) LAC (abc)pyr(abc) 
J2 (-ACt6) accoa(ab)↔ACT (ab) 
J3 (-PYRt2) pyr(abc)↔PYR(abc) 
J4 (PDH) pyr(abc)accoa(bc)+co2(a) 
J5 (CS) oaa(abcd)+accoa(ef)cit(dcbfea) 
J6 (ACONT) cit(abcdef)icit(abcdef) 
J7 (ICDHy) icit (abcdef)akg(abcde)+co2(f) 
J8 (AKGD) akg(abcde)succoa(bcde)+co2(a) 
J9 (SUCD7) succ(1/2abcd+1/2dcba)fum(1/2abcd+1/2dcba) 
J10 (FUM) fum(1/2abcd+1/2dcba)mal-L(abcd) 
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J11 (MDH) mal-L(abcd)oaa(abcd)  
J12 (PPC) pep(abc)+co2(d)oaa(abcd) 
J13 (PPCK) oaa(abcd)pep(abc)+co2(d) 
Glyoxylate shunt 
J14 (ICL) icit(abcdef)glx(de)+succ(1/2abcf+1/2fcba)  
J15 (MALS) accoa(ab)+glx(cd)mal-L(dcab) 
Reversible net fluxes and C1 metabolism  
J16 (GHMT) ser-L(abc)↔glx(ab)+mlthf(c) 
J17 (GLYCL) glx(ab)↔co2(a)+mlthf(b) 
J18 (ME2) mal-L(abcd)↔pyr(abc)+co2(d) 
J19 (-SUCOAS) succoa(abcd)↔succ(1/2abcd+1/2dcba) 
Gluconeogenesis 
J20 (PPS) pyr(abc)pep(abc) 
J21 (-ENO) pep(abc)2pg(abc) 
J22 (-PGM) 2pg(abc)3pg(abc) 
Amino acid biosynthesis  
J23 3pg(abc)ser-L(abc) 
J24 akg(abcde)glu-L(abcde) 
J25 pyr(abc)ala-L(abc) 
J26 oaa(abcd)asp-L(abcd) 
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Notes:  
1) All abbreviations are referred to iSO783, except LAC, PYR and ACT; which 
represent extracellular lactate, pyruvate and acetate, respectively. 
2) The reaction IDs in iSO783 are listed with brackets. The negative sign 
indicates that the net flux of the pathway is in the opposite direction as set by 
iSO783. The amino acids biosynthesis pathways are lumped; hence no ID in 
iSO783 is available. 
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Figure 5.1. Flowchart of dFBA to decipher the dynamic metabolism of S. 
oneidensis MR-1. 
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Figure 5.2. Monod model for growth kinetics. The green dots are the 
measurements, and the blue lines are the simulated growth by the empirical 
Monod model. 
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Figure 5.3. Prediction of growth rates (h
-1
). Blue ○: growth rate determined by 
the Monod model. Red ○: dFBA prediction using the objective function 
(maximization of growth rate). Green □: dFBA prediction using dual-objective 
functions (maximization of growth rate and minimization of overall flux). Yellow 
◊: the weight of the dual-objective functions that predicted the measured growth 
rates. Note: the summation of the square of fluxes (∑v2) was a very large number 
(total 774 fluxes), so the magnitude of weight w was small. 
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Figure 5.4. Dynamic flux distributions (unit: mmol/g DCW/h) in central 
metabolic pathways. The yellow filled cycles are intracellular metabolites; the 
blue filled cycles are substrates and extracellular metabolites (LAC: extracellular 
lactate, PYR: extracellular pyruvate, ACT: extracellular acetate); the dashed lines 
indicate inactive pathways; the green filled boxes are reactions listed in iSO783. 
All the abbreviations refer to iSO783 (7,8,9).  
 230 
 
 
 
 
 231 
 
Figure 5.5. Experimentally observed and simulated isotopomer labeling patterns 
[M-57]
+
 in proteinogenic amino acids. The standard error for GC-MS 
measurement was below 0.02. A1: dynamic isotopomer simulation for glutamate 
from dFBA without considering reaction reversibility (dFBA w/o reversibility). 
A2: dynamic isotopomer simulation for glutamate from dFBA considering 
reaction reversibility (dFBA w/ reversibility). Bar plot: comparison of 
experimentally observed isotopomer labeling to simulated isotopomer labeling 
patterns of glutamate (A1: without considering reaction reversibility; A2: 
considering reaction reversibility). B: The model fitting of the isotopomer 
labeling data of five key amino acids (Ala, Gly, Ser, Asp, and Glu) at t = 24 and 
30 h. 
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Figure 5.S1. Experimental observed and simulated isotopomer labeling patterns 
[M-57]
+
 in key proteinogenic amino acids. The standard error for GC-MS 
measurement was ~0.02. Area plot: dynamic isotopomer simulation (case 1: 
simulation without considering reaction reversibility; case 2: simulation 
considering reaction reversibility). Bar plot: comparison of experimental data to 
simulated isotopomer labeling patterns (case 1: without considering reaction 
reversibility; case 2: considering reaction reversibility). 
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Figure 5.S2. Flux ratio of malate synthase (MALS) and fumarase (FUM) in 
dynamic metabolism of Shewanella oneidensis MR-1. Blue ■: time profiles of flux 
ratio using “maximizing growth rate” as the objective function in dFBA; red ▲: 
time profiles of flux ratio using dual-objective function in dFBA: a combination 
of “maximize growth rate” and “minimize overall flux”. The entire growth of 
MR-1 was divided into three phases. In phase I, lactate was mainly used as the 
carbon substrate. In phase II, lactate, acetate and pyruvate were used as the carbon 
substrates. In phase III, acetate was used as the carbon substrate. 
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Figure 5.S3. Growth kinetics simulated by iFBA using “maximizing growth rate” 
as the objective function (red line) or using the dual-objective function (green 
line). The blue dots are the measurements.  
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Figure 5.S4. Histogram of normalized Monod model residuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 239 
 
Figure 5.S5. Histogram of normalized residuals in growth kinetics simulated by 
iFBA. 
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Table 5.1. Parameters estimated in the empirical Monod model  
Symbols Notation Unit Value 
μmax,L Maximum specific growth rate using lactate h
-1
 0.57±0.11 
μmax,P Maximum specific growth rate using pyruvate h
-1
 0.14±0.02 
μmax,A Maximum specific growth rate using acetate h
-1
 0.13±0.02 
YX/L 
Apparent biomass yield coefficient from 
lactate 
g DCW/mol lactate 17.0±1.3 
YX/P 
Apparent biomass yield coefficient from 
pyruvate 
g DCW/mol 
pyruvate 
16.7±1.3 
YX/A 
Apparent biomass yield coefficient from 
acetate 
g DCW/mol actate 11.1±4.7 
Ks,l Monod lactate saturation constant mM 19.4±7.9 
Ks,p Monod pyruvate saturation constant mM 19.4±8.1 
Ks,a Monod acetate saturation constant mM 10.1±2.2 
kal Acetate production coefficient from lactate L∙ (h∙g DCW)
-1
 0.71±0.06 
kpl Pyruvate production coefficient from lactate L∙ (h∙g DCW)
-1
 0.45±0.04 
kap Acetate production coefficient from pyruvate L∙ (h∙g DCW)
-1
 0.94±0.08 
ke Endogenous metabolism rate constant h
-1
 0.013±0.016 
tL Lag time in growth h 7.10±0.01 
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Table 5.2. Exchange coefficients for key metabolic pathways of MR-1 
Pathways Abbreviation 
Exchange 
coefficients  
Confidence 
intervals 
Malate ↔ CO2 + Pyruvate ME2 0.862 [0.803 0.921] 
Serine ↔ Glycine + C1 unit GHMT 0.270 [0.062 0.477] 
Glycine ↔ C1 unit + CO2 GLYCL 0.109 [0.061 0.157] 
Succinate ↔ Succinyl-CoA SUCOAS 0.944 [0.906 0.983] 
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Table 5.S1. Lack-of-fit test for the Monod model. 
Model 
Name 
Lack-of-
fit sum 
of 
squares, 
SSLOF 
Degree 
of 
freedom,  
df1 
Pure-
error 
sum of 
squares, 
SSPE 
Degree 
of 
freedom,  
df1 
 
2/
/ 1
dfSSPE
dfSSLOF
  
 
F(df1,df2) 
Monod 
model 
2.064 58 0.813 144 6.303 1.390 
 
 
Notes: 
In order to test whether or not a model could fit the data well, we applied the lack-
of-fit test. It partitioned the total sum of squares of residuals in the model (SSE) 
into two sources of variability: 1) the sum of squares from pure error variability 
(SSPE) and 2) the sum of squares from lack of fit (SSLOF), i.e. 
SSE=SSPE+SSLOF.  
For testing the null hypothesis H0: the nonlinear model was adequate versus 
hypothesis Ha: the nonlinear model was inadequate, the test statistic 
is:
2/
/ 1
dfSSPE
dfSSLOF
F . For a specified α-level of significance, we rejected the null 
hypothesis if F > Fα, where Fα is the α-level critical value (α=0.95 in this study) 
corresponding to an F(df1; df2) distribution. The F-test indicates our nonlinear 
model can be further improved by including new parameters. The improved 
kinetic model is presented in another manuscript under review.  
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Table 5.S2. Parameters estimated in iFBA 
 
Symbols Notation Unit iFBA 
μmax,L Maximum specific growth rate using lactate h
-1
 0.53 
μmax,P Maximum specific growth rate using pyruvate h
-1
 0.14 
μmax,A Maximum specific growth rate using acetate h
-1
 0.14 
YX/L 
Apparent biomass yield coefficient from 
lactate 
g DCW/mol lactate 17.5 
YX/P 
Apparent biomass yield coefficient from 
pyruvate 
g DCW/mol 
pyruvate 
15.5 
YX/A 
Apparent biomass yield coefficient from 
acetate 
g DCW/mol actate 10.9 
Ks,l Monod lactate saturation constant mM 19.4 
Ks,p Monod pyruvate saturation constant mM 19.4 
Ks,a Monod acetate saturation constant mM 10.1 
kal Acetate production coefficient from lactate L∙ (h∙g DCW)
-1
 0.70 
kpl Pyruvate production coefficient from lactate L∙ (h∙g DCW)
-1
 0.42 
kap Acetate production coefficient from pyruvate L∙ (h∙g DCW)
-1
 0.94 
ke Endogenous metabolism rate constant h
-1
 0.013 
tL Lag time in growth h 7.10 
p1 Parameters used in tradeoff objective function dimensionless 5.3×10
-6
 
p2 Parameters used in tradeoff objective function h
-1
 0.33 
p3 Parameters used in tradeoff objective function h 26.7 
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Table 5.S3. Lack-of-fit test for iFBA  
 
Model Name 
Lack-of-fit 
sum of 
squares, 
SSLOF 
Degree 
of 
freedom,  
df1 
Pure-
error 
sum of 
squares, 
SSPE 
Degree 
of 
freedom,  
df1 
 
2/
/ 1
dfSSPE
dfSSLOF
  
 
F(df1,df2) 
iFBA 3.726 56 0.813 144 11.78 1.396 
 
Note: In order to test whether or not a model could fit the data well, we applied 
the lack-of-fit test. The F-test indicates that the iFBA model should be further 
improved to describe the experimental data. 
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6.1 Abstract 
Background: Parallel to the efforts currently underway in mapping microbial 
genomes using high-throughput sequencing methods, systems biologists are 
building metabolic models to characterize and predict cell metabolisms. The key 
step in building a metabolic model is querying multiple databases to collect and 
assemble essential information about genome-annotations and the architecture of 
metabolic network for a specific organism. To speed up metabolic model 
development for a large number of microorganisms, we need a user-friendly platform to 
construct metabolic network and perform constraint-based flux balance analysis 
based on genome databases and experimental results. 
Results: We have developed a web-based platform (MicrobesFlux) for 
generating and reconstructing metabolic models for annotated microorganisms. 
The MicrobesFlux is able to load the metabolic network (including enzymatic 
reactions and metabolites) of over 1,100 species from KEGG database (Kyoto 
Encyclopedia of Genes and Genomes) and then automatically converting it to a 
metabolic model. The platform also provides diverse customized tools, such as 
gene knockouts and introduction of heterologous pathways, for users to redefine 
the model network. The reconstructed metabolic network can be formulated to a 
constraint-based flux model to predict and analyze the carbon fluxes in the 
metabolisms. The simulation results can be output in SBML format (The Systems 
Biology Markup Language). Furthermore, we also validate and demonstrate the 
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platform functions by developing an FBA model (including 229 reactions) for a 
recent annotated bioethanol producer, Thermoanaerobacter sp. strain X514, to 
predict its biomass growth and ethanol productions.  
Conclusion: The MicrobesFlux is an installation-free and open-source 
platform that enables biologists with little programming knowledge to develop 
metabolic models for newly sequenced microorganisms. Our system allows users 
to construct metabolic networks of organisms directly from the KEGG database. 
It also provides users with predictions of microbial metabolism via flux balance 
analysis. This prototype platform can be a springboard to advanced and broad-
scope metabolic modeling of complex biological systems by integrating other 
“omics” data or 13C-assisted metabolic flux analysis results. MicrobesFlux is 
available at http://tanglab.engineering.wustl.edu/static/MicrobesFlux.html. 
6.2 Background 
Arising interests have focused on systems analysis of cell metabolisms 
(1,2,3,4,5,6). Metabolic flux analysis is a key systems biology approach that 
determines the final in vivo enzyme activities in a metabolic network and links 
genetics to biological functions. In the past decade, over 100 genome-scale 
metabolic models have been constructed for E.coli (7,8,9), Bacillus subtilis 
(10,11), and Saccharomyces cerevisiae (12,13,14), to expand our understanding 
of their physiologies. While important, the pace of metabolic model 
reconstructions is still much slower than the pace of high throughput genome 
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sequencing of diverse microorganisms (15) due to three reasons. First, 
reconstructing metabolic models is normally a tedious, slow and labor-intensive 
process, including over 90 steps from assembling genome annotations of target 
organisms to validating the metabolic model by various “omics” studies (16). 
Second, a systemic reconstruction of metabolic model often relies on commercial 
software (e.g. MATLAB) and demands proficient programming skills of the 
researchers. The majority of microbiologists, who know the physiology of 
environmental microorganisms well, may not gain access to commercial software 
or programming skills. Third, to study less-characterized environmental 
organisms, it needs to efficiently convert a vast amount of experimental data into 
model constraints to reduce solution space and improve the model predictability. 
Therefore, programming-free and user-friendly software need to be developed to 
overcome rate-limiting steps in metabolic model reconstructions.  
Currently, only a few software tools are available to assist biologists for 
metabolic modeling. SimPheny is commercial software for genome-scale Flux 
Balance Analysis (www.genomatica.com). Webcoli supplies diverse approaches 
for users to reconstruct a genome-scale E.coli metabolic model (17). OpenFLUX 
is computationally efficient software for 
13
C-assisted metabolic flux (18). OptFlux 
is open-source and modular software for FBA and microbial strain design using 
an evolutionary optimization algorithm (19). BioMet Toolbox is a web-based 
resource for FBA and transcriptome analysis (20). Model SEED (21) has been 
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developed to automatically generate genome-scale metabolic models for different 
microbes based on RAST sequencing. Complementing these tools, we are 
developing MicrobesFlux, a web platform to draft and reconstruct metabolic 
models. This system has several features: 1) automatically generate metabolic 
models of over 1,100 microbes sequenced in KEGG dataase 
(www.genome.jp/kegg/), 2) fine tune the metabolic models according to user-
defined requests, and 3) perform constraint-based flux analysis under both 
metabolic steady states (i.e. flux balance analysis, FBA) and dynamic states (i.e. 
dynamic flux balance analysis, dFBA). The marriage of high-throughput model 
generation and the customized genome reconstruction is of great benefit since 
biologists can easily validate or disprove various hypotheses in microbial 
metabolism by drafting and comparing numerous metabolic models. Besides, this 
prototype platform can potentially link to other software (e.g. OptFlux (19), 
COBRA (22)) to perform broad-scope metabolic modeling of complex biological 
systems.   
6.3 Implementation 
MicrobesFlux is an open-source platform that does not require mandatory 
registration. It has three components: logic level, application level, and 
achievement level. The logic level includes two fundamental databases used in 
MicrobesFlux, where KGML is for organism-specific metabolic networks and 
KEGG LIGAND is for general enzymatic reactions and metabolites. The basic 
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principles for metabolic model reconstruction and constraint-based flux analysis 
are summarized in logic level (Figure 6.1). In the application level, organism-
specific metabolic network is loaded from KEGG database to generate the 
metabolic model, which is pursued for customized reconstruction. The 
reconstructed metabolic model is then formulated as either an FBA or a dFBA 
problem to determine the flux distributions under metabolic steady or dynamic 
state, respectively. The constraint-based flux analysis will be accomplished in the 
achievement level, by using state-of-the-art optimization solvers, such as IPOPT 
(Interior Point OPTimizer) and cloud computations. The calculated flux 
distributions and the reconstructed metabolic network are recorded in SBML 
format (The Systems Biology Markup Language), and the metabolic networks are 
visualized using Scalable Vector Graphics (SVG). Both results are sent to users in 
the output module. In summary, three key features are embedded in 
MicrobesFlux: 1) high-throughput and automatic generation of metabolic model; 
2) customized reconstruction of metabolic models; and 3) constraint-based flux 
analysis in steady and dynamic metabolic states. 
6.3.1 High-throughput and automatic generation of metabolic model 
MicrobesFlux can serve as a platform to build metabolic models for 1,194 
organisms sequenced in KEGG database. To generate a metabolic model for a 
specific microorganism, the gene annotation information are loaded from the 
corresponding KGML files, and cross-referred to KEGG LIGAND database. The 
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generated pathway network serves as a seed model and subject to further 
reconstruction based on user-defined requests. The pipeline for metabolic model 
generation is automatic, time-saving and high-throughput.  
6.3.2 Customized reconstruction of metabolic models 
The model of designated microorganisms, automatically generated from 
KEGG database, should be reconstructed to fill the gaps between genome 
annotation and the functional metabolism. Based on experimental knowledge, 
users can manually adjust mis-annotated pathways in the original metabolic 
network. Furthermore, users can knock out the native pathways or introduce 
heterologous pathways in metabolic models for engineered microbial strains. The 
reaction can also be set as reversible in the MicrobesFlux platform. In addition, 
the uptake of carbon substrates and the extracellular secretion of metabolites can 
be experimentally measured, which are constructed as “inflow” pathways and 
“outflow” pathways in the metabolic model, respectively. Since numerous 
metabolites are used as building blocks for biomass production, an independent 
biomass formation pathway can be introduced by allowing users to input the 
organism-specific biomass composition information. The metabolic pathways can 
be grouped by different metabolic features to provide an intuitive manipulation of 
the metabolic network by users.  
6.3.3 Constraint-based flux analysis in steady and dynamic metabolic states 
 252 
 
For each reconstructed metabolic network, users can choose to perform 
either FBA or dFBA to determine flux distribution under metabolic steady or 
dynamic states. In general, the objective functions used in constraint-based flux 
analysis can either be the commonly used “maximizing biomass”, or a user-
defined objective function. The users can also define the upper and lower bounds 
of each flux. MicrobesFlux performs the constraint-based flux analysis of the 
reconstructed model using optimization solver (i.e., IPOPT). As a unique feature, 
dynamic simulation of metabolic fluxes can be achieved in MicrobesFlux, 
following the static optimization approach (SOA) (23). In specific, the users can 
assume that the entire dynamic microbial metabolism decomposed into numerous 
pseudo-steady states. At each pseudo-steady state, a conventional FBA problem is 
formulated with the user-defined inflow and outflow fluxes, so a dFBA problem 
will be converted to multiple mini-FBAs that are subject to constraints from the 
measurement of time-dependent inflow (substrate uptake) and outflow fluxes 
(metabolite production). To avoid extensive analytical efforts to measure inflow 
and outflow fluxes at each time interval, the users can use an empirical or kinetic 
model to estimate the time-dependent inflow fluxes and outflow fluxes for mini-
FBAs through entire growth period based on limited measurement data. The 
dynamic flux simulation is of particular industrial interest since many biological 
systems cannot maintain a meaningful metabolic steady state during fermentation 
process. 
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6.4 Results 
We have applied MicrobesFlux to a few studies in drafting metabolic 
models. We first drafted a TOY model (Figure 6.2), which has 10 metabolites and 
16 fluxes, as a demonstration of MicrobesFlux workflow. We then constructed a 
medium-scale stoichiometric model with 196 metabolites and 229 reactions for 
Thermoanaerobacter sp. strain X514, a thermophilic bacterium that is of great 
interests in cellulosic ethanol production (24). The functionality of MicrobesFlux 
has been proved in both case studies. 
6.4.1 Case study 1: a toy model 
To demonstrate the use of MicrobesFlux platform, a simple toy model was 
constructed, only including central metabolic pathways, namely glycolysis, the 
pentose phosphate pathway, the TCA cycle, and the anaplerotic pathway. Glucose 
represented the carbon substrate and acetate represented the extracellular 
metabolite product. The TOY model was loaded from MicrobesFlux (Figure 6.3), 
which included 10 reactions that described the intracellular fluxes and lumped 
biomass production. The toy model was then reconstructed by introducing the 
inflow flux: “Glucose  G6P” and the outflow flux: “AcCoA  Acetate”. The 
drafted TOY model was then pursued for constraint-based flux analysis, by 
setting the objective function as “maximizing biomass” and fixing the inflow and 
outflow fluxes as 11.0 and 6.4 mmol/g/h. The simulated results from 
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MicrobesFlux were confirmed by an independent linear optimization of the same 
TOY model via “linprog” in MATLAB. 
6.4.2 Case study 2: a medium-scale metabolic model for Thermoanaerobacter 
sp. strain X514 
Based on the similar flowchart, we have drafted a medium-scale metabolic 
model of Thermoanaerobacter sp. strain X514. Thermoanaerobacter species are 
thermophilic bacteria that can covert both pentose and hexose simultaneously to 
ethanol with high yield (25,26). It can also be co-cultured with cellulosic 
Clostridium thermocellum species to produce ethanol from cellulose. Strain X514 
has been sequenced recently and a comprehensive study on the central carbon 
metabolism has been accomplished by using 
13
C-assisted pathway analysis (25). 
Using the experimental data of strain X514 reported in (25) and (26), we apply 
MicrobesFlux to construct a metabolic model that can describe the carbohydrate 
metabolism and amino acids biosynthesis in Strain X514. The drafted model is 
consisted of 196 metabolites and 229 reactions (162 intracellular reactions, 19 
inflow/outflow reactions, 39 gap-filling reactions, and 9 biomass-producing 
reactions). The intracellular reactions in the drafted model are derived from 
genome-annotation, only considering the carbon and cofactor balance. The 
inflow/outflow reactions were introduced into the metabolic model if the 
transporters of the specific substrates or extracellular products have been reported 
by published research. Moreover, two algorithms were employed to fill the gaps 
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in the metabolic pathways. First, we have implemented un-annotated novel 
pathways identified from 
13
C-assisted pathway analysis (e.g. the Re-type citrate 
synthase in TCA cycle) into the metabolic model of strain X514 (25). Since the 
draft model is a simplified model by focusing on carbohydrate metabolism and 
amino acids biosynthesis, the gaps may also be generated due to the lack of 
consideration of the metabolites exchange between the pathways that were 
included in the model (e.g. carbohydrate metabolism) and other pathways that 
were not included in the model (e.g. purine metabolism). Accordingly, we employ 
the principle of introducing the metabolite-exchange-reactions for filling the gaps. 
For example, UTP is involved in both carbohydrate metabolism and RNA 
synthesis. Since we did not include the RNA synthesis pathway in the 
MicrobesFlux model, we instead introduced a UTP exchange pathway to fill the 
gap. The gap-filling reactions were evaluated carefully to make sure that each one 
of them was necessary for feasible predictions of biomass production.  
The biomass composition of Thermoanaerobacter sp. strain X514 is not 
yet available. In the drafted model, we used the reported biomass composition of 
a close species, Clostridium acetobutylicum (27). Besides the biomass 
composition, the growth-associated maintenance (GAM) and non-growth 
associated maintenance (NGAM) energies have been found to play an important 
role in simulating the growth rate of organisms (27,28,29). In our model 
simulation, the NGAM was chosen as 7.6 mmol ATP/g DCW, as reported 
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previously (29). To identify the GAM, we plotted the relations between growth 
rate and GAM (Figure 6.4), and found the value of GAM that can match the 
experimental measurement (i.e. growth rate of strain X514 as 0.043 h
-1
 reported in 
(26)) was 220.0 mmol ATP/g DCW, and this fitted value is qualitatively 
consistent to previous reported GAM value (150.0 mmol ATP/g DCW) in a 
thermopilic ethanol producer Clostridium thermocellum (30). Based on this 
drafted model, we also predicted the correlations between growth rate, ethanol 
production, and waste product outflow (Figure 6.5). The prediction shows a trade-
off relation between ethanol production and growth rate. The ethanol production 
can be increased by 25% (i.e. increased from 6.3 mmol/g/h to 7.8 mmol/g/h) 
while halving the growth rate (i.e. decreased from 0.045 h
-1
 to 0.027 h
-1
). By 
inhibiting the acetate production from 2.0 mmol/g/h to 0.6 mmol/g/h, the ethanol 
production under the optimal growth conditions could be improved by 33%. 
Therefore, we have shown the platform is able to make reasonable predictions for 
the biomass growth in response to metabolites synthesis.    
6.5 Discussion and conclusion 
MicrobesFlux is designed for high-throughput drafting of metabolic 
models for environmental organisms based on genome annotations in KEGG. 
Unlike the model organisms that have been systemically studied via different 
“omics” approaches, the environmental organisms have more complex metabolic 
features but fewer measurements from laboratories. Therefore, MicrobesFlux can 
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be used as a platform to construct models for predicting cell metabolism. On the 
other hand, validation of a genome-scale metabolic model can be a challenge due 
to requirement for manually fine tuning metabolic pathways and due to lack of 
experimental data to confirm functional pathways. For example, 
Thermoanaerobacter sp. strain X514 used in the MicrobesFlux case study is 
capable of growing under high temperature and converting sugars to ethanol, 
which can be simulated by a medium-scale metabolic model. Such a convenient 
FBA model has decent predictive power for in silico studies of a non-model 
environmental microorganism for bioethanol production at different growth rates 
(Figure 6.5). However, many other metabolic features (e.g., secondary 
metabolisms) in the strain X514 are not fully understood yet. It requires extensive 
experimental studies, including transcriptomics and proteomics analysis, for a 
precise reconstruction of genome-scale model. Although the scale of drafted 
MicrobesFlux model in this study is still small (<300 reactions) so that users can 
easily fine tune the metabolic model and manually fill annotation gaps in carbon 
metabolic pathways, MicrobesFlux can serve as a springboard to future advanced 
genome-scale metabolic model by adding more reconstruction steps, such as the 
gene-protein-reaction (GPR) correlation, charge balance, and metabolites 
exchange among metabolic compartments (e.g. mitochondria in eukaryotic cells).  
In summary, we have developed MicrobesFlux to draft the metabolic 
models of environmental organisms from KEGG database and serves as a high-
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throughput tool for systems biology. MicrobesFlux extricates microbiologists 
from programming and commercial software that are normally required to build a 
metabolic model. It covers a large number of sequenced organisms in KEGG 
database and provides multiple approaches to assist the model generation and 
reconstruction. Both FBA and dFBA can be achieved in MicrobesFlux to simulate 
the metabolic behaviors of organisms in metabolic steady state and dynamic state.  
The drafted model can be further used by other software for genome-scale model 
reconstruction and in silico predictions. In the future, we will implement broad 
fluxomic approaches (e.g. 
13
C-metabolic flux analysis) in MicrobesFlux to 
improve the accuracy and predictive power of drafted metabolic models. 
6.6 Availability and requirements 
 Project name: MicrobesFlux 
 Project homepage: 
http://tanglab.engineering.wustl.edu/static/MicrobesFlux.html 
 Operating systems: Platform independent. 
 Programming language: Java and Python. 
 License: MicrobesFlux is freely available for non commercial purposes. 
 Any restrictions to use by non-academics: none 
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Figure 6.1. Architecture of MicrobesFlux. 
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Figure 6.2. (A) Pathway network of TOY model used in MicrobesFlux, and (B) 
simulated flux distribution of TOY model used in MicrobesFlux. The same results 
were obtained by using “linprog” in MATLAB. 
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Figure 6.3. Screenshot of reconstructing TOY model by using MicrobesFlux. (A) 
load TOY model from MicrobesFlux; (B) pathway information of TOY model; 
(C) customized reconstruction of TOY model; and (D) constraint-based flux 
balance analysis of TOY model. 
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Figure 6.4. Estimation of the growth-associated maintenance (GAM) in 
Thermoanaerobacter sp. strain X514. From this comparison, the GAM value (red 
dotted line) consistent with experimental data (i.e. growth rate was 0.043 h
-1
) 
could be estimated and was indicated as a 220.0 mmol ATP/ g DCW. 
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Figure 6.5. Predictions of the relationship between growth rate and outflow 
fluxes [Unit: mmol/g/h] in Thermoanaerobacter sp. strain X514. The glucose 
inflow flux is fixed as 3.92 mmol/g/h.  
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Chapter 7 
 Conclusions and Future Investigations  
7.1 Summary  
I have developed and applied multiple fluxomics tools during my Ph.D. 
training. 
13
C-pathway analysis has been systemically used to discover novel 
pathways, investigate the mixotrophic metabolism, and optimize medium for 
slow-growing bacteria. The achievements from 
13
C-pathway analysis are 
summarized in Table 7.1. Meanwhile, 
13
C-MFA has extended the applications 
from quantifying metabolic fluxes in industrial workhorses to those in 
environmental microorganisms. The accurate metabolic readouts of the flux 
distribution have been determined for Chlorobaculum tepidum, as the first study 
in quantifying the mixotrophic metabolism of green sulfur bacteria. The isotope 
discriminations have been confirmed in heterotrophic metabolism of E.coli, which 
could affect the solution space in flux calculations by 
13
C-MFA. Moreover, to 
investigate the dynamic metabolism of environmental microorganisms, a 
framework that integrates bioprocess models, dFBA, and isotopomer simulations 
has been applied in Shewanella oneidensis MR-1. The dynamic flux distributions 
have been profiled, which revealed a few underlying metabolic features during the 
dynamic metabolism. Such dynamic flux analysis approach can bypass the 
measurement of low-abundant and fast-turnover metabolites, and can address the 
 268 
 
suboptimal microbial metabolisms that are often adopted by environmental 
microorganisms. As one of the steps in bridging the gaps between fast-paced 
genome sequencing and slow-paced metabolic model constructions, a web-based 
platform, MicrobesFlux, is being built based on KEGG database for high-
throughput metabolic models drafting. A large database including 1,192 
sequenced genomes is available in MicrobesFlux. Diverse customized tools are 
provided for model reconstruction. Both FBA and dFBA can be achieved to 
simulate the metabolic fluxes of environmental microorganisms in metabolic 
steady state and dynamic state.  
Beside fluxomics investigation on the metabolisms of environmental 
microorganisms, several projects have also been accomplished by studying 
bioprocess engineering, metabolic engineering, and nano-toxicity. In general, a 
parsimonious kinetic model has been constructed to capture the growth kinetics of 
Shewanella oneidensis MR-1 (Appendix 9). A bioprocess model was built to 
describe the isobutanol fermentation of recombinant E.coli strains (Appendix 10). 
The broad scope research also involved constructing a statistical model that 
analyzed influential factors in production yield of metabolic engineering 
(Appendix 11) (1), and characterizing the bacterial responses to nanoparticles 
(Appendix 12) (2). 
7.2. Current challenges in fluxomics analysis   
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One of the main applications of fluxomics analysis is to identify the 
bottlenecks in biochemical production by engineered microorganisms and to 
assist the rational design of mutants in metabolic engineering. Unfortunately, 
several barriers in current fluxomics analysis stalled the inception of fluxomics-
based biotechnology.  
On one hand, the fluxomics can measure the carbon flows in central 
metabolic pathways to the final product and predict the optimal operation of 
metabolic network. However, the flux measurements and predictions have not yet 
been coordinated systemically and left many key questions unanswered in 
metabolic engineering. For example, metabolic robustness, the ability of 
microorganisms to maintain the similar metabolic performances under genetic or 
environmental perturbations, is a long-recognized property of microbial systems. 
Comparative studies on wide-type and genetically manipulated mutants via 
13
C-
MFA often fail to tell the differences in flux distributions of central metabolism, 
and yield no information or predictions for the mechanisms of microbial 
robustness. Constraint-based flux analysis can in silico test different hypothesis 
about microbial robustness. However, most of the hypotheses cannot be proved 
due to lack of accurate flux measurements in FBA. 
On the other hand, metabolic engineering of industrial chassis is based on 
the premise that the yield of a desired product can be increased by identifying and 
over-expressing the enzymes that catalyze the rate-limiting steps in a given 
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metabolic pathway. However, the rate-limiting enzymes may not always exist in 
reality due to the complicated cell-wide regulations of microbial metabolisms that 
involve both the well-known gene-protein-flux correlations, and the less well-
known post-transcriptional and post-translational regulations. In this case, the 
increases in productivity are often achieved by coordinated expression of multiple 
genes in the metabolic network, in which fluxomics analysis cannot provide 
reasonable guidelines for rational design in metabolic engineering, until it is 
cross-talked with other “omics” data in systems biology.  
7.3 Future development of advanced fluxomics tools 
Fluxomics analysis is playing an increasingly important role in systems 
biology and bioengineering. One of current limits in fluxomics studies is the 
tradeoff between model predictive capacity and model accuracy. FBA is well-
known for the strong predictive power by adopting genome-scale metabolic 
models. However, FBA lacks the accuracy in describing the cellular metabolism. 
Conversely, 
13
C-MFA provides accurate metabolic readouts in a simplified 
metabolic network. Unfortunately, it cannot predict metabolic behaviors well. To 
further refine fluxomics analysis, my future research will focus on developing an 
integrated modeling approach that not only describes the cellular metabolism 
accurately in genome-scale, but also predicts the flux distributions based on 
diverse assumptions. The barriers between model prediction and model accuracy 
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will be removed, which can be of specific help in rational design of metabolically 
engineered mutants. 
Another topic in my future investigation is to cross-talk fluxomics with 
transcriptomics and proteomics to unravel the cell-wide post-transcriptional and 
post-translational regulations. Little is known about the post-transcriptional and 
post-translational network in cellular metabolism except their complex 
characteristics. The fluxomics study can provide reliable and high-throughput of 
cellular metabolism. By quantitatively correlating the input (i.e., transcriptomics 
and proteomics) and output (i.e. fluxomics) of metabolic system, the topology and 
activities of metabolic regulatory network that controls the cellular metabolism 
can be empirically deciphered. The decoding of metabolic regulatory mechanisms 
will be of great value in understanding the physiology, especially the 
pathophysiology of diverse biological systems.  
Finally, open-source software for integrative and broad scope fluxomics 
analysis is planned to be developed in future. It is expected that genome-scale 
metabolic models can be automatically generated from multiple genome 
sequencing databases. The drafted metabolic models can be efficiently and 
successively validated based on heterogeneous databases on systems biology 
experiments (e.g. transcriptional analysis, lethality tests). State-of-the-art flux 
analysis approaches can be achieved in the genome-scale metabolic models, 
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which provide precise readouts on metabolic flux distributions and predictive 
guidelines for in silico genetic manipulations. 
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Table 7.1. Novel metabolic features identified by 
13
C-pathway analysis 
Microbes Interests 
Novel metabolic 
features 
Collaborations 
Shewanella 
oneidensis MR-1 
Bioremediation 
and microbial 
fuel cells. 
Invariability of 
central metabolism 
under environmental 
or genetic 
perturbations 
Dr. Adam Arkin 
Mycobacteria 
smegmatis  
Relative of 
pathogenic 
Mycobacterium 
tuberculosis 
Induced glyoxylate 
pathway and glycine 
dehydrogenase 
under hypoxic stress  
Dr. Carolyn 
Bertozzi and Dr. 
Jay D. Keasling 
Thermoanaerobacter 
X514 
Ethanol 
producing at 
high 
temperature  
(Re)-type citrate 
synthase and 
citramalate pathway 
Dr. Jizhong 
Zhou 
Roseobacter 
denitrificans 
OCh114 
Aerobic 
anoxygenic 
phototrophs, 
CO2 fixation 
Inactive glycolysis 
and active Entner–
Doudoroff pathway  
Dr. Robert 
Blankenship 
Cyanothece 51142 
Biofuel 
producing, 
nitrogen 
fixation  
Citramalate pathway 
for isoleucine 
synthesis; inhibition 
of CO2 fixation by 
glycerol  
Dr. Himadri 
Pakrasi 
Heliobacterium 
modesticaldum  
Gram-positive, 
thermophilic, 
photosynthetic 
bacteria 
(Re)-type citrate 
synthase in TCA 
cycle  
Dr. Robert 
Blankenship 
Dehalococcoides 
ethenogenes 195 
TCE 
degradation 
Exogenous amino 
acids are selectively 
utilized   
Dr. Lisa 
Alvarez-Cohen 
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Carbon Flow of Heliobacteria Is Related More to Clostridia than 
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Appendix 9 
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Abstract 
Understanding microbial kinetic behavior is important for bioprocessing 
engineering, such as chemical synthesis and bioremediation. However, 
development of proper models to capture complicated microbial kinetics is a 
challenging task. In this study, we demonstrate an example for rationally 
modeling the growth of Shewanella oneidensis MR-1 in a batch culture. Based on 
a series of analyses, including residual analysis, scaled sensitivity coefficient 
analysis, parameter correlation analysis, and the F-test, we estimated model 
parameters to construct a parsimonious Monod-based model that used the fewest 
parameters for best simulation of Shewanella growth using different carbon 
substrates. Sequential analysis was also applied to identify the time window for 
estimating each parameter in the kinetic model. This study shows that statistics-
based parameter estimation is an efficient method to successively reconstruct and 
fine tune kinetic models for complex biological systems.  
 
Key words: Monod, Shewanella, parsimonious model, sensitivity, F-test, 
sequential analysis 
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Introduction 
The relation between microbial growth rates and substrate concentrations 
(often referred to as microbial growth kinetics) has been studied and substantiated 
for over a century [1]. Numerous models, including the well-known Monod 
equation [2], have been established to describe the growth kinetics. In spite of the 
wide applications of the Monod model, it does not always lead to a good 
description of a given bioprocess. One criticism of the Monod model is that the 
two parameters in the model, i.e., the maximum specific growth rate (μmax) and 
substrate saturation constant (Ks), can be correlated in estimation, which results in 
reported values that differ by several orders of magnitude [1]. In addition, the 
complicated culture conditions (e.g., growth with mixed substrates rather than a 
single substrate) make the original Monod model insufficient to reflect every 
aspect of growth kinetics. To overcome this problem, the model has to be refined 
by introducing additional parameters to account for the complexity of growth 
kinetics. In doing so, however, there is a risk of over-parameterization [3].  
In this study, we applied parameter estimation techniques [4,5] in 
reconstructing the Monod model to decipher growth kinetics of Shewanella 
oneidensis MR-1.  MR-1 is an environmentally important bacterium that plays 
important roles in bioremediation, microbial fuel cells, and ecological carbon 
cycling [6,7,8,9]. As revealed by our previous kinetic study, S. oneidensis MR-1 
utilizes lactate as the favorable carbon source and produces waste metabolites 
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(acetate and pyruvate) which are consumed during the late growth stage [6]. 
However, the previous model has not rigorously considered the optimal selection 
of model parameters to improve the quality of data fitting. To build a 
parsimonious model for capturing MR-1 growth dynamics (i.e., a model with the 
best simulation and fewest parameters), we applied a series of tools that were 
originally used in nonlinear parameter estimation to reconstruct the Monod model 
successively until it satisfied all the statistical assumptions used in parameter 
estimation. During the model reconstruction, several underlying metabolic 
features of MR-1 were uncovered. Finally, the impact of each experimental 
measurement on estimating the updated kinetic parameters was also evaluated by 
sequential parameter estimation [10,11,12,13] of the parsimonious model.  
 
Methods 
Cell culture and analytical methods 
S. oneidensis MR-1 was first grown in LB medium in shake flasks 
overnight. A 0.1% inoculum volume was then cultured into the modified MR-1 
defined medium [14] in shaking flasks at 150 rpm and 30°C. The initial carbon 
source was 30 mM lactate. The growth curve was monitored by dried biomass 
weight. The concentrations of lactate and acetate in the medium were measured 
using enzyme kits (r-Biopharm, Darmstadt, Germany). The concentration of 
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pyruvate in the medium was measured with the enzyme assay developed by 
Marbach and Weli, 1967. For each sampling point, we made triplicate 
measurements. 
Seed model for growth kinetics 
To find a parsimonious model describing MR-1 growth with the fewest 
parameters, a seed model was built first and then successively reconstructed 
(Table 1). In the seed model, a multiple-substrate Monod model was developed to 
simulate the cell growth, lactate consumption, and acetate and pyruvate secretion 
and reuse.  
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The growth rates of MR-1 on different carbon substrates were assumed to be 
additive: 
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In the above model, X is biomass (g dry cell/L); LACT, ACT, and PYR are 
lactate, acetate, and pyruvate concentrations (mmol/L), respectively; μ is the 
overall specific growth rate (h
-1
); ke is the endogenous metabolism rate constant 
(h
-1
); YX/L, YX/A, and YX/P are the biomass yield coefficients (g dry cell /mmol 
substrate) of lactate, acetate, and pyruvate, respectively; rP,L and rA,L are the 
production rate (mmol/L/h) of pyruvate and acetate from lactate, respectively; rA,P 
is the production rate (mmol/L/h) of acetate from pyruvate. The biomass yield 
coefficients were the reported values: YX/L = 0.0212 (g dry cell /mmol lactate), YX/A 
= 0.0132 (g dry cell /mmol acetate) and YX/P = 0.0195 (g dry cell /mmol pyruvate) 
[15]. μL, μA, and μP are the specific growth rates (h
-1
) on lactate, acetate, and 
pyruvate, respectively; μmax,L, μmax,A, and μmax,P are the maximal growth rates (h
-1
) 
for fully aerobic growth on lactate, acetate, and pyruvate, respectively; and Ks,l, 
Ks,a, and Ks,p are Monod constants (mmol/L) for lactate, acetate, and pyruvate, 
respectively.  
The acetate and pyruvate secretions were assumed to follow first order 
kinetic forms in the seed model:  
 
(7) 
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where kal and kpl are rate constants of acetate and pyruvate production from 
lactate, respectively (L∙ (h∙g DCW)-1). kap is rate constant of acetate production 
from pyruvate (L∙ (h∙g DCW)-1). The seed model was then reconstructed 
following the flowchart in Figure 1. In general, parameter estimation was 
accomplished for each reconstructed model, and then it guided the addition or 
removal of parameters. Ten different models (Table 1) were built and compared 
until the parsimonious model was capable of satisfying all the statistical 
assumptions. 
Nonlinear parameter estimation 
To estimate the parameters in the seed model and the reconstructed 
models, an ordinary least squares (OLS) method [4] was applied to solve the 
inverse problems. In general, OLS aims to minimize the residual sum of the 
squares (R) between model simulations and experimental measurements:  
R = [Y – η (t ; β)]T [Y – η (t ; β) ]                                                      (12) 
where t is the time of the experimental measurements, η represents four dependent 
variables (i.e., concentration of biomass, lactate, acetate and pyruvate) simulated 
by the kinetic model; β represent the vector of the parameters to be estimated; and 
(9) 
(10) 
(11) 
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Y is the vector of the experimentally measured value of the dependent variables. 
Our experiment had a total of n measurements for each of the four dependent 
variables, so η and Y were vectors with a length of 4×n. The scales of the four 
dependent variables had order of magnitude differences (e.g., the scale of the 
biomass measurement was < 1 g/L, while the lactate measurement was > 10 
mmol/L), and the direct application of OLS would overemphasize the fitting of 
dependent variables with large scales. To overcome the estimation bias, each 
simulated dependent variable η j  (n×1 vector) and the corresponding experimental 
measurements Yj (n×1 vector) were normalized by dividing by the maximum 
concentrations observed in the n experimental measurements (i.e., Y j
’ 
= Y j / max( 
Y j ), η j
’ = η j / max (Y j ), j = 1…4). The weighted OLS method was  
R = [Y
’
 – η’ ( t ; β ) ]T [Y’ – η’ ( t ; β )]                                          (13) 
To check the simulation quality, we applied a series of analyses, including 
residual analysis, scaled sensitivity coefficient analysis, parameter correlation 
analysis, and the F-test. The mean of the residuals in the model simulation (i.e., ε 
= Y′ – η΄ (t ; β) in each model) should be close to zero (i.e., E (ε) should be close 
to zero, where E is the expectation function), should be normally distributed (i.e., 
the histogram of ε should follow Gaussian distribution), and should be 
uncorrelated (i.e. E { [ε i  – E (ε i) ] [ε j –E (ε j)]} = 0). A simple check for 
uncorrelated residuals was to count the number of runs (i.e., number of changes in 
signs of the residuals) [4]. In this study, n measurements (triplicates) were taken 
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at m time points (i.e., n = 3∙m). The means of the triplicates at each time point 
were used to check the residual correlations. For m independent, zero-mean, 
random model fitting residuals, the minimum value for non-correlated residuals 
should be [4]  
r = (m+1) /2                                                                                              (14) 
If the number of runs in the model simulation was smaller than r, the model fitting 
residuals were correlated with each other, and vice versa.  
The impact of parameters on the model simulation was identified by 
formulating and analyzing a scaled sensitivity (SS) matrix. The scaled sensitivity 
matrix is the normalization for the commonly-used Jacobian matrix, which can be 
applied to compare the impact of the parameters on model simulation:  
' '
1 1
1 p
1 p
' '
n n
1 p
1 p
...
SS
...
                                                                      
(15)
 
where ηi 
’
 is the simulation in ith time point, βj is the jth parameter, n is the 
number of time points in experimental measurements, and p is the number of 
parameters. The units of the scaled sensitivity coefficients (SSCs) are 
dimensionless since all the dependant variables are normalized in η’. Each column 
of the SS matrix reflects the dynamic impact of different parameters on the model 
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simulation. The SSCs of the two most influential parameters are plotted in Figure 
S1, for both the seed model and the parsimonious model. From a comparison of 
the scale of each column (i.e., the maximum of the absolute values in the column), 
the impact generated by each parameter could be compared and used to guide the 
model reconstruction. For each dependent variable, the SSCs versus time could be 
plotted for each parameter.  For better parameter estimation that would result in 
the smallest standard error for that parameter, we desired SSCs to be large and 
uncorrelated. 
The correlations among parameters were characterized by a correlation 
matrix Corr, which yielded the correlation coefficient of the two parameters βi 
and βj, by using the covariance matrix C: 
C(i,i)
Corr(i, j)   [ 1.0 1.0]
C(i, j) C(i, j)                                                        
(16)
 
A higher absolute value of Corr (i, j) in the correlation matrix indicated a strong 
correlation between the two parameters and hence more difficult estimation for 
both parameters. 
 
The “ode23” command in MATLAB (2009a) was used to solve 
differential equations, and the “fmincon” command was used to estimate the 
parameters. Since many local solutions existed around the real parameter settings, 
the likely global solution of parameters was derived by randomly choosing the 
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initial guesses within a known range in the nonlinear optimization and running for 
100 times. Next, a bootstrap method was used to find the confidence intervals of 
each parameter by following the approach described before [4,16]. In general, the 
residuals in the parsimonious model were randomly re-sampled to obtain a new 
bootstrap set Y
΄
, which constructed a new parameter estimation problem that was 
solved by the same procedure. The 95% confidence intervals of the parameters 
were derived by running the bootstrap method 999 times [4], which added to the 
original estimate gave 1,000 values for each parameter.  For each parameter, the 
1,000 values were sorted from lowest to highest, and the confidence interval was 
found by choosing the 25
th
 and 975
th
 value. The standard deviation of each 
parameter was calculated from the 1,000 values.  
The F-test for the reconstructed models 
Introducing more parameters in the reconstructed model usually led to a 
better (or at least equally good) simulation of the microbial growth kinetics. 
However, it was unclear whether the improvement in simulation was statistically 
significant. In this study, the F-test was applied to address this question. For the 
original model ηi and the reconstructed model ηj, the critical F value was 
calculated as 
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i j
j i
j
j
R - R
p - p
F
R
n - p
=
                                                                                              
(17)
 
where Ri and Ri are the residual sum of the squares of models ηi  and ηj , 
respectively; n is the number of  experimental measurements; and pi and pj  are the 
number of parameters in models ηi  and ηj , respectively. If  the F value calculated 
from the reconstructed model was larger than the critical F value for some desired 
false-rejection probability (e.g., 0.05 in this study), the improvement of the 
reconstructed model was significant. Otherwise, the new model could not provide 
a significantly better fit than the original model. The F-test can check not only 
whether introducing new parameters leads to a significant improvement in model 
simulation, but also can be used in a reversible way to test whether some 
parameters can be removed from the original model. If the reconstructed model 
with fewer parameters has a smaller F value than the critical F value, then by 
removing redundant parameters, the simulation in the reconstructed model is not 
degraded (i.e., the original model is over-parameterized).
 
Sequential analysis of the parsimonious model 
To estimate the effect of experimental measurements on model 
parameters, we applied a sequential analysis [10,11,12,13] by successively adding 
experimental data. Each experimental data point was treated as one step in the 
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parameter estimation. There were four dependent variables and 18 time-course 
samples (triplicates), so the total steps were 4×18×3 = 216. At each step, the 
parameters in the parsimonious model were estimated by the sequential procedure 
which was developed based on a matrix inversion lemma [4]. A series of 
equations was used iteratively to find the parameter at each step: 
'
' '
1 1
1 p
1 p
' '
n n
1 p
1 p
T
2
for j=1:m 
Y (t, )
...
...
for i=1:n-1 
(i 1) (i) (i 1)
(i 1) (i 1) (i 1) (i 1)
(i 1) (i 1) \ (i 1)
(i 1) (i) (i 1) (i 1) (i)
(i 1)
e b
J
A P J
J A
K A
P P K X P
B (i) (i 1){ (i 1) (i 1)[ (i) ]}
(n);
if ( )<tol  break;  else = ;
B K e X B b
b_new B
b_new b b b_new
                        
(18) 
where e is the vector for normalized residuals; b is the vector for parameters 
estimated by sequential analysis; J is the scaled sensitivity matrix, P was the 
parameter covariance matrix; Ф is the vector for variance of measurement; A, ∆, 
K, B, and b_new are matrices used in the sequential analysis; n is the number of 
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steps in sequential analysis (i.e., 216 in this study), m is the number of runs of the 
sequential analysis; tol is the convergence tolerance in the sequential analysis. 
In general, the parameter vector b and the parameter covariance matrix P 
were initialized. The residual vector e and the scaled sensitivity matrix J were 
calculated based on b, and they initiated one round of sequential analysis, as 
shown in the inner for-loop. The sequential analysis then updated b, which was 
used as the new initial parameter vector in the next round of sequential analysis. 
This procedure was repeated until the difference between b and B converged 
below the tolerance, 0.3% in this study. 
 
Results and discussion  
Simulation of growth kinetics by the seed model 
As a starting point to investigate the growth kinetics of S. oneidensis MR-
1, a seed model (Model 0, eq.1-11) assumed that the growth rate on different 
carbon substrates was additive and that first-order kinetics in the carbon substrate 
switch from lactate to acetate and pyruvate. The seed model showed gaps between 
the model simulation and experimental measurements. For example, the 
concentrations of lactate were always overestimated, while the biomass 
productions were underestimated by the model prediction at the early growth 
stage (Figure 2A). The differences between the simulation and experimental 
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measurements made the residuals of the seed model highly correlated (Figure 2B) 
and of large variance as indicated in the width of histogram (Figure 2C).  
In the seed model, the largest SSCs for the seed model are those related to 
the growth rates of lactate (μmax,L) and of acetate (μmax,A). These two SSCs v.s. 
time are plotted for each dependent variable (i.e., biomass, lactate, acetate and 
pyruvate) in Figure S1A, C, E & G, respectively. For best estimation results, we 
desire SSCs to be large and uncorrelated. The maximum absolute value of each 
SSC is shown by its corresponding length in the bar charts in Figure S2 A-F, 
where each chart is for a different model. For example, the maximum absolute 
value of SSC for μmax,L in acetate simulation was 5.57 (Figure S1E). The 
corresponding bar runs from 5.78 to 11.35 (Figure S2A, green bar). In this way, 
Figure S2 A-F could readily show which parameter is the most or least influential 
for each model. Figure S2 usefully summarizes the large number of SSCs and 
avoid clutter in Figure S1. 
In addition, the scaled sensitivity analysis (Figure S2A) of the seed model 
indicated that the impacts of μmax,P and Ksp (the two parameters related to MR-1 
growth with pyruvate) on simulation of growth kinetics were 7~8 magnitudes 
lower than the other parameters. The correlation analysis among parameters (Text 
S1) showed that the two parameters μmax,L and Ksl (the two parameters related to 
Shewanella growth with lactate) were correlated with each other (correlation 
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coefficient was 0.885). Based on the fitting analysis of the seed model, a series of 
model reconstructions were made following the procedure in Figure 1. 
Monod model reconstructions 
The imperfection of the growth kinetics simulation in the seed model 
initiated the successive model reconstructions to find the parsimonious model 
(Figure 1). In general, based on the statistical analysis of the seed model, the 
model was reconstructed by either adding or removing parameters in the growth 
kinetics. The reconstructed model with the hypothesized kinetics was analyzed by 
a series of statistical methods, including scaled sensitivity analysis (Figure S2), 
residual analysis (Figure S3), parameter correlation analysis (Text S1), and 
residual correlation analysis (Text S2). The reconstructed model was accepted as 
the new seed model if it passed the F-test. The procedure was repeated until a 
parsimonious model was found to satisfy all the statistical assumptions.  
In this study, ten reconstructed models were built and improved (labeled 
as Model 0-Model 3.1 in Table 2). The entire reconstruction procedure was 
composed of two steps. The first step in model reconstruction (Model 0-Model 
1.3) was to remove the parameters in Model 0 that were not necessary in 
describing the growth rates with multiple carbon substrates. Since the scaled 
sensitivity coefficients of the parameters μmax,P and Ks,p related to Shewanella 
growth with pyruvate were 7~8 magnitudes lower than for the other parameters 
(Figure S2A), the pyruvate term had a trivial contribution to MR-1growth. 
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Therefore, we built Model 1.1 (Table 1) by removing μmax,P and Ks,p from the seed 
model. By using the F-test in reverse, it was found that the reconstructed model 
did not lead to a significantly worse simulation (i.e. F < F_critical in Table 2), and 
thus Model 1.1 was accepted for further reconstruction. To build Model 1.2, the 
Monod constant Ksa was then removed because it had the lowest maximum value 
of scaled sensitivity (Figure S2B). This assumption was again proved to be 
reasonable by the F-test. Next, it was found that μmax,L and Ksl could be mildly 
correlated (the correlation coefficient is 0.776) in Model 1.2, which indicated that 
the value of the Monod constant Ksl was much more influential than lactate 
concentrations in the experimental measurements, and hence first-order kinetics 
would be sufficient to describe the growth kinetics with lactate. Model 1.3 was 
accordingly built by assuming that the biomass production from lactate followed 
first order kinetics. Although such an assumption affected the kinetic model 
simulation (Figure S3), the smaller F (F = 2.308) than the critical F (F = 4.043) 
value in Table 2 suggested that the reconstructed model avoided over-
parameterization.  
Reconstruction from Model 0 to Model 1.3 aimed at a more concise 
description of the growth kinetics. However, owing to the improper assumption of 
first-order kinetics in the substrate switch, the simulated growth kinetics needed to 
be improved. Therefore, the second step in model reconstruction (Model 2.1-
Model 2.3.3) was to increase the complexity of products secretion kinetics in the 
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reconstructed model. From Model 2.1 to 2.3.3 (Table 1), five different kinetics 
were constructed to describe the acetate and pyruvate production. We used the 
rational function to empirically simulate the product secretion kinetics. The 
denominator function was set as a first-order polynomial, while the numerator 
function was gradually made more complicated from Model 2.1 to Model 2.3.3 
(Table 1) by increasing the degrees of the polynomial function. The F-test was 
applied to each reconstructed model to test whether the rational function was 
sufficient to describe the growth kinetics. As identified in the F-test (Table 2), 
first-order kinetics was sufficient for acetate production from lactate or pyruvate. 
However, the kinetics of pyruvate production from lactate was more complicated 
than first-order or Monod kinetics. Therefore, we described pyruvate production 
from lactate by adding a second order polynomial term in the numerator of the 
Monod equation (i.e., Model 2.2, Table 1). The reconstructed model, Model 2.2, 
dramatically improved the fitting of biomass, acetate, and pyruvate concentrations 
by decreasing both the scale and variances of residuals (Figure S3 D1 and D2, vs. 
E1 and E2). However, correlated residuals were still found in the model 
simulation. So we added a hypothetical kinetic term to describe additional lactate 
loss during the cultivation or measurement processes (Model 3.1). Based on the 
F-test, the introduction of the hypothetical lactate loss coefficient did not 
significantly reduce the residual sum of squares for the entire model. However, it 
did improve the overall fitting by eliminating the correlated residuals (Text S2) in 
the biomass, lactate, and acetate simulations. Accordingly, the lactate loss term 
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was retained in the parsimonious model to account for the consumption of lactate 
not considered by the original Monod kinetics (Model 3.1, Table 3).  
Compared to Model 0, the residuals in the parsimonious model were 
smaller (a root mean square error of 0.15, compared to 0.26 in Model 0, Figure 
2D). The residuals were also non-correlated in biomass, lactate, and acetate 
simulations (Figure 2E), and normally distributed with a smaller variance (0.004, 
compared to 0.012 in Model 0, Figure 2F). All parameters were confirmed to be 
uncorrelated and to influence the growth kinetics simulation. Therefore, the 
statistical assumptions were satisfied in the parsimonious model. The largest 
SSCs for the parsimonious model were those related to the growth rate of lactate 
(β2) and of acetate (β1), as shown in Figure S1 B, D, F, H and Figure 3. The 
parameter values in the parsimonious model and 95% confidence intervals 
derived from the bootstrap method are listed in Table 4. 
Sequential analysis of the parsimonious model 
In designing experiments to reveal microbial growth kinetics, it is 
necessary to know the best time window for estimating each parameter. By 
gradually including more experimental measurements in parameter estimation, we 
applied a sequential analysis to investigate the impact of experimental 
measurements on parameter estimation in the parsimonious model. The 
sequentially estimated parameters initially fluctuated as expected with the 
addition of more experimental measurements (Figure 4), but eventually converged 
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to results similar to those from nonlinear parameter estimation (Text S3). 
However, the measurement steps in sequential analysis at which the parameters 
no longer varied were not the same. For example, parameter ke could be 
accurately estimated within 100 measurement steps (i.e., ~18 h), while kap could 
not be reasonably estimated until the 150
th
 measurement step (i.e., ~25 h). Some 
parameters (i.e., β11) could not smoothly converge, indicating that current 
experimental measurements may not be effective in estimating such parameters, 
or that a longer experiment may be necessary for estimating the parameter. All 
other parameters converged to a constant well before the experiment ended, 
strengthening the conclusion that the model is appropriately reconstructed to 
simulate the growth kinetics of MR-1.    
Concluding remarks 
The Monod model was successively reconstructed in this study until a 
parsimonious model emerged that described the growth kinetics of Shewanella 
oneidensis MR-1. From the model reconstructions, we found that pyruvate made a 
trivial contribution to biomass production; rather, it served as a transient 
metabolite in producing acetate. The growth rate with lactate and acetate could be 
sufficiently described by first-order and zero-order kinetics, respectively. The 
kinetics of carbon substrate utilization, especially for pyruvate production by 
lactate, was more complicated than first-order reactions, and it suggest that 
unidentified lactate loss may be involved in the growth of MR-1. Finally, by using 
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sequential analysis in the parsimonious model, the time windows necessary for 
parameter estimation were provided, which can be further used for guiding the 
experimental designs in microbial growth kinetics studies. The general modeling 
approach in this research can also be potentially used to study other complex 
biological systems. 
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Figure Legends 
Figure 1. Flowchart of Monod model reconstruction. 
Figure 2. Growth kinetics of Shewanella oneidensis MR-1. Left (A, B, and C), 
simulation by seed model; right (D, E, and F), simulation by the reconstructed 
parsimonious model. In the fitting plots (A, D), the experimental measurements 
are plotted with markers (○: lactate concentration, mmol/L; ◊: measured acetate 
concentration, mmol/L; ×: pyruvate concentration, mmol/L; □: biomass, g/L) and 
the model predictions were plotted in solid lines. In the residual plots (B, E), the 
normalized residuals were plotted with different markers (○: normalized lactate 
residuals; ◊: normalized acetate residuals; ×: normalized pyruvate residuals; □: 
normalized biomass residuals). The residual histograms (C, F) are plotted for all 
the normalized residuals. 
Figure 3. The maxima of scaled sensitivity for parameters in the parsimonious 
model. Black bars: the maximum scaled sensitivity for biomass simulation; red 
bars: maximum scaled sensitivity for lactate simulation; green bars: the maximum 
scaled sensitivity for acetate simulation yellow bars: the maximum scaled 
sensitivity for pyruvate simulation. 
Figure 4. Sequential analysis for the reconstructed Monod model. 
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Table 1. Models used in the F-test 
Model Assumptions 
0 Seed model as developed in eq. (1) - (11) 
1.1 
Extracellular pyruvate was neglected for biomass production: μ = μL+ μA 
in eq. (5) 
1.2 
Biomass production from acetate was assumed to follow zero order 
kinetics: μA = β1 in eq. (7) 
1.3 
Biomass production from lactate was assumed to follow first order 
kinetics: μL = β2∙LACT in eq. (6) 
2.1 
Pyruvate production from lactate was assumed to follow Monod kinetics:
 
3
P,L
4
LACT
r
LACT
in eq. (10) 
2.2 
Pyruvate production from lactate was assumed to follow the kinetics: 
2
5 3
P,L
4
LACT LACT
r
LACT
in eq. (10) 
2.3.1 
Pyruvate production from lactate was assumed to follow the kinetics:
 
3 2
6 5 3
P,L
4
LACT LACT LACT
r
LACT
 in eq. (10) 
2.3.2 
Acetate production from lactate was assumed to follow Monod kinetics: 
7
A,L
8
LACT
r
LACT
in eq. (9) 
2.3.3 
Acetate production from pyruvate was assumed to follow Monod 
kinetics:
 
9
A,P
10
PYR
r
PYR
in eq. (11) 
3.1 
Lactate was assumed to have non-growth related degradation:
 
L
P,L A,L 11
X/L
XdLACT
( r r LACT)  
dt Y
in eq. (1) 
. 
435 
 
Table 2. F-test for different models 
Model 
No. 
No. of 
Parameters
, 
p 
Degree of 
freedom, 
n-p 
Sum 
of  
squar
es, R  
Mean square, 
s2=R/(n-p) 
Mode
ls 
comp
ared 
∆R 
 
F_ critical 
Bes
t 
Mo
del 
No. 
0 10 44 2.9174 0.0663  
   
 
1.1 8 46 2.9174 0.0634 
Model 
0 v.s. 
1.1 
0.0
000 
0.000 
F(0.95,2,46
)=3.200 
1.1 
1.2 7 47 2.9717 0.0632 
Model 
1.1 
v.s. 
1.2 
0.0
543 
0.215 
F(0.95,1,47
)=4.047 
1.2 
1.3 6 48 3.6794 0.0767 
Model 
1.2 
v.s. 
1.3 
0.7
077 
2.308 
F(0.95,1,48
)=4.043 
1.3 
2.1 7 47 2.4463 0.0520 
Model 
1.3 
v.s. 
2.1 
1.2
331 
5.923 
F(0.95,1,47
)=4.047 
2.1 
2.2 8 46 1.1603 0.0252 
Model 
2.1 
v.s. 
2.2 
1.2
860 
12.746 
F(0.95,1,46
)=4.052 
2.2 
2.3.1 9 45 1.1603 0.0258 
Model 
2.2 
v.s. 
2.3.1 
0.0
000 
0.000 
F(0.95,1,45
)=4.057 
2.2 
2.3.2 9 45 1.1603 0.0258 
Model 
2.2 
v.s. 
2.3.2 
0.0
000 
0.000 
F(0.95,1,45
)=4.057 
2.2 
2.3.3 9 45 1.1603 0.0258 
Model 
2.2 
v.s. 
2.3.3 
0.0
000 
0.000 
F(0.95,1,45
)=4.057 
2.2 
3.1 9 45 0.9650 0.0214 
Model 
2.2 
v.s. 
3.1 
0.1
953 
2.277 
F(0.95,1,45
)=4.057 
3.1
* 
 
* Based on the F-test, Model 3.1 cannot significantly improve the sum of squares, 
R. However, Model 3.1 can eliminate the correlation among residuals and hence 
improve the overall fitting. 
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Table 3. A parsimonious model for S. oneidensis MR-1 growth 
No. Reaction Equations 
1 Bacteria growth L A e
dX
( k ) X
dt
 
2 Lactate consumption 
L
P,L A,L 11
X/L
XdLACT
( r r LACT)  
dt Y
 
3 
Acetate production and 
reuse 
A
A,L A,P
X/A
XdACT
(r r )   
dt Y
 
4 
Pyruvate production and 
reuse P,L A,P
dPYR
(r r )   
dt
 
6 
Specific growth rate with 
lactate L 2
LACT  
7 
Specific growth rate with 
acetate A 1
 
8 
Acetate production from 
lactate 
A,L alr k LACT X  
9 
Acetate production from 
pyruvate 
A,P apr k PYR X  
10 
Pyruvate production from 
lactate 
2
5 3
P,L
4
LACT LACT
r
LACT
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Table 4. Parameters of Monod model for S. oneidensis MR-1 growth 
Symbols Notation Unit Value 
SD 
(%) 
95% 
Confidence 
Intervals 
β1 
Zero order 
growth 
coefficient 
from 
acetate 
h
-1
 
0.0773
[6][16][16](Tang 
et al., 2007)
 
0.33 
[0.0768 
0.0778] 
β2 
First order 
growth 
coefficient 
from lactate 
L∙(h∙mmol 
lactate)
-1
 
0.0070 0.37 
[0.0070 
0.0071] 
β3 
Coefficient 
for pyruvate 
production 
from lactate 
mmol lactate∙ 
(h∙g DCW)-1 
18.8010 0.35 
[18.6442 
18.9666] 
β4 
Coefficient 
for pyruvate 
production 
from lactate 
mmol 
lactate∙L-1 
1.6223 7.36 
[1.4174 
1.9163] 
β5 
Coefficient 
for pyruvate 
production 
from lactate 
L∙ (h∙g DCW)-
1
 
-0.6916 2.64 
[-0.7315 -
0.6630] 
β11 
Non-growth 
related 
lactate 
g 
DCW∙(h∙mmol 
lactate)
-1
 
0.0057 0.36 
[0.0057 
0.0058] 
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degradation 
coefficient 
kal 
Acetate 
production 
coefficient 
from lactate 
L∙ (h∙g DCW)-
1
 
0.4672 4.86 
[0.4378 
0.5334] 
kap 
Acetate 
production 
coefficient 
from 
pyruvate 
L∙ (h∙g DCW)-
1
 
2.5487 3.36 
[2.3986 
2.7851] 
ke 
Endogenous 
metabolism 
rate  
h
-1
 0.0063 5.46 
[0.0061 
0.0074] 
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Figure S1. Scaled sensitivity coefficients (SSCs) in the seed model and the 
parsimonious model. Left column (A, C, E and G): the scaled sensitivity 
coefficients of μmax,L (blue line) and μmax,A (green line) in the seed model. These 
two parameters were chosen as examples to plot because they had the largest 
values.  Right column (B, D, F and H): the SSCs of β1 (blue line) and β2 (green 
line) in the parsimonious model.  These two parameters were chosen because they 
had the largest value. The maximums of the scaled sensitivity coefficients plotted 
in Figure 3 were the maximums of the absolute values in the corresponding scaled 
sensitivity plots above.  We desire SSCs to be large and uncorrelated for best 
parameter estimation.  
Note: SSCs for triplicate measurements were the same.   
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Figure S2 The maximal scaled sensitivity coefficients (SSCs) of parameters in 
reconstructed models. A: Model 0; B: Model 1.1; C: Model 1.2; D: Model 1.3; E: 
Model 2.1; F: Model 2.2. Black bars: scaled sensitivity on biomass simulation; 
red bars: scaled sensitivity on lactate simulation; green bars: scaled sensitivity on 
acetate simulation; yellow bars: scaled sensitivity on pyruvate simulation.  The 
length of each colored bar came from the absolute maximum value of the 
corresponding scaled sensitivity coefficient plots such as those in Figure S1.  
A B 
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E
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F
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Note: the maximal SSCs of certain parameters (e.g. μmax,P and Ks,p in Figure S2A) 
were too small to see. 
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Figure S3 Residual analysis for reconstructed models. A1 and A2: Model 1.1; B1 
and B2: Model 1.2; C1 and C2: Model 1.3; D1 and D2: Model 2.1; E1 and E2: 
Model 2.2. Green dots: normalized lactate residuals; orange diamonds: 
normalized acetate residuals; red crosses: normalized pyruvate residuals; blue 
squares: normalized biomass residuals.  
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Text S1 Correlation matrix in reconstructed models. 
 
Correlation matrix in Model 0 
 
umax_L umax_A umax_P Ksl Ksa Ksp kpl kal kap ke 
umax_L 1.000 0.700 0.027 0.885 0.931 0.056 0.653 -0.187 0.373 -0.300 
umax_A 0.700 1.000 -0.058 0.433 0.854 0.040 0.359 -0.456 0.888 -0.500 
umax_P 0.027 -0.058 1.000 0.046 0.046 0.993 0.357 0.331 -0.169 0.019 
Ksl 0.885 0.433 0.046 1.000 0.683 0.036 0.603 0.010 0.064 -0.303 
Ksa 0.931 0.854 0.046 0.683 1.000 0.105 0.627 -0.278 0.593 -0.387 
Ksp 0.056 0.040 0.993 0.036 0.105 1.000 0.341 0.246 -0.052 -0.043 
kpl 0.653 0.359 0.357 0.603 0.627 0.341 1.000 0.341 0.001 0.070 
kal -0.187 -0.456 0.331 0.010 -0.278 0.246 0.341 1.000 -0.713 0.497 
kap 0.373 0.888 -0.169 0.064 0.593 -0.052 0.001 -0.713 1.000 -0.519 
ke -0.300 -0.500 0.019 -0.303 -0.387 -0.043 0.070 0.497 -0.519 1.000 
 
Correlation matrix in Model 1.1 
 
umax_L umax_A Ksl Ksa kpl kal kap ke 
umax_L 1.000 0.887 0.937 0.962 0.746 -0.046 0.680 -0.211 
umax_A 0.887 1.000 0.858 0.899 0.859 0.313 0.797 -0.166 
Ksl 0.937 0.858 1.000 0.834 0.625 -0.097 0.696 -0.405 
Ksa 0.962 0.899 0.834 1.000 0.825 0.084 0.666 -0.179 
kpl 0.746 0.859 0.625 0.825 1.000 0.246 0.829 0.009 
kal -0.046 0.313 -0.097 0.084 0.246 1.000 0.031 0.247 
kap 0.680 0.797 0.696 0.666 0.829 0.031 1.000 -0.118 
ke -0.211 -0.166 -0.405 -0.179 0.009 0.247 -0.118 1.000 
 
Correlation matrix in Model 1.2 
 
umax_L beta_1 Ksl kpl kal kap ke 
umax_L 1.000 -0.149 0.776 -0.406 -0.593 0.031 -0.048 
beta_1 -0.149 1.000 0.294 0.477 0.551 0.582 0.014 
Ksl 0.776 0.294 1.000 -0.259 -0.412 0.300 -0.500 
kpl -0.406 0.477 -0.259 1.000 0.279 0.655 0.287 
kal -0.593 0.551 -0.412 0.279 1.000 -0.082 0.292 
. 
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kap 0.031 0.582 0.300 0.655 -0.082 1.000 -0.005 
ke -0.048 0.014 -0.500 0.287 0.292 -0.005 1.000 
 
Correlation matrix in Model 1.3 
 
beta_2 beta_1 kpl kal kap ke 
beta_2 1.000 -0.762 -0.558 -0.620 -0.514 0.535 
beta_1 -0.762 1.000 0.687 0.863 0.601 0.120 
kpl -0.558 0.687 1.000 0.365 0.865 0.050 
kal -0.620 0.863 0.365 1.000 0.216 0.104 
kap -0.514 0.601 0.865 0.216 1.000 0.049 
ke 0.535 0.120 0.050 0.104 0.049 1.000 
 
Correlation matrix in Model 2.1 
 
beta_2 beta_1 kal kap ke beta_3 beta_4 
beta_2 1.000 -0.704 -0.478 -0.431 0.411 -0.517 0.187 
beta_1 -0.704 1.000 0.643 0.624 0.342 0.689 -0.141 
kal -0.478 0.643 1.000 -0.058 0.110 0.003 -0.214 
kap -0.431 0.624 -0.058 1.000 0.292 0.849 0.112 
ke 0.411 0.342 0.110 0.292 1.000 0.231 0.026 
beta_3 -0.517 0.689 0.003 0.849 0.231 1.000 0.217 
beta_4 0.187 -0.141 -0.214 0.112 0.026 0.217 1.000 
 
Correlation matrix in Model 2.2 
 
beta_2 beta_1 kal kap ke beta_3 beta_4 beta_5 
beta_2 1.000 -0.690 -0.549 -0.243 0.466 -0.600 -0.271 0.461 
beta_1 -0.690 1.000 0.695 0.514 0.301 0.392 -0.098 -0.273 
kal -0.549 0.695 1.000 -0.029 0.069 0.311 0.104 -0.361 
kap -0.243 0.514 -0.029 1.000 0.351 0.011 -0.361 0.130 
ke 0.466 0.301 0.069 0.351 1.000 -0.246 -0.430 0.213 
beta_3 -0.600 0.392 0.311 0.011 -0.246 1.000 0.672 -0.936 
beta_4 -0.271 -0.098 0.104 -0.361 -0.430 0.672 1.000 -0.588 
beta_5 0.461 -0.273 -0.361 0.130 0.213 -0.936 -0.588 1.000 
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Correlation matrix in Model 3.1 
 
beta_2 beta_1 kal kap ke beta_3 beta_4 beta_5 beta_11 
beta_2 1.000 -0.486 -0.586 -0.234 0.621 -0.417 0.245 0.275 -0.432 
beta_1 -0.486 1.000 0.552 0.398 0.360 0.293 -0.515 0.003 -0.271 
kal -0.586 0.552 1.000 -0.042 -0.209 0.096 -0.338 -0.210 0.295 
kap -0.234 0.398 -0.042 1.000 0.075 0.308 -0.763 -0.152 0.129 
ke 0.621 0.360 -0.209 0.075 1.000 -0.174 -0.101 0.331 -0.806 
beta_3 -0.417 0.293 0.096 0.308 -0.174 1.000 -0.457 -0.852 0.187 
beta_4 0.245 -0.515 -0.338 -0.763 -0.101 -0.457 1.000 0.437 -0.204 
beta_5 0.275 0.003 -0.210 -0.152 0.331 -0.852 0.437 1.000 -0.432 
beta_11 -0.432 -0.271 0.295 0.129 -0.806 0.187 -0.204 -0.432 1.000 
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Text S2 Residual correlations in reconstructed models 
Model 
No. 
Residuals of 
biomass 
simulation 
Residuals of  
lactate 
simulation 
Residuals of  
acetate 
simulation 
Residuals of 
pyruvate 
simulation 
0 Correlated Correlated Correlated Correlated 
1.1 Correlated Correlated Correlated Correlated 
1.2 Correlated Correlated Correlated Correlated 
1.3 Non-correlated Correlated Correlated Correlated 
2.1 Correlated Correlated Correlated Correlated 
2.2 Correlated Correlated Correlated Correlated 
3.1 Non-correlated Non-correlated Non-correlated Correlated 
 
Note: the criteria for checking residuals correlations were following the counting-
number-of-runs method as described in the main content. The residuals were 
treated as correlated if the number of runs was smaller than value given by Eq 14 
in the main content.  
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Text S3 Parameters estimated by sequential analysis in the Parsimonious 
model 
Symbols Unit Value from OLS 
Value from Sequential 
analysis 
β1 h
-1
 
0.0773
[6][16][16](Tang 
et al., 2007)
 
0.0768
[6][16][16](Tang et al., 2007)
 
β2 L∙(h∙mmol lactate)
-1
 0.0070 0.0071 
β3 
mmol lactate∙ (h∙g 
DCW)
-1
 
18.8010 19.1150 
β4 mmol lactate∙L
-1
 1.6223 1.7057 
β5 L∙ (h∙g DCW)
-1
 -0.6916 -0.7078 
β11 
g DCW∙(h∙mmol 
lactate)
-1
 
0.0057 0.0058 
kal L∙ (h∙g DCW)
-1
 0.4672 0.4631 
kap L∙ (h∙g DCW)
-1
 2.5487 2.5951 
ke h
-1
 0.0063 0.0064 
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Abstract 
This study constructed an E. coli strain for isobutanol fermentation via the 
Ehrlich pathway, which included two genes from Lactococcus lactis: a kivd gene 
encoding 2-ketoisovalerate decarboxylase and an adhA gene encoding aldehyde 
reductase. We performed fermentation under aerobic and oxygen-limited 
conditions, and then built an empirical Monod model with 19 parameters to 
simulate glucose consumption, biomass growth, and product secretion and loss. 
Based on fermentation kinetics and 
13
C-isotopic experiments to analyze nutrient 
utilization for isobutanol and biomass synthesis, we had following findings. 1) 
Oxygen-limited conditions showed the highest isobutanol titer (0.95 g/L). 2) 
Isobutanol production took place during both growth and stationary phases 
(described by mixed-growth-associated product formation kinetics). 3) Aerobic 
condition had better isobutanol yield from glucose than oxygen-limited 
conditions. 4) Nutrient supplement (yeast extract) provided building blocks for 
both biomass and isobutanol synthesis, but it also enhanced the waste product 
secretion (such as acetate and lactate) and thus reduced glucose-based isobutanol 
yield. This study offered both metabolic insights and bioprocess guidelines for 
designing scaled-up isobutanol fermentation using engineered E. coli strains. 
 
Key words: 
13
C-isotopic experiment, Ehrlich pathway, Mixed-growth-associated, 
scaled-up bioprocess, yeast extract 
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Introduction 
Bioethanol produced by yeast fermentation is a common biofuel used as a 
gasoline additive. Other biofuels, such as butanol and biodiesels, have higher 
energy density and lower water solubility than ethanol, and thus receive extensive 
study. Among these biofuels, butanol is compatible with automotive internal 
combustion engines. Acetone-butanol-ethanol (ABE) fermentation is a bioprocess 
that uses Clostridium acetobutylicum to produce n-butanol [17], but such a 
process is restrained by a relatively low alcohol production rate during the 
anaerobic fermentation. To overcome this disadvantage, the n-butanol pathway 
derived from Clostridium has been reconstructed in fast-growing E. coli or yeast 
strains [18,19,20,21]. Butanol biosynthesis via Clostridium pathway has 
limitations including low product titer, accumulation of toxic metabolites, and the 
requirement of large nutrient supplements (such as yeast extract). Another novel 
approach is via the non-fermentative pathway to produce low-toxicity isobutanol 
[22], where the amino acid biosynthesis pathways and the Ehrlich pathway 
[23,24] are utilized for alcohols synthesis. The non-fermentative pathway was 
previously found in yeast and lactic acid bacteria, which form fuel alcohols from 
intermediates in amino acids pathways [23]. A non-fermentative pathway, with 
ketoisovalerate as the central intermediate, has shown promising industrial 
potential for effective isobutanol production.  
. 
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Diverse butanol production strategies have been reported (Table 1), 
including overexpression of targeted pathway, elimination of competing 
pathways, systems redesign of host metabolism, and in situ removal of inhibitory 
products using gas stripping. However, very few studies have developed process 
models to study the kinetics of engineered microbial platform for butanol 
fermentation. To apply a newly developed host in the biofuel industry, a kinetic-
based model is of practical importance not only for designing optimal scaled-up 
fermentation, but also for understanding the internal metabolic features of 
microbial hosts in responses to various nutrient sources and cultivation 
conditions. To fulfill the gap between microbial strain reconstruction and 
industrial bioprocess engineering, we have first created an E. coli mutant that is 
able to produce isobutanol via the standard non-fermentative pathway. The model 
strain provided isobutanol fermentation data from a well-controlled bioreactor 
under different cultivation conditions. Based on the experimental data, we 
developed an empirical model to simulate the key bioprocess variables and 
investigate the influential factors affecting isobutanol fermentation. To provide 
metabolic insights into the kinetic model,
 13
C-experiments were also performed to 
investigate the nutrient utilization for biomass and isobutanol synthesis.    
Materials and Methods 
Pathway construction 
. 
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The non-fermentative isobutanol pathway was introduced into E. coli 
BL21 (DE3) (Fig. 1), in which glucose was converted to 2-ketoisovalerate via 
glycolysis and valine biosynthesis pathway, and then transformed to isobutanol by 
the Ehrlich pathway. Via heterologous expression of Kivd (2-ketoisovalerate 
decarboxylase) and AdhA (aldehyde reductase), the E. coli strain can produce 
isobutanol as well as other higher alcohols. In this study, kivd and adhA were 
amplified from Lactococcus lactis by PCR with high fidelity DNA polymerase 
Pfx (Invitrogen).  
Primers for kivd:  
5’-GACACTCGAGTAATGTATACAGTAGGAGATTAC-3’; 
 5’- TGCGGGTACCTTATGATTTATTTTGTTC-3’.  
Primers for adhA:  
5’-
TCAACTAGTGGTACCAGGAGATATAATATGAAAGCAGCAGTAGTAAG
AC-3’;  
5’- ATTTGCGGCCGCGCATGCTTATTTAGTAAAATCAATGAC-3’.  
The genes kivd (treated with XhoI / KpnI) and adhA (treated with KpnI / 
SphI) were cloned into pTAC-MAT-Tag-2 Expression Vector (Sigma-Aldrich) 
using XhoI / SphI to create the plasmid pTAC-KA, and then transformed into E. 
. 
455 
 
coli BL21 (DE3). To confirm the expression of Kivd and AdhA, we performed 
SDS-PAGE analysis of the recombinant strain and observed the protein bands of 
Kivd (60.9 kDa) and AdhA (30.8 kDa). Moreover, the measurement also showed 
that the strain synthesized isobutanol, acetate, lactate, ethanol, and a small amount 
of n-propanol and methyl-butanol. Therefore, the host had similar product profiles 
to other isobutanol producing E.coli strains [22], and thus could be used as a 
model to study the general kinetic behaviors of engineered E.coli for isobutanol 
fermentation.  
Fermentation conditions  
Fermentations were performed in a 1 L New Bruswick Bioflo 110 
fermentor with dissolved oxygen (DO) electrode, temperature electrode, and pH 
meter.  The 100% DO value was defined as the point where the cell-free medium 
was saturated and achieved by purging air (~2 L/min) for 15 minutes. The culture 
reached 0% DO in the oxygen limited condition (air rate 0 L/min) after the cell 
had consumed the residual oxygen in the culture. Two culture media were used in 
this study: A minimal medium contained 2% glucose, M9 salts (Difco), 10 mg/L 
vitamin B1, and 50 mg/L ampicillin; a rich medium contained minimal medium 
with 5 g/L yeast extract. The culture (400 mL) was inoculated with 5 ml overnight 
LB culture (OD600~2) of the recombinant E. coli strain. The pH value, measured 
by the pH meter, was maintained around 7.0 by addition of 2 mol/L NaOH via an 
auto-pump. The temperature was held at 30 °C and the stirring speed was kept at 
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200 rpm. Cultures in the bioreactor were first grown for 5~7 hours under aerobic 
conditions (OD600 0.3~0.5; DO>50%), before adding 0.2 mM IPTG (Isopropyl β-
D-1-thiogalactopyranoside) to induce the isobutanol pathway. 
After the E. coli entered the isobutanol production phase, we imposed 
three different fermentation conditions. The first fermentation (F1: aerobic 
condition and minimal medium) was carried out in aerobic condition. Air (airflow 
rate: ~1 L/min) was bubbled in the bioreactor to provide oxygen and to remove 
isobutanol (i.e., gas stripping) from bioreactor. In the second fermentation (F2: 
oxygen-limited condition and minimal medium), air was turned off and the DO 
was maintained around zero throughout the fermentation in a closed bioreactor. In 
the third fermentation (F3: oxygen-limited condition and rich medium containing 
5 g/L yeast extract), air was turned off and the DO was maintained around zero 
for the duration of the fermentation in a closed bioreactor.  
Analytical methods for biomass and metabolites 
The biomass growth was monitored based on optical density (OD600). 
There was a linear relationship between the dry weight of E. coli cells and OD600. 
To measure the dry biomass weight, biomass samples were harvested by 
centrifugation and washed with DI water and dried at 100
°
C until their weight 
remained constant. The concentrations of glucose, ethanol, acetate, and lactate 
were measured using enzyme kits (R-Biopharm). The alcohols could be detected 
using GC (Hewlett Packard model 7890A, Agilent Technologies, equipped with a 
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DB5-MS column, J&W Scientific) and a mass spectrometer (5975C, Agilent 
Technologies). The GC-MS spectrum revealed that alcohols in the culture 
samples were mainly ethanol and isobutanol. We also detected small amounts of 
propanol and methyl-butanols. Isobutanol concentration was determined by a 
modified GC-MS method [19]. Briefly, 400 µl of supernatant was extracted with 
400 µl of toluene (Sigma-Aldrich) by 2-min vortex, followed by high-speed 
centrifugation (16000×g). The organic layer was taken for GC-MS analysis under 
the following program: hold at 70 °C for 2 min, ramp to 230 °C at 20 °C min
-1
, 
and then hold at 300 °C for 6 min. The carrier gas was helium. The MS scan 
mode was from m/z 20 to 200. Samples were quantified relative to a standard 
curve of 16, 32, 64, 125, 250, 500, and 1000 mg/L isobutanol for MS detection, 
and methanol was taken as an internal standard. 
13
C-experiments for analyzing carbon substrates 
In the 
13
C-experiments, the minimal medium with 2% fully labeled 
glucose (U-
13
C, Cambridge Isotope Laboratories) was supplemented with either 
0.1% or 0.5% yeast extract (Bacto). By measuring 
13
C-abundance in key 
metabolites, we could estimate the contribution of yeast extract (non-labeled) to 
biomass and isobutanol synthesis in the 
13
C-glucose medium. Specifically, 5 mL 
cultures (with 
13
C-glcuose and yeast extract)
 
were inoculated with 5 µl of 
overnight LB culture of engineered strain in a 50 mL falcon tube with a closed 
cap to prevent product vaporization (shaking at 200 rpm, 30°C). The cultures 
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were induced by 0.2 mM IPTG (at t=7 hours), and the samples were taken (at 
t=24 hours, middle-log growth phase) for isotopomer analysis. The isobutanol 
content was determined using the previously described GC-MS procedure [19]. 
The ratio of two mass-to-charge peaks (m/z=74 for unlabeled isobutanol and 
m/z=78 for labeled isobutanol) corresponded to the ratio of isobutanol synthesized 
from unlabeled yeast extract vs. labeled glucose. Concurrently, we also performed 
isotopic analysis of proteinogenic amino acids to identify the incorporation of 
unlabeled carbon from yeast extract into biomass (i.e., protein). The 
measurements were based on a previously published GC-MS based protocol [25], 
using TBDMS (N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide, Sigma-
Aldrich) to derivatize hydrolyzed amino acids from the biomass. The m/z ions 
[M-57]
+
 from unfragmented amino acids were used for analysis [26] except 
leucine and isoleucine. Because the [M-57]
+
 in leucine and isoleucine overlap 
with other ions, the [M-159]
+
 group was used to obtain the isotopomer labeling 
information of leucine and isoleucine. 
Model formulation 
We developed a Monod-based kinetic model, with six ordinary differential 
equations, to describe three different batch fermentation processes. Here, we 
should emphasize that the model only describe the fermentation data after IPTG 
induction (i.e., the E. coli strain entered into the butanol production phase).  
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The model contained six time-dependent process variables:  X, ACT, 
LACT, EtOH, IB, and Glu, which represented the concentrations (g/L) of biomass, 
acetate, lactate, ethanol, isobutanol, and glucose, respectively. In the above 
equations, kd was the cell death rate; YAL was the acetate yield from lactate (equal 
to 0.67 g ACT/g LACT, based on a 1:1 mol ratio); YXG, YAG, YEG, YLG, and YIG were 
the glucose-associated yields of biomass, acetate, ethanol, lactate, and isobutanol, 
respectively. kIB was the first-order removal rate of isobutanol due to gas stripping 
under aerobic fermentation F1. The isobutanol loss was minimal in a closed 
bioreactor during oxygen-limited fermentations (kIB was equal to zero). Under 
oxygen-limited conditions (i.e. F2 and F3), we used a first-order kinetic parameter 
(kact) to describe acetate production from lactate. 
X
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Equations 7 represented a Monod-based growth kinetics. Since acetate 
inhibited E. coli growth by decreasing the intracellular pH and interfering with 
enzyme reactions, a non-competitive inhibition KiA (assumed to be constant in F1, 
F2 and F3) was included in the model [27]. The dependence of the growth rate on 
oxygen necessitates (i.e., aerobic growth vs. anaerobic growth) was implicitly 
included in the calculation of the apparent maximal growth rate, μmax,app, (i.e., the 
oxygen conditions affected μmax,app in different fermentation process). The Monod 
constant KS was set to be constant for all three cultures (F1, F2 and F3). Equations 
8~11 simulated the extracellular metabolite production associated with biomass 
growth. RX, RA, RE, RL, and RIB were the production rates of biomass, acetate, 
ethanol, lactate, and isobutanol from glucose, respectively; αAX, αEX, αLX, and αIBX 
were the growth-associated coefficients of acetate, ethanol, lactate, and isobutanol 
productions, respectively. β was the non-growth associated isobutanol production 
coefficient. For experiments using rich medium (F3), the isotopic experiments 
indicated that the yeast extract was quickly consumed to support biomass growth 
at the early stage of the fermentation. Since precise measurement of yeast extract 
concentrations was difficult, we included a yeast-extract-associated biomass 
 
(8) 
(9) 
(10) 
(11) 
(12) 
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growth rate (RX,YE) using a two-parameter exponential decay function (Equation 
12). Table 2 summarized model parameters and their units. 
For each batch culture, 18 unknown model parameters were determined by 
minimizing the sum of the squares of the differences between the model’s 
predictions and the experimentally observed growth and metabolite profiles (data 
after IPTG induction) [28]. The “ode23” command in MATLAB (R2009a, 
Mathworks) solved differential equations, while the “fmincon” command 
searched suitable values of parameters. To avoid having local solutions during the 
nonlinear parameter estimation, we perturbed the initial guesses for 30 times 
within the range of possible values (as observed experimentally) to identify the 
global solution. Meanwhile, to narrow the search-range for reasonable parameters, 
we assumed that the values of each parameter acquired from different 
fermentations differed by less than one order of magnitude. 
To evaluate the quality of the parameter estimates, a statistical analysis 
checked the reliability and the sensitivity of the estimated parameters to the 
measurement inaccuracies. Fifty simulated fermentation data sets (including both 
biomass and metabolite data) were generated by addition of normally distributed 
noise to the measured fermentation data set (i.e., randomly perturbed the 
measured data by 30%). The same data-fitting algorithm found new sets of 
parameters. From the probability distribution of these parameter distributions, 
confidence limits of model-fitted parameters were estimated. 
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Results and discussion 
Isobutanol fermentation results  
We engineered an E. coli strain which was used as a model to study 
isobutanol fermentation kinetics. The isobutanol pathway of the strain was in 
Fig.1. The key precursor, 2-ketoisovalerate (KIV), is also an intermediate of 
valine biosynthesis and degradation pathways. When E. coli converts one mole of 
glucose to two moles of pyruvate through glycolysis, it generates two moles of 
NADH, whereas the isobutanol synthesis consumes one mole of NADPH by keto-
acid reductoisomerase and one mole of NADH by aldehyde reductase. To keep 
balance, the cell metabolism has to remove the redundant NADH by O2 
oxidization (aerobic condition) or by synthesis of reduced metabolites (leading to 
lactate and ethanol secretion). In the F1 (Fig. 2), ethanol and lactate were barely 
detected. Isobutanol concentration only reached (0.2 g/L), and the in situ removal 
of isobutanol was considerable since the airflow carried isobutanol out of the 
fermentor. Such gas stripping has been reported as an effective strategy to avoid 
the isobutanol accumulation in the bioreactor to cause inhibitory effect on alcohol 
production [29].   
In the oxygen-limited conditions (Fig. 3 & 4), the F2 generated 0.95 g/L 
isobutanol, 1.5 g/L ethanol, 2 g/L acetate, and 5 g/L lactate, while the lactate was 
reused in the late fermentation stage (stationary growth phase). With the addition 
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of yeast extract, the F3 had fast biomass growth (Fig. 4). The cell density reached 
the peak (2 g DCW/L biomass) after seven hours of IPTG induction, and glucose 
was consumed within ~12 hours (compared to ~40 hours in the F1 and F2). The 
high rates for biomass growth and glucose uptake promoted isobutanol production 
rate. It took the F3 15 hours to generate 0.6 g/L isobutanol (it took F2 40 hours to 
generate same amount of isobutanol). The F3 produced 0.7 g/L isobutanol and 2.0 
g/L ethanol. The addition of yeast extract also resulted in a large amount of 
growth-associated organic acids (6.0 g/L lactate and 3.6 g/L acetate).  
Kinetic modeling of isobutanol fermentation   
The kinetic model simulated biomass growth, isobutanol production, and 
metabolic byproduct (lactate, ethanol, and acetate) secretion and reuse in all three 
culture conditions. Here, we should emphasize that all data points in Fig. 2~4 
were after IPTG induction (i.e., cell entered isobutanol production metabolic 
status). Table 2 listed the kinetic parameters, where the maximal glucose-based 
cell growth rate μmax,app (0.007~0.026 h
-1
) in the anaerobic culture conditions was 
lower than that in the aerobic culture condition (0.051 h
-1
). To simulate the 
influence of yeast extract on alcohol fermentation, the Monod growth equation 
included a yeast-extract associated biomass growth rate (μmax,YE=0.44 hr
-1
) that 
was more than one order of magnitude higher than glucose-associated growth 
rates.  
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As for the intrinsic biomass yield YXG, YXG (0.18) under aerobic condition 
was higher than that in the anaerobic condition F2 (0.11). Aerobic fermentation 
produced less extracellular waste metabolites, while the citric acid cycle in cell 
metabolism was highly active to provide energy and building blocks for biomass 
and butanol synthesis. Isobutanol was produced in both aerobic and oxygen-
limited conditions. The growth (αIBX) and non-growth (β) associated isobutanol 
production coefficients were both positive, indicating the isobutanol production 
took place during both growth and stationary phases. Although cell metabolism 
shared the same pathway for synthesizing both biomass building block (valine) 
and isobutanol, this pathway was still functional after biomass growth stopped. 
The theoretical isobutanol yield from glucose is 0.41 g isobutanol/g glucose. In 
this study, coefficient YIG under aerobic condition was 0.25 g isobutanol/g 
glucose, which was higher than anaerobic conditions. For anaerobic condition F2, 
non-growth associated isobutanol production β was ~0.11 (g isobutanol/g biomass 
∙ h), while aerobic condition F1 showed much smaller non-growth associated 
productivity (β ~0.002 g isobutanol/g biomass ∙ h). For anaerobic condition F3, 
the addition of yeast extract significantly improved the growth associated 
isobutanol production (αIBX = 0.91 g isobutanol/g biomass), but it also generated 
significantly more acetate, lactate and ethanol. The yield coefficients associated 
with waste products (YAG, YEG, YLG) were all the highest in the F3. Although the 
addition of nutrients improved the biomass growth and cell energy (such as 
NADH) generation, the NADPH-dependent valine synthesis pathway could not 
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utilize NADH to produce isobutanol precursors (Figure 1). The excessive NADH 
from fast cell metabolism had to be redirected to waste extracellular metabolites. 
To alleviate such co-factor imbalance, an NADH-dependent keto-acid 
reductoisomerase or transhydrogenase PntAB could be used to consume NADH 
for isobutanol synthesis [30]. 
Analysis of the role of yeast extract for isobutanol synthesis 
Nutrient supplements often plays important role in improving fermentation 
performance. Rich media have been commonly used for butanol fermentations 
[19,21,22,31]. In addition to providing the building blocks for biomass growth, it 
has been reported that E. coli can also utilize the Ehrlich pathway to convert 
protein hydrolysates to higher alcohols by engineering nitrogen flux [32]. To 
reveal the contribution of nutrient to biomass and isobutanol production during 
the cell growth stage, we used 
13
C-experiemnts to determine the ratio of carbon 
utilization from two different sources (nonlabeled yeast extract vs. fully labeled 
13
C-glucose) under oxygen limited condition via GC-MS analysis (Fig. 5). When 
yeast extract was minimal (1 g/L), isobutanol mostly came from labeled glucose 
in the medium (isobutanol was all labeled with four carbons, m/z=78), and yeast 
extract mainly supported biomass growth. In the more nutrient-rich medium, yeast 
extract (5 g/L, commonly used for biobutanol production) provided major 
building blocks for cell growth. Based on the labeling data, proteinogenic amino 
acids (histidine, leucine, isoleucine, valine, lysine, and proline) in the biomass 
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protein were highly imported from exogenous amino acids  (>95%, corresponding 
to the 
12
C-dilutions), while other proteinogenic amino acids (alanine and serine) 
were largely synthesized from 
13
C-glucose (50~60%). Furthermore, high 
concentration of yeast extract (5g/L) provided the precursors (i.e., keto-acids from 
exogenous amino acid degradation pathway) for production of alcohols (non-
labeled isobutanol ~ 50%). A similar observation was also found in the glucose-
labeled medium supplemented with Lysogeny broth (LB) powder (data not 
shown). These results implied that the nutrient supplements provided building 
blocks for both biomass and isobutanol synthesis in the glucose-based culture 
medium. However, nutrient addition may not enhance butanol yields from its 
main carbon source (glucose) due to higher waste metabolite production.    
Concluding remarks  
This study developed an empirical Monod model for capturing the 
influential process factors during isobutanol fermentation using an engineered E. 
coli strain. The model strain shared common kinetic features with other reported 
isobutanol producers. These features included similar biomass growth behavior 
and generation of multiple-metabolites, such as acetate, ethanol, and isobutanol. 
The model results implied that byproducts were deleterious to isobutanol 
synthesis (which could be the genetic targets for future improvement). Nutrients 
(such as yeast extract) increased the production rates for both alcohols and 
organic acids, but reduced isobutanol yields. The kinetic model may not only 
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provide guidelines for controlling isobutanol fermentation conditions, but also 
serve as a springboard to develop useful bioprocess models for higher alcohols 
fermentations in the biotechnology industry.   
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Table 1. Recent studies on butanol production by genetically engineered 
microorganisms 
 
Products Substrate Host cell Titer Research Highlights Ref 
Isobutanol Glucose E. coli 22 
g/L 
Introduction of a non-fermentative 
pathway to produce isobutanol; 
elimination of competing pathways to 
reduce waste metabolite secretion 
[22] 
Isobutanol Glucose E. coli 50 
g/L 
In situ isobutanol removal from the 
bioreactor using gas stripping 
[29] 
Isobutanal CO2 Synechococcus 
elongatus 
1.1 
g/L 
Overexpression of both non-
fermentative pathway and Rubisco for 
autotrophic isobutanol production 
[33] 
Isobutanol Cellulose Clostridium 
cellulolyticum 
0.66 
g/L 
Direct conversion of cellulose to 
isobutanol using engineered 
cellulolytic bacterial species 
[34] 
Isobutanol Glucose E. coli 1.7 
g/L 
A strain optimized for isobutanol 
production via elementary mode 
analysis  
[35] 
Isobutanol Glucose E. coli 13.4 
g/L 
Utilization of the NADH-dependent 
enzyme to enable anaerobic 
isobutanol production 
[30] 
Isobutanol 
 
Amino 
acids 
E. coli ~1g/L        
 
 
Utilization of protein hydrolysates for 
C4 and C5 alcohols synthesis by 
introducing enzymes for exogenous 
transamination and deamination 
cycles to biobutanol producing strains 
[32] 
n-Butanol Glucose E. coli 1 g/L 
 
A strain engineered for 1-butanol and 
1-propanol production via isoleucine 
biosynthesis pathway 
[36] 
n-Butanol Galactose Saccharomyces 
cerevisiae 
2.5 
mg/L 
Overexpression of n-butanol pathway 
derived from Clostridium  
[21] 
n-Butanol Glucose E. coli 4.6 
g/L 
Increase of the barrier for the reverse 
reaction of butyryl-CoA to crotonyl-
CoA via trans-enoyl-CoA reductase 
[19] 
n-Butanol Gluocse E. coli 30 
g/L 
Construction of butanol pathway by 
employing trans-enoyl-CoA reductase 
and creating NADH & acetyl-CoA 
driving forces 
[20] 
n-Butanol CO2 Synechococcus 
elongatus 7942 
14.5 
mg/L 
 
Anaerobic production of 1-butanol 
from CO2 using CoA-dependent 
butanol pathway 
[37] 
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Table 2. Parameters of Monod kinetic model for E. coli isobutanol 
fermentation 
Symbo
l 
Notations Units 
Aerobic,  
condition F1 
Anaerobic,  
condition F2 
Anaerobic,  
condition F3 
KS Monod parameter for Glu g/L  
0.30±0.08 a  
KiA Inhibition of acetate for growth g/L  
26±5 a  
μmax,app Maximal growth rate with glucose /h 0.051±0.005 
0.0070±0.002
0 
0.026±0.004 
YXG Intrinsic biomass yield from Glu 
g 
biomass/g 
glucose 
0.18±0.03 0.11±0.01 0.23±0.03 
YAG Acetate yield from Glu 
g acetate/g 
glucose 
0.08±0.01 0.08±0.01 0.39±0.03 
YEG Ethanol yield from Glu 
g ethanol/g 
glucose 
NA 0.27±0.01 0.46±0.03 
YLG Lactate yield from Glu 
g lactate/g 
glucose 
NA 0.60±0.02 0.85±0.06 
YIG Isobutanol yield from Glu 
g 
isobutanol/
g glucose 
0.25±0.05 0.03±0.00 0.18±0.02 
αAX Growth associated acetate synthesis 
g acetate/g 
biomass 
0.62±0.02 0.29±0.03 2.8±0.3 
αEX Growth associated ethanol synthesis 
g ethanol/g 
biomass 
NA 6.7±1.0 3.2±0.3 
αLX Growth associated lactate synthesis 
g lactate/g 
biomass 
NA 26±4 11±2 
    αIBX Growth associated isobutanol synthesis 
g 
isobutanol/
g biomass 
0.57±0.04 0.10±0.01 0.91±0.12 
YAL Acetate yield from lactate 
g acetate/g 
lactate 
NA 0.67 0.67 
kd Cell death rate /h 0.010±0.002 
0.0010±0.000
5 
0.0087±0.000
7 
kIB gas stripping rate coefficient for isobutanol /h 0.11±0.02 NA NA 
kact First-order acetate production from lactate 
(h∙g 
biomass/L)
-1 
NA 0.012±0.001 
0.0022±0.000
3 
kYE Yeast extract first-order decay rate  /h NA NA 0.55±0.04 
μmax,YE 
Apparent maximal growth rate with yeast 
extract 
/h NA NA 0.44±0.05 
β 
Non-growth associated isobutanol production 
rate 
(g isobutanol)/( g 
biomass∙h) 
0.0021±0.001
7 
0.011±0.001 
0.0038±0.000
6 
 
 
a): assuming same value for all three fermentations. 
Glu: glucose; NA: not applicable.
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Figure legend 
Figure 1. Pathways and kinetics for isobutanol and metabolites production in 
the recombinant E. coli BL21 (DE3)/pTAC-KA. RX, RX,YE, RA, RE, RL, and RIB 
were shown in the Equation 1~12. Abbreviations: G6P, glucose 6-phosphate; 
F6P, fructose 6-phosphate; G3P, glyceraldehydes 3-phosphate; PYR, pyruvate; 
ACA, acetyl-CoA; ALA, 2-acetolactate; DHI, 2,3-dihydroxy-isovalerate; KIV, 2-
keto-isovalerate; Val, valine; IBA, isobutanal; NADH, reduced nicotinamide 
adenine dinucleotide; NADPH, reduced nicotinamide adenine dinucleotide 
phosphate; PP pathway, pentose phosphate pathway; TCA cycle,  tricarboxylic 
acid cycle; Kivd, 2-keto-isovalerate decarboxylase; AdhA, aldehyde reductase. 
Figure 2: Growth kinetics of aerobic culture after IPTG induction (condition F1). 
The dots were experimental measurements, and the solid lines are simulations 
from the Monod kinetic model. 
Figure 3: Growth kinetics of anaerobic culture after IPTG induction (condition 
F2). The dots are experimental measurements, and the solid lines are simulations 
from the Monod kinetic model. 
Figure 4: Growth kinetics of anaerobic culture with 0.5% yeast extract after IPTG 
induction (the F3 includes two replicated cultivation experiments). The dots were 
experimental measurements, and the solid lines were simulations from the Monod 
kinetic model. 
. 
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 Figure 5. The fraction of 13C carbon (13C carbons/total carbons) in each 
metabolite. The fraction of 
13
C carbon represents the contribution of labeled 
glucose to metabolite synthesis.  The cells were grown on M9 medium (Difco), 
containing 20 g/L fully labeled 
13
C-glucose, with 1 g/L (black bar) or 5 g/L (gray 
bar) nonlabeled yeast extract. All samples were taken at 24 hrs (n=2, GC-MS 
standard errors < 2%). 
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Fig. 3 
 
 
 
 
 
 
. 
477 
 
Fig. 4 
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Appendix 11       
Evaluating Factors That Influence Microbial Synthesis Yields by 
Linear Regression with Numerical and Ordinal Variables 
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Appendix 12       
Bacterial Responses to Cu-doped TiO2 Nanoparticles 
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